Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.6874136616181573,2.0681991647223636,0.0,0.030873533569013886,0.03,16/29,17.65%,GRIA4;GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GABRB3;GRID1;GRIK1;GABRA5;CHRNB1;GLRA3;GABRB1;GABRG1;GABRG3;GABRG2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.8094841514247659,2.0392241179718753,0.0,0.0293796529124487,0.056,3/13,1.32%,BMP6;BMP2;BMP5
prerank,BMP receptor binding (GO:0070700),0.8094849711325268,2.013433972612798,0.0,0.0315374805274873,0.083,3/12,1.32%,BMP6;BMP2;BMP5
prerank,vinculin binding (GO:0017166),-0.8292172411606896,-2.0125203862805483,0.0,0.024086096371582974,0.022,6/11,6.61%,UTRN;SORBS3;DMD;PXN;CTNNA1;ACTN1
prerank,ligand-gated channel activity (GO:0022834),0.6560769367976035,1.9997171854096993,0.002183406113537118,0.03037557335015882,0.107,14/29,14.41%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;CHRNA4;GRIA3;CHRNB1;GRIN2A;GABRB1;GRIA1
prerank,ligand-gated ion channel activity (GO:0015276),0.6502364867641747,1.9910146207229895,0.002207505518763797,0.02768658816834148,0.121,14/30,14.41%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;CHRNA4;GRIA3;CHRNB1;GRIN2A;GABRB1;GRIA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6670798996403323,1.9899877613007542,0.0,0.023570117025806296,0.124,15/28,17.65%,GRID2;CHRNA1;GABRA2;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNA4;CHRNA7;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7701522654749062,1.9733462365228756,0.0,0.024471187898020223,0.145,5/15,9.48%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1;ALDH1L1
prerank,cadherin binding (GO:0045296),-0.42728937658701105,-1.966388852826472,0.0,0.028100445766846803,0.047,144/315,25.92%,DOCK9;PTPRB;PKP4;COBLL1;MRTFB;ITGA6;AHNAK;BSG;STXBP6;CDH1;NOTCH3;PTPRJ;PROM1;BAIAP2L1;TMOD3;SPTBN1;ESYT2;WASF2;RPL6;FNBP1L;RACK1;BMPR2;F11R;KDR;FXYD5;CTNNA1;IQGAP1;EEF2;EHD4;CLIC1;PLCB3;TJP2;ANXA1;DAB2IP;CD2AP;TRIM25;EPS8L2;HSP90AB1;PDLIM1;MPRIP;ARHGAP1;RPL14;ANXA2;PAICS;TES;HSPA8;SHTN1;ATXN2L;CAST;PTPRM;LRRFIP1;CDH4;CHMP2B;EZR;PKM;RPL23A;GIPC1;PFKP;HCFC1;RPL29;JUP;RPL34;EEF1D;NOP56;UBAP2;USP8;SPTAN1;PFN1;ADD1;CTNNA3;VCL;LDHA;ZC3H15;CDH6;TRPC4;HSPA5;SH3GLB2;RAB11B;DBNL;STK38;ACVR1;LASP1;DBN1;YWHAZ;PLIN3;ABI1;TAGLN2;RPL15;SLC3A2;EPN2;RAB1A;EGFR;HNRNPK;EPHA2;RPL24;STAT1;TXNDC9;PPFIBP1;IST1;HSPA1A;PCBP1;GIGYF2;CCS;EIF5;BZW2;RPS26;TBC1D2;EHD1;RANGAP1;CAPG;GLOD4;CCT8;CTTN;SERBP1;PACSIN2;NCK1;SFN;CDH5;PPP1CA;BZW1;PTPRO;STX5;DNAJB1;CNN3;PTPN1;ENO1;MYH9;RSL1D1;ARHGAP18;ANLN;NUMB;YWHAB;FSCN1;LRRC59;RPL7A;TJP1;EVPL;CIP2A;EPS15;YWHAE;EIF4H;UBFD1;RDX;PARK7
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7078867136630104,1.949495431504622,0.00205761316872428,0.029753123076589994,0.195,12/19,17.65%,GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.7056572500853895,1.9264371406287235,0.006550218340611353,0.038508923591458175,0.26,5/18,5.36%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;ALDH6A1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7761227379788922,1.9215872193884171,0.0,0.03704824028281666,0.275,5/13,9.48%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1;ALDH1L1
prerank,glutamate receptor activity (GO:0008066),0.6985667559263198,1.909191519149477,0.0021645021645021645,0.04164758194060524,0.336,9/19,14.41%,GRIA4;GRID2;GRIK5;GRIK2;GRM1;GRID1;GRIK1;GRM4;GRIA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7134876457967777,1.8247703996049345,0.0022123893805309734,0.10648049346517423,0.69,2/14,0.06%,SLC7A11;SLC1A3
prerank,voltage-gated calcium channel activity (GO:0005245),0.5595512655870858,1.8208314433327089,0.0022935779816513763,0.10204354023306822,0.706,9/37,8.22%,CACNA2D3;CACNA1E;CACNA2D1;CACNA1I;CACNG4;CACNA1G;CACNB4;CACNB2;CACNB1
prerank,ephrin receptor activity (GO:0005003),0.6678721251361243,1.8199253227507126,0.004366812227074236,0.08910168182713255,0.708,8/17,12.88%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6678721251361243,1.8199253227507126,0.004366812227074236,0.08910168182713255,0.708,8/17,12.88%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,amino acid:sodium symporter activity (GO:0005283),0.7617309423686447,1.818254547635491,0.009259259259259259,0.08546242256100013,0.718,6/11,9.33%,SLC1A3;SLC6A12;SLC6A13;SLC38A1;SLC6A11;SLC6A1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.5156356254659469,-1.8180606370314756,0.0,0.1759623151590645,0.363,35/57,28.25%,COX4I1;NDUFV2;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;UQCRQ;COX15;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;CYBRD1;NDUFC1;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFA4L2;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;CYB561D2;NDUFA8
prerank,protein phosphatase 1 binding (GO:0008157),-0.6350863317608447,-1.8174969719428997,0.0017857142857142857,0.13247353004370638,0.364,11/21,24.04%,PPP1R3B;PPP1R16B;SHOC2;KCNQ1;SH3RF2;PHACTR4;PPP1R3F;PPP1R3C;PPP1R16A;PPP1R3E;SMTNL2
prerank,double-stranded RNA binding (GO:0003725),-0.48520797458464016,-1.816307860860676,0.0,0.10858815114188657,0.374,22/70,14.18%,VIM;MBNL1;IFIH1;STRBP;TFRC;HSP90AB1;MSN;ADAR;LRRFIP1;ACTN1;TLR3;DUS2;RC3H1;DHX15;DHX9;HSPD1;DHX58;ILF2;TUBB4B;FMR1;SLC3A2;EIF4A1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6652148139447169,-1.8019823702809679,0.0,0.11173272483484323,0.438,6/18,4.62%,STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;ANXA2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.6464378501524514,1.7964887355262067,0.008602150537634409,0.09935770955037485,0.777,8/21,13.02%,CHRNA1;P2RX4;CHRNB4;GRIK2;GLRB;CHRNA4;CHRNA7;CHRNB1
prerank,phospholipid transfer activity (GO:0120014),-0.6336937403158895,-1.7885903766345503,0.0,0.114695697007538,0.488,8/21,14.03%,PITPNC1;CERT1;PLTP;TNFAIP8L3;PITPNA;PITPNM2;PRELID2;PITPNM1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6182091354143967,1.773972043804425,0.008547008547008548,0.11657802012529078,0.849,8/21,14.41%,CHRNA1;CHRNB4;GRM1;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1;GRIA1
prerank,lipase activator activity (GO:0060229),0.7617005893717905,1.7562547184162496,0.009111617312072893,0.13104216285659542,0.886,3/10,2.26%,ARHGAP6;APOH;PDPK1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5486197700504084,-1.7230495181648813,0.0,0.19558802331368766,0.777,22/34,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5486197700504084,-1.7230495181648813,0.0,0.19558802331368766,0.777,22/34,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,rRNA binding (GO:0019843),-0.5060568136443345,-1.722206874140004,0.0036231884057971015,0.17733388453577964,0.779,21/42,23.22%,RPS14;RPS9;RPS3;RPL11;RPL23;RPS5;CAVIN1;RPS13;PTCD3;ERI1;RPL12;CIRBP;PPAN;ERAL1;MRPL16;EMG1;MRPS18C;MRPS18A;RPL5;MRPS6;MRPL11
prerank,calcium:sodium antiporter activity (GO:0005432),0.7241976203162482,1.7171639430871968,0.015021459227467811,0.17896690265650952,0.951,5/10,8.94%,SLC24A3;SLC8A1;SLC24A5;SLC24A4;SLC24A2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7219143701861379,-1.7052117851915274,0.012433392539964476,0.19515212173793936,0.835,4/10,1.27%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.7290807178925489,1.688493951171579,0.01160092807424594,0.21597246063485287,0.976,5/10,9.33%,SLC6A12;SLC6A13;SLC10A1;SLC6A11;SLC6A1
prerank,GABA-A receptor activity (GO:0004890),0.6348090650358053,1.6830601831401817,0.02575107296137339,0.2164316187587322,0.978,9/18,17.65%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2
prerank,acetylcholine receptor activity (GO:0015464),0.5893967134742997,1.680819348082546,0.024830699774266364,0.21161144256910358,0.979,8/22,13.02%,CHRNA1;CHRNB4;CHRM2;CHRM3;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.715748950910001,-1.6785352849859312,0.005263157894736842,0.23584302697174994,0.905,6/11,18.52%,MAP3K5;MAP3K1;MAP3K20;TAOK2;EGFR;MAP3K6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4792158548852837,1.6570460827199558,0.015086206896551725,0.24225764647298798,0.99,21/53,15.98%,SLC7A11;SLC1A3;SLC6A9;SLC43A1;SLC7A2;SLC38A1;SLC36A2;SLC7A9;SLC25A13;SLC1A5;SLC38A3;CTNS;SLC38A9;SLC25A15;OCA2;SLC1A2;SLC38A6;SLC7A3;SLC1A7;SLC3A1;SLC25A18
prerank,protein phosphatase binding (GO:0019903),-0.40621397767451795,-1.6548391440907948,0.0040650406504065045,0.27606371995122025,0.94,43/117,18.76%,MAP3K5;ITGA1;CTTNBP2NL;PXN;RACK1;FOXO1;IQGAP1;PTK2;PPP1R3B;PPP1R16B;SHOC2;DAB2IP;CDKN1B;AP3B1;MFHAS1;KCNQ1;SH3RF2;JUP;FLT4;STRN4;VRK3;PHACTR4;PPP1R3F;VCP;PPP3CB;FBXL2;EGFR;ERBB2;STRN;PPP1R3C;MET;STRN3;ANAPC7;CDC27;PIK3R2;IGBP1;BAD;GTF2F1;JAK3;BOD1;PPP1R16A;PPP6R3;SMG7
prerank,GABA receptor activity (GO:0016917),0.608125493280492,1.6523731311334038,0.021052631578947368,0.24045503048073266,0.992,10/21,18.35%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2;GPR156
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6783057802413452,1.6522013636852029,0.032679738562091505,0.2315131971353845,0.992,5/11,13.02%,CHRNA1;CHRNB4;CHRNA4;CHRNA7;CHRNB1
prerank,MHC class II protein complex binding (GO:0023026),-0.6863799618181214,-1.6324136273067944,0.01841620626151013,0.31849561362780704,0.968,9/11,25.60%,HSP90AB1;HSPA8;CD81;PKM;ATP1B1;CD74;HSP90AA1;ANXA11;YWHAE
prerank,hexosaminidase activity (GO:0015929),0.6826505135699704,1.6322570298153969,0.036613272311212815,0.25868111220967066,0.996,3/12,1.32%,CEMIP;SPAM1;HYAL3
prerank,ligand-gated anion channel activity (GO:0099095),0.6218885474153265,1.6242668266430798,0.0273109243697479,0.2632075442519617,0.997,9/17,17.65%,GABRA2;GLRB;GABRB3;GABRA5;GLRA3;GABRB1;GABRG1;GABRG3;GABRG2
prerank,receptor ligand activity (GO:0048018),0.3703708647367171,1.6225933992407062,0.0,0.2570161570973302,0.998,24/245,5.86%,GREM2;IGF1;BMP6;EPHA7;WNT4;BMP2;IL34;AREG;PTN;SEMA5A;NRG3;GPHB5;BMP5;NRG1;GDNF;VEGFB;SEMA3A;ARTN;TGFA;SEMA3D;IL4;FAM3D;TAFA2;TAFA5
prerank,CARD domain binding (GO:0050700),-0.6382684355205299,-1.6153376300540265,0.00922509225092251,0.34697359939730366,0.985,11/14,29.98%,NOD1;CARD14;CARD19;MAVS;NOD2;CASP1;CARD16;BCL10;CARD10;CARD11;IRGM
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6013644687763706,-1.6031689874816746,0.014760147601476014,0.3627968265969686,0.992,5/16,4.25%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5629900304803586,1.6016696229490228,0.029473684210526315,0.28705746749598177,0.998,7/23,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,poly-purine tract binding (GO:0070717),0.5435532387201047,1.6009765486020067,0.025806451612903226,0.2791789872161609,0.998,7/27,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,"DNA binding, bending (GO:0008301)",-0.6212191290976592,-1.5967246631144094,0.02617801047120419,0.36170468742325707,0.993,5/14,16.39%,LEF1;FOXD1;HHEX;TOP2A;SAP30L
prerank,outward rectifier potassium channel activity (GO:0015271),0.6411061586371576,1.5924682433312864,0.04279279279279279,0.2870118211425868,0.998,4/11,8.58%,KCNK2;KCNT2;KCND2;KCND1
prerank,protein phosphatase activator activity (GO:0072542),-0.6285011232757383,-1.591824739619617,0.03302752293577982,0.35677530250407286,0.994,6/13,17.33%,CALM1;IGFBP3;PPP2R5A;PHACTR4;CALM3;PPP2R5E
prerank,poly(U) RNA binding (GO:0008266),0.5750385884603921,1.5854994003722274,0.030434782608695653,0.2915934323986434,0.999,7/20,10.46%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,phospholipase activator activity (GO:0016004),0.6748457042584017,1.5809825506293844,0.03160270880361174,0.29195114713696524,0.999,2/10,2.26%,ARHGAP6;PDPK1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.47569980047542304,-1.5793275623391858,0.011428571428571429,0.3758698723249659,0.998,10/42,4.96%,ESAM;BSG;STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;JAM3;ANXA2;ROBO4
prerank,disordered domain specific binding (GO:0097718),-0.5358082519304306,-1.5787284284830116,0.017857142857142856,0.35858175973194156,0.998,11/23,18.22%,FN1;HSP90AB1;CALM1;GAPDH;RB1;TEAD2;CALM3;FKBP8;HSP90AA1;HSPA1A;SMAD2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6586092829223099,-1.5706570952924017,0.02214022140221402,0.3649234759789834,0.998,3/11,10.12%,SGMS1;SGMS2;PIGF
prerank,tropomyosin binding (GO:0005523),-0.5890556868076114,-1.5671064869014122,0.03008849557522124,0.36056156386551486,0.998,5/16,9.78%,NEBL;TMOD3;LMOD1;TMOD1;S100A6
prerank,actin monomer binding (GO:0003785),-0.5377922826188563,-1.5658962379734378,0.02448210922787194,0.3485502496670377,0.998,8/22,14.25%,TMSB4X;NOS3;COBL;PFN1;TMSB10;ABL2;PRKCE;MRTFA
prerank,Wnt-activated receptor activity (GO:0042813),-0.60469249033553,-1.5622842595787536,0.019400352733686066,0.34381229924853335,0.998,6/15,8.56%,LRP5;FZD6;FZD4;PKD1;FZD3;FZD7
prerank,phosphatidylinositol binding (GO:0035091),-0.4045022926206034,-1.5602967570666342,0.008064516129032258,0.3357200399259141,0.998,26/91,15.71%,PITPNC1;ITPR2;MCF2L;ESYT2;PARD3;SCARB1;SNX11;DENND1A;TNFAIP8L3;ITPR3;BCAS3;EEA1;HIP1R;DENND1B;PITPNA;AIDA;MREG;HIP1;PITPNM2;RPH3A;FCHO2;MITD1;PHF12;PITPNM1;MTM1;ESYT3
prerank,histone methyltransferase binding (GO:1990226),-0.6483189607977535,-1.5602014350608875,0.03389830508474576,0.32307792729190626,0.998,5/11,13.35%,HSP90AB1;PRDM4;CBX1;NOP56;LCOR
prerank,phospholipase binding (GO:0043274),0.6238539107240914,1.5582502457937286,0.039301310043668124,0.32859683470504364,0.999,3/13,5.39%,ARHGAP6;PDPK1;PRKN
prerank,FAD binding (GO:0071949),0.5374385496690959,1.555368119894364,0.03333333333333333,0.3262469367198752,0.999,8/24,10.68%,MICAL3;KDM1B;PRODH;CYB5R2;KMO;DDO;CRY1;MICAL1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4994029861209922,-1.5550317593977634,0.021621621621621623,0.3241958835693622,0.999,11/34,10.94%,CYTH3;PARD3;ARAP3;IQGAP1;FERMT2;ARAP2;HIP1R;JPH2;AKT1;MAPKAP1;KIF16B
prerank,ligand-gated cation channel activity (GO:0099094),0.4287201591074215,1.5498881841594663,0.006185567010309278,0.32929974689042363,0.999,26/75,17.80%,GRIA4;CHRNA1;GRIN3A;P2RX4;CCDC51;CHRNB4;GRIK5;GRIK2;TRPM5;KCNJ16;KCNJ3;ASIC2;GRIK1;KCNJ5;CHRNA4;GRIA3;KCNJ14;CHRNA7;CHRNB1;GRIN2A;GRIA1;KCNJ6;KCNN1;KCNJ9;GRIN2B;ASIC4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.43598825812637376,1.549766970717688,0.03406813627254509,0.3207650062403743,0.999,26/60,12.88%,EPHA7;NRP1;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;ROR1;EPHA1
prerank,phosphate ion binding (GO:0042301),-0.6537011870682694,-1.5459829376998429,0.03804347826086957,0.3370261371755874,0.999,5/10,19.73%,PDE2A;ADSS2;RPH3A;RELA;ADSS1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6424905945163408,1.5433871303903532,0.05263157894736842,0.3255383010238122,0.999,7/12,17.29%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6334998549163271,1.5414280888738994,0.05518763796909492,0.3213835252490574,0.999,2/12,0.26%,IGF1;PIK3R1
prerank,aspartic-type peptidase activity (GO:0070001),-0.6566983414639873,-1.5405275351994234,0.04936014625228519,0.3398700466455696,0.999,3/10,8.59%,BACE2;BACE1;CTSD
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5922097932449755,1.5390622171368495,0.056818181818181816,0.31869454006724013,0.999,2/15,2.58%,PLA2G5;PLA2G4A
prerank,neurexin family protein binding (GO:0042043),0.66240439299618,1.5376384351126344,0.07048458149779736,0.3140469113579262,0.999,5/10,7.72%,SYTL5;NLGN2;NLGN3;SYTL2;NLGN1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.36605019211662315,-1.5370034618586805,0.002004008016032064,0.3383762011091136,0.999,53/147,20.92%,DOCK9;RAPGEF5;CYTH3;PLCE1;FGD5;ARHGEF28;RAP1A;DOCK1;RIN3;RASGRF2;RAPGEF1;RGL1;ARHGEF15;DENND1A;EPS8L2;DOCK4;FGD6;DENND1B;SPATA13;BCR;NUCB1;EEF1D;DENND3;DENND6A;ITSN1;HERC2;PREX1;EEF1B2;ABR;DENND2C;ARHGEF5;ARHGEF18;LAMTOR2;RGL2;MADD;EIF2B3;HPS1;DENND5B;RAPGEF3;CYTH2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;RAB3GAP2;RASGRP4;ARHGEF6;RCC1;FGD2;DNMBP;CYTH4;RINL;RAPGEF2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5764642071105603,-1.536721370054889,0.0223463687150838,0.3281406892773724,0.999,7/17,10.27%,PITPNC1;ATP10A;PLTP;ATP8B1;PITPNA;ABCG1;PITPNM2
prerank,calcium channel activity (GO:0005262),0.40976515454252527,1.5342197945172056,0.018480492813141684,0.31260321273892,0.999,16/84,8.94%,CACNA2D3;SLC24A3;CACNA1E;SLC24A5;CACNA2D1;P2RX4;TRPM1;ORAI2;CACNA1I;TRPM5;CACNG4;CACNB4;CACNB2;CACNB1;SLC24A4;SLC24A2
prerank,sodium channel activity (GO:0005272),0.47625240422987514,1.5312779696317653,0.03164556962025317,0.3104329273453265,0.999,9/37,7.76%,SCN7A;GRIK5;GRIK2;SCN3A;CACNA1I;ASIC2;SCN2A;CACNA1G;GRIK1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6273710289215826,1.5294221581626966,0.059322033898305086,0.307009073598108,0.999,7/13,17.65%,GABRA2;GLRB;GABRA5;GLRA3;GABRG1;GABRG3;GABRG2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4354373668528308,1.5280820499924535,0.0288659793814433,0.3033010741713293,0.999,25/60,12.88%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;ROR1;EPHA1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.583771427128013,1.5264604041203726,0.05333333333333334,0.300005139512765,0.999,5/15,13.91%,P2RY13;P2RX4;GPR171;P2RY1;GPR34
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6432380042963359,1.5224130547905161,0.05947136563876652,0.3012244357224083,0.999,8/12,21.66%,GABRA2;GABRB3;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2;GABRB2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6260824758607149,-1.520840577724835,0.03804347826086957,0.35824932142264626,1.0,5/11,4.97%,ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A
prerank,insulin-like growth factor binding (GO:0005520),-0.5873697900024436,-1.5201255087769265,0.022556390977443608,0.3495221030285393,1.0,8/15,8.53%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGF2R;IGFBP3;INSR
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.6002432406053823,-1.5185832939688497,0.04129263913824058,0.3429021832704405,1.0,6/13,22.73%,KCNQ1;EZR;PRKAR2B;PRKAR2A;SOX9;CSK
prerank,LRR domain binding (GO:0030275),0.5949637326631588,1.514617604560713,0.06783369803063458,0.30836948736608205,0.999,3/14,4.39%,ROBO1;PAWR;PMF1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.32967679501113184,-1.5021543632760341,0.0022123893805309734,0.37657464719999906,1.0,85/254,21.43%,ACTG1;NFKBIA;FZD6;FOXO1;NLK;GPI;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;MID1;RPL23;MFHAS1;UBB;HSPA8;RALB;PRR5L;PPARGC1A;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;CCDC50;UBE2L6;CKB;DNAJA1;CAMLG;TRIM28;VCL;OTUB1;ARRDC1;ATP6V0C;TRIB1;RB1;HERC2;ERLIN2;HSPD1;UCHL1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;FAF2;TRAF1;MAP1LC3A;CCT2;RNF20;SLF1;RBX1;UBE2G1;TSG101;RAD18;EGFR;LAPTM4B;CDKN1A;AMBRA1;HSP90AA1;HSPA1A;PRKAR2A;RELA;CUL1;SMAD2;HSPA9;SKI;CASC3;ELOB;LAPTM5;LTBR;TMBIM6;UBE2B;RPL5;FZD5;RRAGA;TRIB3;HSPA1B
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.32738771733928146,-1.5015460353695071,0.0,0.36823292473638836,1.0,90/269,21.43%,ACTG1;NFKBIA;FZD6;FOXO1;NLK;GPI;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;MID1;RPL23;MFHAS1;UBB;HSPA8;RALB;PRR5L;PPARGC1A;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;CCDC50;UBE2L6;CKB;DNAJA1;CAMLG;TRIM28;VCL;OTUB1;ARRDC1;ATP6V0C;TRIB1;RB1;HERC2;ERLIN2;DDRGK1;HSPD1;UCHL1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;ITCH;FAF2;TRAF1;MAP1LC3A;CCT2;SUMO3;RNF20;SLF1;RBX1;UBE2G1;TSG101;RAD18;EGFR;LAPTM4B;CDKN1A;STAT1;AMBRA1;HSP90AA1;HSPA1A;PRKAR2A;RELA;CUL1;SMAD2;HSPA9;CDK5RAP3;SKI;CASC3;ELOB;LAPTM5;LTBR;TMBIM6;UBE2B;RPL5;FZD5;RRAGA;TRIB3;HSPA1B
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5579158669778854,1.489804432079363,0.06873614190687362,0.3482733770672309,1.0,9/17,17.48%,GRIA4;GRIN3A;GRIK5;GRIK2;GRIK1;GRIA3;GRIN2A;GRIA1;GRIN2B
prerank,SH3 domain binding (GO:0017124),-0.409783176054882,-1.4855816189706108,0.01002004008016032,0.402384278910398,1.0,21/62,20.37%,AFAP1L1;SHANK3;AFAP1L2;WASF2;ARHGAP27;DAB2IP;CD2AP;ADAM15;CRK;ABI3;GPX1;SGIP1;RUFY1;ABI1;PTPN12;RAD9A;SYNJ1;CABYR;WIPF1;SHANK1;DNM2
prerank,nuclear receptor coactivator activity (GO:0030374),-0.4223964149235683,-1.4839254369688115,0.019417475728155338,0.39583597852772545,1.0,21/52,22.76%,ACTN4;ETS1;PPARGC1B;PPARGC1A;DCAF6;TACC1;ACTN1;MED24;ENY2;FGF2;ZMIZ2;SS18;CCAR2;KDM1A;MED14;USP22;SRA1;HELZ2;SFR1;MED13;RBM14
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5608570675813508,1.4831777712649112,0.07327586206896551,0.3547234264902829,1.0,4/16,9.42%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,translation elongation factor activity (GO:0003746),-0.5714323182659931,-1.480307774777675,0.05762081784386617,0.3964427357912471,1.0,5/14,12.70%,EEF1A1;EEF2;EEFSEC;EEF1B2;TSFM
prerank,lipoprotein particle binding (GO:0071813),-0.5233041939011954,-1.4780735176884632,0.054307116104868915,0.39277899864284527,1.0,6/20,10.02%,PLTP;THBS1;SCARB1;SCARF1;STAB1;HSPD1
prerank,acylglycerol lipase activity (GO:0047372),-0.6216546167926241,-1.4776155021933621,0.0724907063197026,0.3841536549345765,1.0,3/11,13.79%,ABHD2;MGLL;FAAH
prerank,chemorepellent activity (GO:0045499),0.5062934436166373,1.477000470995196,0.062370062370062374,0.3611552248826891,1.0,6/25,4.77%,EPHA7;SEMA5A;NRG3;NRG1;SEMA3A;SEMA3D
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6149951504056983,-1.4689105749313045,0.06191369606003752,0.3995233445762573,1.0,3/11,9.91%,PPP1R1A;PABIR1;PPP1R8
prerank,BMP binding (GO:0036122),0.6178842528987818,1.4653266026592306,0.1004566210045662,0.3797275510423814,1.0,1/11,0.03%,GREM2
prerank,phosphatidylglycerol binding (GO:1901611),-0.5900334642263424,-1.4646966897875215,0.0600375234521576,0.40185504585844545,1.0,3/13,6.89%,PITPNC1;PLTP;PITPNA
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5869394717479505,-1.4620473039824984,0.060550458715596334,0.40045416098094916,1.0,6/13,17.60%,SH3BP4;ARHGDIA;ARHGDIB;GDI1;GDI2;EIF5
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5139719643243895,1.461349532547045,0.07534246575342465,0.366925544122059,1.0,7/22,12.43%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,serotonin receptor activity (GO:0099589),0.5139719643243895,1.461349532547045,0.07534246575342465,0.366925544122059,1.0,7/22,12.43%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5139719643243895,1.461349532547045,0.07534246575342465,0.366925544122059,1.0,7/22,12.43%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5919639402464826,1.458313212909586,0.09976798143851508,0.36688311142170543,1.0,3/11,9.52%,SLC22A4;SLC22A3;SLC25A47
prerank,metalloendopeptidase activity (GO:0004222),0.39924829958370384,1.4579405914161483,0.03621730382293763,0.36139892159456904,1.0,14/76,12.00%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;MMP11;ECE2;EEF1AKMT4-ECE2;THOP1;ADAMTS9;ADAMTSL4
prerank,actin binding (GO:0003779),-0.34131313364273447,-1.4505204904852387,0.010869565217391304,0.42340235149491,1.0,41/170,12.60%,UTRN;ABLIM1;TMSB4X;MYRIP;SYNE1;NOS3;SORBS1;PARVB;DMD;COBL;EPS8;ACTN4;FXYD5;PTK2;FERMT2;EPS8L2;PDLIM1;SSH2;MICAL2;KLHL2;EZR;GIPC1;FLII;CAP1;TMOD1;PFN1;TMSB10;ADD1;VCL;SYNPO;SPEF1;PHACTR4;TRPV4;MAEA;ABL2;FHDC1;MLPH;DBNL;DBN1;PRKCE;BCL7B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4812904132308371,-1.4499159329354046,0.07400379506641366,0.41587787050282127,1.0,4/23,3.36%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.538230263212299,1.4492536971441619,0.08114035087719298,0.3729131238964761,1.0,5/18,9.35%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,poly(A) binding (GO:0008143),0.5211239825443899,1.445056409326055,0.07991360691144708,0.3758271758438776,1.0,4/21,7.13%,RBMS3;RBMS1;PABPC1L;KHDRBS1
prerank,gated channel activity (GO:0022836),-0.5706654331725662,-1.4404258616027241,0.06630824372759857,0.43387002852322204,1.0,6/14,17.43%,PIEZO2;PIEZO1;TMC6;PACC1;TMEM266;TMEM63B
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5538009754001413,-1.4394116057013937,0.06642066420664207,0.42788364778163673,1.0,4/15,7.32%,SLC26A7;SLC26A2;SLC39A8;SLC4A8
prerank,voltage-gated sodium channel activity (GO:0005248),0.4990119398973347,1.4343720445890598,0.08280254777070063,0.3907599960025269,1.0,6/22,7.51%,SCN7A;SCN3B;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4446623739965929,-1.4338726139081266,0.045364891518737675,0.4354135397648661,1.0,16/37,20.84%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;COX4I1;COX6B1;UQCRQ;COX15;SLC22A6;NDUFA4;UQCR11;SLCO4A1;COX10;UQCRH;NDUFA4L2
prerank,leak channel activity (GO:0022840),0.5361044987488663,1.431984504655374,0.0794979079497908,0.38953339700758927,1.0,2/18,0.55%,KCNK2;NALCN
prerank,CoA-ligase activity (GO:0016405),0.5718267064102524,1.431389175798441,0.11506276150627615,0.3846624128698488,1.0,2/14,4.21%,ACSS3;ACSL1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5926685929024733,1.4280210696758224,0.09153318077803203,0.3851099842570341,1.0,4/12,6.02%,SULF1;SULF2;GNS;GALNS
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5862806688059783,-1.4274890470955077,0.06890130353817504,0.4456329263682377,1.0,9/12,31.66%,FXN;ISCA2;SDHB;ISCA1;AOX1;CIAPIN1;CISD3;XDH;CISD1
prerank,nucleosomal DNA binding (GO:0031492),-0.49748682272781436,-1.4230856969863968,0.06533575317604355,0.44944970680306795,1.0,10/21,22.69%,ACTB;H3-3A;MTA2;MBD3;SMARCA4;GATAD2B;RBBP4;CHD4;RCC1;SMARCC1
prerank,insulin-like growth factor I binding (GO:0031994),-0.5695417389801964,-1.4198471389138962,0.0708955223880597,0.45016682521408086,1.0,7/13,8.53%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGFBP3;INSR
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6041551796370145,-1.4193770011041806,0.07992895204262877,0.4432826384109728,1.0,5/10,19.17%,CXADR;JUP;DSG2;DSP;CD200
prerank,retinoid binding (GO:0005501),0.49578423534579874,1.4149878816417505,0.0755939524838013,0.40491060626716124,1.0,3/22,3.53%,ALDH1A2;NR2F2;ABCA4
prerank,nucleotidyltransferase activity (GO:0016779),0.5051514357281288,1.4121954748183634,0.10730593607305935,0.40386082719505745,1.0,11/19,26.29%,TUT4;CRPPA;PAPSS1;YRDC;PNPT1;PAPSS2;TENT4A;TENT2;MTPAP;REV1;TENT4B
prerank,GTP binding (GO:0005525),-0.32869811833513396,-1.4112544401356688,0.010526315789473684,0.4580632849308685,1.0,56/172,25.44%,RAP1A;EEF1A1;RHOJ;RAP1B;RASL12;TGM2;GBP5;GCH1;TUBA1A;RAB27A;MFHAS1;RAC1;RALB;ADSS2;REM1;GBP7;KRAS;ATL3;RIT1;ARF5;INSR;ATL2;RHOT1;RAB8A;RHOB;RHOT2;RAB11B;RAB7A;TUBD1;TUBB4B;RAB4A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;RAB32;ARL8B;ADSS1;DNM2;RND2;RRAGA;ARL4C;TUBE1;TUBA4A;RRAGC;NRAS;NMUR2;NME1;CDC42;TSR1;RNF112;ARL3
prerank,MHC class I protein binding (GO:0042288),-0.5596391755012607,-1.4088139871104342,0.09647495361781076,0.4567964670956123,1.0,7/13,29.76%,ATP5F1A;TAPBP;ATP5F1B;TUBB4B;TAP2;LILRB1;DERL1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5457667383493783,-1.406383185616624,0.10338345864661654,0.45630966206342694,1.0,6/14,13.28%,MINDY2;MINDY1;USP7;OTUD5;USP9X;USP15
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5291284253037599,-1.4058493461211825,0.08288288288288288,0.44971277304310847,1.0,4/16,7.32%,SLC26A7;SLC26A2;SLC1A1;SLC4A8
prerank,solute:anion antiporter activity (GO:0140323),0.5469803769353142,1.4028314679743306,0.10561797752808989,0.41824199038581783,1.0,2/14,5.34%,SLC7A11;SLC26A1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.445750587287834,-1.4018754765914532,0.0782122905027933,0.4531542944507087,1.0,10/31,21.93%,SLC12A7;SLC12A2;KCNK5;ABCC9;KCNK9;KCNA2;SLC12A5;SLC12A9;PKD2;ABCC8
prerank,myosin binding (GO:0017022),-0.3930299580829334,-1.400569316867779,0.046468401486988845,0.4490287937973498,1.0,13/55,11.50%,SHROOM4;MYRIP;DMD;RAB11A;TRAK1;MYOC;GIPC1;TRAK2;RAB6B;RAB8A;LMTK2;MLPH;RAB11B
prerank,RNA binding (GO:0003723),-0.27081645764955226,-1.400460447146234,0.0,0.4419798684185476,1.0,449/1321,27.71%,MSI2;TMSB4X;AHNAK;SORBS2;SYNE1;EEF1A1;TPT1;SPTBN1;DDX5;RPS16;RPS14;RPL41;VIM;NOVA2;RPL6;RPL26;RPL19;MBNL1;RPS11;RACK1;RPSA;IFIH1;RPS12;STRBP;ACTN4;RPS23;RPL13;CTNNA1;RPS25;EEF2;RPS15;NOP14;RPL28;TFRC;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;LARP1B;RPS3;HNRNPA2B1;RPL37A;RPL38;LBR;RPL39;TRIM25;MAP3K20;HSP90AB1;KMT2C;DDX17;RPL11;MAP4;HNRNPLL;FAU;RBM20;CNBP;RPL18A;DHX32;RPS28;RPS8;RPL32;MSN;RPS10;ADAR;RPL23;RPL17;RPL14;RPS15A;EIF4G3;ANXA2;TES;HSPA8;QKI;PPARGC1B;RPS5;PPIA;CAVIN1;SARS1;RPL21;EIF5B;ATXN2L;PPARGC1A;CAST;RPS24;UBC;RPS27A;PEBP1;RPL18;PRPF8;DIAPH1;LRRFIP1;RPS13;SRSF2;RPS19;MTREX;RPL35;SRSF5;ATP5F1A;PTBP3;RPL27;DDX55;LTA4H;ACAA2;RBFOX2;SNRPA;PCDHGA9;SNRPC;EZR;PTCD3;PKM;ANP32A;ACTN1;RPL23A;N4BP1;ZNF326;PRKDC;SAFB;ERI1;TLR3;PSMA6;SRPK1;HSPB1;FAM120A;ISY1;DUS2;RPL29;RPL34;CMSS1;RPL31;NOP56;RPL35A;ISG20L2;UBAP2;YBX3;DDX41;THUMPD1;RC3H1;RPL8;HDGF;SRSF6;DHX15;YY1;NMD3;RPS18;CARS1;RBM47;RPL22L1;FUS;NOP2;RBM22;NCL;DHX9;PCBP4;PFN1;TNS1;TRMT9B;ADD1;ACO1;TRIM28;SNRPD3;TDRD7;MRPL28;IFIT1;RPL12;PPP1R8;JMJD6;RPS20;U2AF1;ZC3H8;HSPD1;RPL13A;CAPRIN1;ZC3H15;SEC63;UTP14A;VCP;LUC7L2;RPS27L;HNRNPDL;PELP1;DHX58;EIF3D;PES1;DHX37;ILF2;LARP4B;SFPQ;YTHDF2;PDAP1;FAM133B;ZC3H18;FNDC3A;EIF3I;CIRBP;RPL10A;NELFE;STAU1;TUBB4B;FAM98A;TRIM56;ZC3H11A;YWHAZ;RCC2;RPS7;RBMS2;SARS2;MRPL43;NUDT4;RPL36;TSFM;RNPS1;RPS6;RPL3;DKC1;FMR1;PPAN;MRPL32;MRPL14;RBM6;BTF3;RPL15;DHX40;RBM42;NUFIP2;SRSF4;SLC3A2;SEC61B;PEF1;S100A16;SAMHD1;MAGOH;RPP38;EIF4A1;TRMT10C;RBM4B;DDX23;MRPS30;RPL22;URB1;CHTOP;FARS2;SRF;GDI2;PURG;DYNC1LI1;HNRNPK;ERAL1;TOP2A;RBM45;HMGN2;YWHAG;ALYREF;AGFG1;CDK13;PNO1;RPL24;EFTUD2;SRP19;TASOR;RPUSD4;MTHFSD;OAS2;LGALS1;DSP;ASCC3;PSMC1;SF3A3;HSP90AA1;ANKRD17;MRPL16;DDX51;EMG1;DDX20;MRM3;FASTKD3;NQO1;CCT3;DDX39B;HSPA1A;PCBP1;DUSP14;LSM14A;GIGYF2;CCAR2;GTF2F1;KDM1A;HNRNPA1;MCRS1;EIF5;NOSIP;DNM1;SPATS2;DCP1B;RPS26;HSD17B10;SCAF11;PPIG;HSPA9;PPIL4;PHF5A;DUSP11;SNRPG;SMG7;HSPE1;PNN;EXD1;LSM14B;LSM2;RANGAP1;CASC3;MRPL54;SRP68;CHERP;PRPF40A;PUM2;TRIP6;RPP21;SERBP1;RPL7;LSM1;NOL7;EDF1;SYNCRIP;PTCD2;LSM7;RBM7;STIP1;EIF1;KIF1C;HELZ2;ZCCHC7;UBA1;DDX10;PDIA4;CPNE3;RPL5;PSMA1;RBM19;CPSF4;FKBP4;ZC3H7A;UTP4;MEPCE;YTHDF1;LSM3;MKI67;TRMT6;TBRG4;BZW1;MEX3D;HSPA1B;SRRM2;AARS2;DDX49;ZCCHC3;ANXA11;EIF4G1;DDX39A;EIF4A2;NSA2;API5;PWP2;PHF6;NCBP2;PEG10;NOM1;RBM14;FDPS;LSM10;PTPN1;PPIB;TUFM;PYM1;MRPL13;KCTD12;MRPL11;ENO1;TBL3;MYH9;RTCB;ABT1;RSL1D1;ANXA7;NME1;WDR6;REPIN1;CCDC137;SMG1;CSTF2T;FSCN1;TSR1;LRRC59;DDX47;SNRPB;SF3A1;RPL7A;EIF4E;MRPL21;GANAB;ACIN1;EIF4B;DHX57;NSUN5;MRPS24;RPP25L;PABPC1;YWHAE;RBPMS2;EIF4H;UBFD1;RDX;MRPL2;UTP15;PARK7;PSIP1;MRPL42;FTSJ3;RPF2;ADAT1;FAM50A;KNOP1;NUP42;DNA2;SF3A2;CEBPZ;RO60;CLNS1A;RAD51AP1;TXN;TUBA1B;PRRC2A;GOLGB1;PDCD11;NTPCR;KIN;NPM1;ZRANB2;IBA57;RTRAF;TDRD9;NOCT;NUP98;DQX1;TSNAX;RBM25;MAZ
prerank,phosphatidic acid binding (GO:0070300),-0.5104092622678378,-1.399761937147669,0.064030131826742,0.43705406428353943,1.0,8/19,20.92%,PITPNC1;PLTP;JPH2;MAPKAP1;PITPNM1;OPA1;PACSIN2;RAPGEF2
prerank,MHC protein binding (GO:0042287),-0.4879011317219935,-1.3980921285337278,0.07985480943738657,0.43434289243191265,1.0,7/20,18.23%,CD81;ATP5F1A;TAPBP;ATP5F1B;CD74;TUBB4B;TAP2
prerank,steroid hydroxylase activity (GO:0008395),0.5113718132819851,1.3961753152735124,0.11363636363636363,0.4263857603390423,1.0,4/16,9.74%,CYP7B1;CYP27A1;CYP2A6;CYP46A1
prerank,phospholipase inhibitor activity (GO:0004859),-0.6026471532161521,-1.3949808683821119,0.08602150537634409,0.43609852795532766,1.0,3/10,7.31%,ANXA1;ANXA2;ANXA4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.40865387300353756,1.3945605809165145,0.0668103448275862,0.4238579648376165,1.0,12/47,11.87%,SLC7A11;SLC43A1;SLC7A2;SLC6A13;SLC22A4;SLC38A1;SLC36A2;SLC7A9;SLC6A1;SLC1A5;SLC38A3;SLC38A9
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5960309634274712,-1.392606639938653,0.08545454545454545,0.43552554728147497,1.0,6/11,10.93%,ITPR2;TRPC3;ITPR3;TRPC6;RPH3A;TRPC4
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6001967887856174,-1.390656643606369,0.09773123909249563,0.43382765118508876,1.0,2/10,4.27%,MECOM;PRDM16
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5711970003746064,1.3900450452823772,0.1277533039647577,0.42764823595272783,1.0,5/12,9.35%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.602036157274223,1.384733152084765,0.12314225053078556,0.4326222273219111,1.0,5/10,17.65%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2
prerank,E-box binding (GO:0070888),0.4381214198855652,1.3819329304885966,0.09917355371900827,0.4325476112171296,1.0,7/34,11.53%,TCF4;ZEB1;MITF;HES3;ATOH8;GATA3;AHR
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.46295236254456323,-1.3799330245305883,0.0888468809073724,0.45789433083174125,1.0,5/27,5.47%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC39A8
prerank,semaphorin receptor activity (GO:0017154),0.5813273282778136,1.3756532508238162,0.15575620767494355,0.4392691267587755,1.0,2/11,0.36%,PLXNA2;NRP1
prerank,acid-thiol ligase activity (GO:0016878),0.5506607762199789,1.369164004858974,0.1488469601677149,0.44691256723027206,1.0,2/13,4.21%,ACSS3;ACSL1
prerank,store-operated calcium channel activity (GO:0015279),-0.5835849874457266,-1.364570845844751,0.10771992818671454,0.49428923766533994,1.0,5/10,10.93%,TRPC3;STIM2;TRPC6;ORAI1;TRPC4
prerank,single-stranded DNA binding (GO:0003697),0.36118735706123684,1.3598910016544679,0.050980392156862744,0.46100493114643226,1.0,25/93,15.01%,RBMS1;DMC1;MCM3;STN1;JCHAIN;TOP1;RNF138;TOP3A;SETMAR;SWSAP1;POLR2G;RADX;BLM;FUBP1;RPA2;MCM2;MCM9;NUP35;MCM8;RAD51B;PMS2;SSBP2;MAPT;RPA1;SMC6
prerank,protein kinase binding (GO:0019901),-0.2823178656328453,-1.3550211957662894,0.002145922746781116,0.5151207240547553,1.0,119/479,17.09%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;PTPRJ;CCND3;ESR1;PLCG2;RACK1;BMPR2;CAVIN2;CAV2;DCTN2;IQGAP1;EEF2;WNK1;TFRC;PTK2;FOXO3;RPS3;TJP2;CSPG4;DAB2IP;FERMT2;GCH1;MAP3K1;RICTOR;CALM1;CDKN1B;MAPKAPK3;MSN;ADCY4;RAC1;NBEA;HDAC7;HDAC9;LIMS1;ADAM10;KCNQ1;NEDD9;PKD1;LYST;ADIPOR1;PEBP1;CRK;RPS19;ACTA2;CAVIN3;IKBKB;RARA;EZR;GATA6;ATF4;PRKAR2B;SHC1;CEP192;NR3C1;HSPB1;RGCC;TRIB2;MAP3K11;WARS1;MAP3K2;TRIM14;LRBA;MAPKAP1;RELB;TRIB1;INKA2;EMP2;PPP1CB;DCTN1;TIRAP;RHOB;TRPV4;BAG5;TAOK2;VRK1;MTCP1;STK38;DUSP3;GRK5;CALM3;ACVR1;YWHAZ;BCL2L1;RCC2;FBXW5;RPS7;SRCIN1;MAVS;HINT1;RPS6;ACE;TRIM68;JAK2;CEP68;SPAG9;TRIM5;PRKAG1;TOP2A;AP2A1;YWHAG;SIKE1;NOD2;PTPN6;RAD9A;CDKN1A;UFL1;DSP;TCF3;CCNK;HSP90AA1;PRKAR2A;RELA;BAD
prerank,potassium ion antiporter activity (GO:0022821),0.5183082470663269,1.3541614315037733,0.11946902654867257,0.4679122509120453,1.0,5/15,8.94%,SLC24A3;SLC24A5;SLC9A7;SLC24A4;SLC24A2
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3083295862415419,-1.3536509389473343,0.018633540372670808,0.5117422794310238,1.0,60/196,24.44%,RAP1A;EEF1A1;RHOJ;PDE5A;RAP1B;RASL12;TGM2;GBP5;RAB8B;GCH1;TUBA1A;RAB27A;MFHAS1;PDE2A;RAC1;RALB;ADSS2;REM1;MIEF1;RAB18;GBP7;KRAS;ATL3;RIT1;ARF5;INSR;ATL2;RHOT1;RAB8A;RHOB;RHOT2;RAB11B;RAB7A;TUBD1;TUBB4B;RAB4A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;RAB32;ARL8B;ADSS1;DNM2;RND2;RRAGA;RAPGEF2;ARL4C;TUBE1;TUBA4A;RRAGC;NRAS;NMUR2;NME1;CDC42;TSR1
prerank,GTPase activity (GO:0003924),-0.30870596665442696,-1.3517450039273706,0.012552301255230125,0.5102524820622846,1.0,57/192,22.87%,DNM3;RAP1A;EEF1A1;RHOJ;RAP1B;RAB11A;RASL12;EEF2;GBP5;RAB8B;GCH1;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;RIT1;GPN3;HBS1L;RAB6B;ATL2;RHOT1;RAB8A;RHOB;ENTPD7;RHOT2;RAB11B;RAB24;RAB7A;RAB4A;GNB1;HRAS;RAB1A;GNG5;EFTUD2;OPA1;RRAGD;DNM1;AGAP2;ARL2;RAB32;NKIRAS2;ARL8B;DNM2;RND2;GNG11;RRAGA;GNA11;RAB23;RAP1GAP;RRAGC;GNGT2;NRAS
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3924127503321103,-1.350940636314715,0.07465618860510806,0.5054687830092766,1.0,11/48,10.66%,PIEZO2;SLC12A7;SLC12A2;TRPM7;ABCC9;TRPM6;PIEZO1;TMEM165;TRPC6;SLC39A1;TRPV4
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5506277505624038,-1.3505963249118538,0.12274368231046931,0.49946590930725276,1.0,10/12,24.65%,VEGFC;DAB2IP;VEGFA;VEGFD;GREM1;PGF;ITGB3;CDH5;CADM4;CCDC88A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5149569712081548,1.3474905594361113,0.12581344902386118,0.4769941535365157,1.0,7/15,18.22%,SLC1A3;SLC25A13;SLC1A5;SLC1A2;SLC1A7;SLC25A18;SLC38A7
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4625197035081645,-1.3465078704492928,0.09872029250457039,0.5039245790527249,1.0,10/24,23.58%,RPS14;RPL41;RPL26;RPS13;NCL;RPS7;FMR1;SYNCRIP;RPL5;RSL1D1
prerank,anion transmembrane transporter activity (GO:0008509),-0.5653980058616868,-1.3461618389074987,0.11839708561020036,0.49802344085431866,1.0,5/12,14.43%,ABCG2;SLCO2B1;SLC39A8;SLC4A2;SLC22A6
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5410156916209389,1.3457775279628617,0.15311004784688995,0.4746965388870133,1.0,7/12,22.36%,TENT5A;PAPOLB;TENT5B;PAPOLA;TENT4A;TENT2;MTPAP
prerank,ion channel activity (GO:0005216),0.35846334693417986,1.3419179128926897,0.06349206349206349,0.4772854148317132,1.0,23/80,15.21%,NALCN;GRIA4;GRID2;CHRNA1;GRIN3A;TRPM3;TRPM1;CHRNB4;GRIK5;GRIK2;UNC80;TRPM5;GRID1;GRIK1;CHRNA4;GRIA3;CALHM6;CHRNA7;CHRNB1;GRIN2A;GABRB1;GRIA1;TRPC1
prerank,ion channel inhibitor activity (GO:0008200),-0.411887357253013,-1.3414991234139104,0.08560311284046693,0.5042959521976931,1.0,8/35,6.19%,NEDD4L;RACK1;WNK1;MCUB;CAMK2D;CALM1;FKBP1A;STX1A
prerank,ligand-gated calcium channel activity (GO:0099604),0.4855707768011169,1.3373967351952962,0.15450643776824036,0.480979775392105,1.0,7/19,17.48%,ITPR1;P2RX4;TRPM5;TRPA1;RASA3;GRIN2A;GRIN2B
prerank,adenylate cyclase binding (GO:0008179),0.5634356143517683,1.3334644794214676,0.1564625850340136,0.4834763389091056,1.0,2/10,1.26%,ADCY2;ADCY5
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.40904649670864,1.331932044591775,0.1075050709939148,0.48127247883782226,1.0,15/46,17.29%,B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;MGAT3;B3GALT2;PIGP;EXTL1;B3GALT5;MGAT2;MGAT5B;EXTL2;B4GAT1;B3GNT6
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.4313106101335658,-1.3296468241070143,0.10256410256410256,0.5336707778295803,1.0,14/29,25.37%,CDKN1B;PRKAR2B;HSPB1;INKA2;CIB1;YWHAG;CDKN1A;PRKAR2A;CDKN2C;SFN;CDKN2B;CIT;RPTOR;PKIG
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4549184505295745,1.3288419605573167,0.1437908496732026,0.48228947076290096,1.0,6/24,7.17%,CAMK1D;PHKA1;MAPKAPK5;CAMK4;DAPK1;CAMK2B
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.33971953232959273,-1.3274120359662605,0.043560606060606064,0.5337520663468972,1.0,37/100,24.70%,CYTH3;CERT1;PARD3;ARAP3;SNX11;IQGAP1;DAB2IP;DENND1A;FERMT2;ARAP2;HIP1R;DENND1B;ZFYVE26;JPH2;AKT1;TECPR1;MAPKAP1;HIP1;RPH3A;KIF16B;TTPAL;GAB2;LAPTM4B;SAP30L;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL;BTK;VEPH1;PLEKHA4;RUBCN;GOLPH3;ZFYVE16;ANXA8;MYO10
prerank,ribosomal small subunit binding (GO:0043024),-0.4910054089924561,-1.3268561202954485,0.1342155009451796,0.5286074697276255,1.0,12/17,41.06%,PTCD3;ERAL1;EIF1;NME1;EIF4B;EIF4H;NPM1;MTIF2;CPEB2;UNG;PIM1;EIF1B
prerank,glycine binding (GO:0016594),0.5519600469171221,1.3257335858332346,0.17817371937639198,0.48319925522471613,1.0,5/11,17.48%,GRIN3A;GLDC;GLRB;GLRA3;GRIN2B
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5081410301827466,-1.3252372808958806,0.14339622641509434,0.5267055072058026,1.0,11/15,37.90%,COX4I1;COX6B1;COX15;NDUFA4;COX10;NDUFA4L2;COX8A;COX4I2;COX7A2L;COX5B;COX6A1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.2788894229813863,-1.3250872853009474,0.004618937644341801,0.5205983923564176,1.0,132/431,23.84%,CDK6;MAP3K5;RAP1A;EEF1A1;RPS6KA5;RHOJ;RAP1B;MAP4K3;RASL12;TGM2;PEAK1;NLK;WNK1;ATP1A1;SMC4;GBP5;GCH1;TUBA1A;MAP3K20;HSP90AB1;PI4K2A;RAB27A;MFHAS1;RAC1;HSPA8;ATP5F1D;RALB;ADSS2;MINK1;REM1;MTREX;GBP7;ATP5F1A;ACLY;PRPS2;PFKP;PSMA6;SRPK1;IDE;KRAS;ATL3;RIT1;ARF5;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;ATL2;DHX9;CDC42BPB;RHOT1;TRIB1;RAB8A;LMTK2;RHOB;RHOT2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;RAB11B;RAB7A;TUBD1;STK38;TUBB4B;ACVR1;PPP5C;RAB4A;SARS2;PNKP;ABCA2;ARL4A;TARS1;RRM1;ARHGEF5;HSPA4;TBCK;HRAS;ARL6;CAD;CARS2;NUAK2;UHMK1;DYNC1LI1;PRKAG1;STK38L;STK26;PGK1;OAS2;MLKL;RRAGD;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;ARL2;RAB32;BMPR1B;ARL8B;ADSS1;PYGL;DNM2;SNRK;RND2;RRAGA;ARL4C;HSPA1B;TUBE1;BTK;AARS2;EIF4G1;TUBA4A;PFKL;RRAGC;MTHFS;NRAS;NMUR2;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,metallopeptidase activity (GO:0008237),0.3353489181159575,1.3220789053310344,0.0670611439842209,0.48612634071286,1.0,23/113,14.82%,ADAMTS6;ADAMTS12;PAPPA;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;ADAM12;MMP11;ANPEP;ADAM21;CHMP1A;ECE2;EEF1AKMT4-ECE2;THOP1;ADAMTS9;ADAMTSL4;ADAM2;NRDC;MMP19;METAP1
prerank,sialyltransferase activity (GO:0008373),-0.46270688324400017,-1.3211278828017883,0.1237721021611002,0.525780651041407,1.0,6/20,6.49%,ST3GAL6;ST3GAL4;ST6GALNAC3;ST8SIA4;ST6GAL1;ST8SIA6
prerank,GTPase activator activity (GO:0005096),-0.2884778397493235,-1.3183048448568435,0.00425531914893617,0.5275075405038607,1.0,98/313,20.64%,ARHGAP31;DOCK9;RAPGEF5;CYTH3;CHN2;PLCE1;FGD5;RGS3;ARHGEF28;ARHGAP42;RAP1A;RGS5;RASGRP3;DOCK1;SIPA1L1;OPHN1;RIN3;ASAP2;RASGRF2;ARAP3;STARD13;SGSM2;RALGAPA2;IQGAP1;STARD8;RAPGEF1;ARHGAP17;RGL1;TBC1D8;ARHGAP26;ARHGAP27;ARHGEF15;GRTP1;DENND1A;EPS8L2;ARHGAP1;DOCK4;CHN1;TBC1D1;ARHGAP25;FGD6;TBC1D12;DENND1B;SPATA13;BCR;NUCB1;EEF1D;TBC1D22A;RALGAPB;DENND3;RGS6;SIPA1;DENND6A;ITSN1;HERC2;SIPA1L3;ADAP1;WNT11;PREX1;GMIP;NF1;EEF1B2;ABR;DENND2C;TBC1D9B;ARHGEF5;TBCK;PGAM5;ARHGEF18;LAMTOR2;RANBP2;RAP1GDS1;RGL2;MADD;EIF2B3;HPS1;DENND5B;RAPGEF3;CYTH2;TBC1D25;AGAP2;TSC2;TBC1D2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;RASA1;RAB3GAP2;RANGAP1;RASGRP4;ARHGEF6;RCC1;FGD2;RGS10;DNMBP;CYTH4;RINL
prerank,lipase activity (GO:0016298),-0.3883757554886202,-1.3142159353797842,0.09864603481624758,0.5332555332226668,1.0,10/43,20.00%,ABHD2;MGLL;PNPLA2;PITPNM3;FAAH;LYPLA1;PLA1A;LCAT;DAGLB;LDAH
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5370219675853252,-1.309281725985351,0.1391304347826087,0.5412561626596347,1.0,3/12,8.78%,PIEZO2;PIEZO1;TMC6
prerank,NAD binding (GO:0051287),0.44530979973144563,1.3080233592032788,0.16630196936542668,0.5129800887121561,1.0,6/26,14.73%,ALDH1A1;CRYL1;SIRT2;HPGD;GRHPR;SIRT6
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5286516555221157,1.306487077669151,0.17543859649122806,0.5107011320409405,1.0,2/12,4.01%,PIK3R1;STAP1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.37515033482816024,-1.3056205395345546,0.0928030303030303,0.5453965929865355,1.0,10/51,8.22%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;SLC7A5;SLC5A6;SLC25A3;MFSD2A;CLCN3
prerank,ubiquitin protein ligase activity (GO:0061630),0.2975582104135405,1.3017006306066106,0.023722627737226276,0.5163168432864924,1.0,43/228,13.67%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;PELI2;RNF24;CBLB;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;PRKN;HECW1;UBE2O;RNF138;RNF149;DTX1;ASB2;SMURF2;RNF181;TRIM27;KCMF1;MGRN1;RNF26;TOPORS;UBR3;PPIL2;SIAH2;GID4;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1
prerank,phosphatase binding (GO:0019902),-0.33060786563240496,-1.2982662182456703,0.07625272331154684,0.559639982408917,1.0,34/105,18.62%,MAP3K5;ITGA1;PXN;RACK1;MAPK3;IQGAP1;WNK1;PTK2;SHOC2;CDKN1B;AP3B1;SH3RF2;CEP192;CTSC;JUP;FLT4;CHCHD3;VRK3;PPP1R3F;VCP;FBXL2;EGFR;ERBB2;PPP1R3C;MET;ANAPC7;CDC27;PIK3R2;BAD;GTF2F1;JAK3;TSC2;SMAD2;PPP6R3
prerank,death domain binding (GO:0070513),-0.545878761114533,-1.2978310100273724,0.16489361702127658,0.5545569908848085,1.0,6/11,12.16%,RACK1;DAPL1;CRADD;RIPK1;BAX;BCL2L1
prerank,kinase binding (GO:0019900),-0.27402861504773945,-1.2970893580134697,0.006396588486140725,0.5504676608255525,1.0,103/434,16.27%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;TTC28;PTPRJ;CCND3;ESR1;TAX1BP1;PLCG2;CAV2;DCTN2;IQGAP1;EEF2;WNK1;TFRC;PTK2;FOXO3;RPS3;CSPG4;DAB2IP;FERMT2;MAP3K1;RICTOR;HSP90AB1;CALM1;CDKN1B;MSN;RAC1;NBEA;HDAC7;LIMS1;HTT;ADAM10;PKD1;LYST;CHP1;MYOM1;ADIPOR1;PEBP1;CRK;RPS19;ACTA2;PIK3IP1;STX1A;IKBKB;GATA6;ATF4;SHC1;CEP192;PDE8A;NR3C1;HSPB1;PPP2R5A;RGCC;WARS1;MAP3K2;TRIM14;LRBA;MAPKAP1;RELB;FAS;RB1;INKA2;EMP2;PPP1CB;DCTN1;RHOB;TOLLIP;TRPV4;BAG5;VRK1;MTCP1;DUSP3;CALM3;YWHAZ;BCL2L1;RCC2;FBXW5;RPS7;SRCIN1;MAVS;RPS6;TRIM68;JAK2;CEP68;TRIM5;EGFR;PRKAG1;AP2A1;CAB39;SIKE1;NOD2;PTPN6;LAPTM4B;BCAR3;RAD9A;CDKN1A;MYOM2;UFL1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5611816187058872,1.2957989869899713,0.19196428571428573,0.5247605497350148,1.0,5/10,13.30%,PRDM9;SETMAR;NSD1;SETD5;NSD3
prerank,cation:chloride symporter activity (GO:0015377),-0.5576942779577573,-1.2949244020669683,0.16725352112676056,0.5505071277437644,1.0,2/10,0.97%,SLC12A7;SLC12A2
prerank,sodium:proton antiporter activity (GO:0015385),-0.5424569361790843,-1.294404662589347,0.16994633273703041,0.5457954041682872,1.0,2/11,1.78%,SLC9A2;SLC9B2
prerank,calcium activated cation channel activity (GO:0005227),-0.47963784103700224,-1.292980478346404,0.15178571428571427,0.5438561155990123,1.0,2/17,1.35%,ANO6;ANO1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4485806117073057,1.2897839344610837,0.16849015317286653,0.533160473436795,1.0,8/25,10.68%,MICAL3;CYP27B1;CYP27A1;POR;MSMO1;KMO;CYP46A1;MICAL1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5345682547505964,-1.289497404554175,0.17592592592592593,0.5478277897558411,1.0,6/11,24.46%,DAB2IP;MAP3K11;STK38;TCF3;TRAF6;PPEF2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5261706816315856,-1.2887814963937716,0.17190388170055454,0.5438795954873575,1.0,7/12,23.23%,PIK3R6;IPMK;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,estrogen receptor binding (GO:0030331),-0.41563030606282775,-1.2832091028122188,0.13285457809694792,0.5534784228720004,1.0,9/32,14.87%,LEF1;ESR1;PPARGC1B;TACC1;NRIP1;WBP2;LCOR;PHB2;STRN
prerank,voltage-gated cation channel activity (GO:0022843),0.33256436467307926,1.283164533589593,0.08695652173913043,0.5437287822671918,1.0,26/97,20.15%,CACNA2D3;CACNA1E;GRIN3A;CACNA2D1;CACNA1I;KCND2;CACNG4;CACNB4;CACNB2;CACNB1;KCND1;KCNMA1;KCNH7;GRIN2A;KCNQ4;KCNS3;KCNS1;KCNG2;KCNC2;GRIN2B;KCNG4;KCNH5;KCNH1;HVCN1;KCNS2;KCNH4
prerank,transforming growth factor beta binding (GO:0050431),0.4460875492651579,1.2822598970537689,0.1545253863134658,0.5395182466851624,1.0,6/23,10.14%,LTBP1;TGFBR3;TGFBR3L;LRRC32;TGFBR1;LTBP3
prerank,growth factor activity (GO:0008083),0.3480225420218235,1.2822512390598295,0.12043010752688173,0.5337276840373403,1.0,11/74,8.25%,AREG;PTN;NRG3;NRG1;GDNF;VEGFB;ARTN;TGFA;IL4;THPO;IGF2
prerank,peptidase activator activity (GO:0016504),-0.44857198923100894,-1.281950781565091,0.16337522441651706,0.5511279156602998,1.0,8/22,17.36%,CAV1;PSENEN;MAL;VCP;PCOLCE2;PSMD14;APH1A;VSIR
prerank,epidermal growth factor receptor binding (GO:0005154),0.4337873650135271,1.2791270092701348,0.15904139433551198,0.5353496148622864,1.0,5/25,13.30%,AREG;TNK2;TGFA;ERBB4;BTC
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.29315673119391583,1.277020228326961,0.041970802919708027,0.5346205743358238,1.0,46/232,14.55%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;PELI2;RNF24;CBLB;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;PRKN;HECW1;UBE2O;RNF138;RNF149;DTX1;ASB2;SMURF2;RNF181;TRIM27;KCMF1;MGRN1;RNF26;TOPORS;UBR3;PPIL2;SIAH2;GID4;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1;RNF34;PIAS1;UBE3C
prerank,5'-nucleotidase activity (GO:0008253),-0.5101109929704934,-1.2764928161612115,0.15925925925925927,0.561360765174159,1.0,5/13,15.77%,NT5E;NT5C;NT5C1A;NT5DC3;NT5C3B
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5193526165733083,-1.2759504319831751,0.1925925925925926,0.5572082500807444,1.0,6/12,21.92%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;CANT1;NUDT18
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.47826620030894734,1.2722521728021625,0.18340611353711792,0.5403802049987783,1.0,10/16,24.38%,SLC13A3;SLC25A13;SLC25A10;SLC1A5;SLC25A30;SLC25A18;SLC38A7;SLC13A5;SLC25A14;SLC1A6
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5332221394474921,1.2708929943984508,0.22494432071269488,0.5380229152256287,1.0,3/11,9.59%,ITPR1;TRPA1;RASA3
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.473187717849627,-1.2686196117634538,0.17117117117117117,0.5662260096511527,1.0,3/16,5.26%,PTPRB;PTPRG;PTPRM
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.473187717849627,-1.2686196117634538,0.17117117117117117,0.5662260096511527,1.0,3/16,5.26%,PTPRB;PTPRG;PTPRM
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.4948035882237628,-1.2661274346744242,0.17562724014336917,0.5674583946410068,1.0,8/14,37.85%,CAPN2;CAPN15;CAPN5;CAPN10;CAPN6;CAPN3;CAPN11;CAPNS1
prerank,deoxyribonuclease activity (GO:0004536),-0.4895434972532144,-1.2635429775212939,0.2018181818181818,0.5689147886777983,1.0,6/14,28.92%,RPS3;ERCC4;DNASE1L2;DFFB;NME1;MRE11
prerank,nucleotide diphosphatase activity (GO:0004551),0.5035518588937357,1.2618695347285989,0.22435897435897437,0.5533151027755427,1.0,1/14,0.21%,ENPP1
prerank,GTPase binding (GO:0051020),-0.2884625714533299,-1.26089709957645,0.04970178926441352,0.570923132376419,1.0,53/195,20.02%,PLCE1;FGD5;CAV1;EXOC4;SPTBN1;FNBP1L;EPS8;RASIP1;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;GNB2;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;MAPKAP1;RAB8A;TNFAIP1;RTKN;MLPH;CIB1;RCC2;SPHK2;GNB1;RAB11FIP3;RANBP2;GOLGA5;TNPO3;SIKE1;STRN3;NCKAP1;RRAGD;AMBRA1;HSP90AA1;GCC2;TSC2;EHD1;ARHGEF2;RASA1;RAB3GAP2;LSM2;RANGAP1;RCC1;FGD2
prerank,nucleotidase activity (GO:0008252),-0.4837409564465568,-1.2598423638858087,0.16822429906542055,0.5683812078235927,1.0,5/15,15.77%,NT5E;NT5C;NT5C1A;NT5DC3;NT5C3B
prerank,MAP-kinase scaffold activity (GO:0005078),0.5382546396836154,1.259558280526681,0.20087336244541484,0.5535708065284118,1.0,3/11,7.83%,KSR1;SH3RF1;MAPK8IP2
prerank,DNA replication origin binding (GO:0003688),0.436279269824492,1.2594375414737864,0.17954070981210857,0.5483039969813095,1.0,10/23,23.13%,MCM3;ORC4;MCM2;MCM9;MCM8;ORC1;ORC3;ORC5;MCMDC2;MCM7
prerank,protein homodimerization activity (GO:0042803),-0.25911297375917985,-1.2580091112547713,0.016227180527383367,0.5677988423493359,1.0,141/589,18.05%,ABCG2;PECAM1;MAP3K5;B2M;NADK2;SYNE1;ANO1;DPP4;ZHX3;RASIP1;NOD1;RACK1;ACTN4;F11R;CAV2;TPD52;PAXX;TFRC;MID2;FAP;TBX1;STK10;FZD4;CAMK2D;TPD52L1;IRAK2;GBP5;DAB2IP;MGLL;GCH1;SLIT2;HSP90AB1;CUBN;TGFB2;MID1;ST6GAL1;PDE2A;ADAM10;SARS1;EEA1;BHLHE40;MYOM1;ZBTB16;LRRFIP1;VEGFA;HIP1R;S100B;NRBP1;USF2;PSAP;IKBKB;SNRPC;PRPS2;ACTN1;CEP57;HSPB1;TOX3;IDE;JUP;RIPK1;TBC1D22A;FLT4;STK25;STARD3NL;FBXO4;BAX;AKT1;ABCG1;MAP3K11;GSTA4;PDGFC;PDGFA;PRMT8;WARS1;TRPC6;ADD1;TRIM14;HHEX;S100A10;S100A6;ATG7;PON3;FOXP2;HIP1;CARNMT1;S100A13;SFPQ;PRPS1;PRPS1L1;GSTM2;ACVR1;BCL2L1;APOE;BAK1;HES1;TMEM266;FMR1;GRHL1;CSF1R;QTRT2;S100A1;HSPB8;INHBB;MLX;PHB2;TRIM68;NAA60;S100A16;JAML;RAB11FIP3;CASQ2;BNIP3L;TSG101;TRIM5;MFSD1;GOLGA5;SRF;LDB1;TOP2A;SMAD4;GSTM1;ALDH1A3;ATP5IF1;SNF8;STK26;SOX6;NPR3;STAT1;GREM1;TCF3;HSP90AA1;IMPA2;GALM;RABEP1;RELA;MAP3K9;NR6A1;SP1;QTRT1;CHUK;TSC2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.543067682599958,1.257150112828751,0.18487394957983194,0.5479830345036119,1.0,6/10,21.64%,B3GALT1;B3GALT2;B3GALT5;B4GALT7;B4GALT6;B3GALT6
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5321226191175424,-1.2561407422919788,0.19891500904159132,0.5677914900610661,1.0,4/10,19.90%,SHANK3;SHISA7;NSF;SHANK1
prerank,deubiquitinase activity (GO:0101005),-0.32545217303576146,-1.2557024793240685,0.08695652173913043,0.5637131202688876,1.0,26/88,20.53%,USP53;MINDY2;MINDY1;EIF3F;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;JOSD1
prerank,protein tyrosine kinase activity (GO:0004713),0.32283505904371046,1.2524672353980937,0.10358565737051793,0.5532923867031341,1.0,31/108,12.88%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;TNK2;EPHA6;LYN;DDR1;AXL;BAZ1B;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;WEE2;MST1R;MERTK;ITK;FGFR1;TEC;ROR1;EPHA1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4384546837253236,1.2514269538787732,0.19955654101995565,0.5501445159649806,1.0,8/21,14.55%,PDE1A;PDE7B;PDE1C;PDE3B;PDE11A;PDE4B;PDE3A;PDE4A
prerank,cytokine activity (GO:0005125),0.3105520440328352,1.2512743638827186,0.10693069306930693,0.5452089826979641,1.0,15/131,9.96%,BMP6;WNT4;BMP2;IL34;BMP5;NRG1;IL4;FAM3D;CXCL16;PPBP;SCG2;IL18;CCL25;AIMP1;CNTF
prerank,histone deacetylase binding (GO:0042826),-0.3200368987871409,-1.25097932308657,0.10121457489878542,0.5718853403678071,1.0,34/88,25.91%,LEF1;MEF2C;NCOR1;MEF2A;HSP90AB1;HDAC9;HDAC4;TAL1;MTA2;MTA1;SFPQ;MIER2;HES1;SATB2;LCOR;TOP2A;RAD9A;RBBP4;HSP90AA1;MIER1;HSPA1A;RELA;SP1;CHD4;CCND1;NIPBL;HSPA1B;PHF6;YWHAB;CAMTA2;TRAF6;YWHAE;HDAC5;ANKRA2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5143802394766448,-1.2505147063905602,0.1996370235934664,0.5678910522980518,1.0,2/12,1.78%,SLC9A2;SLC9B2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5040062446017207,1.2490749268432266,0.23300970873786409,0.5448728139494843,1.0,5/14,7.28%,TIMP3;RECK;SPOCK3;COL4A3;TIMP4
prerank,nuclear receptor binding (GO:0016922),-0.31282205330425145,-1.2489295805742169,0.09826589595375723,0.5671465459850031,1.0,30/111,17.36%,LEF1;FOXP1;ESR1;DDX5;ACTN4;JMJD1C;NCOR1;ZBTB7A;TACC2;NR4A2;BCAS3;PPARGC1B;PPARGC1A;TACC1;NRIP1;KDM3A;JUP;MED24;ARID1A;WBP2;LCOR;PHB2;TRIM68;SMARCA4;GAS2L1;STRN;STAT1;YWHAH;KDM1A;MED14
prerank,calcium ion binding (GO:0005509),0.2763681675906143,1.248526042789352,0.046511627906976744,0.5410196845722843,1.0,48/323,10.91%,ENPP1;ADGRV1;FBN1;CLEC3B;PLSCR2;PAM;FBLN1;SLC8A1;KCNIP4;LRP1;NRXN1;CDH8;SCUBE1;ITPR1;PLA2G5;ANXA10;PLA2G4A;CDH18;DCHS1;AMY1A;AMY1B;AMY1C;TNNC1;ATP2A2;MAN1C1;ASTN2;ASPH;CDH11;CDH20;CDH19;CDH7;LOXL2;SYT1;SLC25A13;MICU3;OTOF;SCIN;S100A7A;C2CD5;CDK5R1;CDH10;MCTP2;MEX3B;NAALADL1;EML1;SYT13;CDHR3;BAIAP3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4930729656921161,-1.2468688408547326,0.1982142857142857,0.5677202397038341,1.0,2/14,1.09%,SLC26A7;SLC26A2
prerank,protein phosphatase 2A binding (GO:0051721),-0.4195860503306222,-1.2452466600794474,0.16822429906542055,0.567207678630352,1.0,10/23,18.76%,CTTNBP2NL;FOXO1;DAB2IP;MFHAS1;STRN4;STRN;STRN3;IGBP1;BOD1;SMG7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.35759445077464946,1.2447691430596592,0.16089613034623218,0.5446474797480906,1.0,18/55,15.99%,SLC13A3;SLC6A12;SLC16A12;SLC7A2;SLC6A13;SLC22A4;SLC16A14;SLC38A1;SLC36A2;SLC25A10;SLC6A11;SLC38A3;SLC46A1;SLC38A9;SLC38A6;SLC7A3;SLC3A1;SLC16A7
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.32369855831498856,-1.2445726122739267,0.10978043912175649,0.5639892082305819,1.0,19/78,13.37%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;CTSC;USP7;CASP8;USP8;CAPN15;USP9X;CTSF;CAPN5;UCHL1;USP5;CTSB;USP15;CAPN10
prerank,protein kinase regulator activity (GO:0019887),-0.3156037926301038,-1.2440789623283843,0.08875739644970414,0.5603214675822898,1.0,25/95,20.41%,CCND3;RPLP1;CCNY;WNK1;CDKN1B;TAOK3;PRKAR2B;RGCC;DUS2;CCNG2;TRIB1;CSNK2B;WNT11;KIDINS220;PRKAG1;CAB39;MADD;CCNF;CDKN1A;CCNK;PRKAR2A;AGAP2;CCND1;TPX2;NCK1
prerank,phosphotyrosine residue binding (GO:0001784),-0.3854178009762239,-1.2425128536195535,0.16135084427767354,0.559693621716422,1.0,16/37,18.94%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;SHF;ABL2;SYK;PIK3R3;PTPN6;YES1;BCAR3;PIK3R2;HCK;RASA1
prerank,sulfotransferase activity (GO:0008146),0.3991390770007842,1.2422834054243523,0.17410714285714285,0.5455984131255303,1.0,8/33,11.02%,CHST8;GAL3ST3;GAL3ST2;UST;TPST1;SULT6B1;CHST1;HS2ST1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4770868520792457,1.2406385385348635,0.2214765100671141,0.5442019925729612,1.0,4/15,8.81%,CCR6;ACKR4;ACKR2;CCR9
prerank,retinoic acid binding (GO:0001972),0.5003218904665675,1.2397017258583056,0.2534883720930233,0.5412193811403261,1.0,1/12,1.19%,NR2F2
prerank,NAD+ binding (GO:0070403),0.5230045068153981,1.2386748615838472,0.21806167400881057,0.5386852897268307,1.0,7/12,23.59%,CRYL1;SIRT2;HPGD;SIRT6;ZC3HAV1;SIRT3;SIRT1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.504918280526997,1.2380337704909494,0.2169811320754717,0.5352805588288966,1.0,5/11,22.26%,AKR1B1;AKR1B10;RDH13;RDH11;AKR1A1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.41161319884285524,-1.235413973632409,0.17307692307692307,0.5743661299971395,1.0,6/27,7.32%,ITPR2;SLC12A2;SLC9B2;TMEM165;ATP2A3;SLC4A8
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3894211486288731,-1.2352994934949766,0.16206261510128914,0.5696828979093478,1.0,15/35,22.73%,PTK2B;PEAK1;PTK2;BMX;STYK1;ABL2;FRK;CLK1;SYK;YES1;HCK;SLA;TXK;BTK;CSK
prerank,anion:anion antiporter activity (GO:0015301),-0.4593265178780902,-1.2351918029223459,0.21284403669724772,0.565139764758456,1.0,2/17,1.09%,SLC26A7;SLC26A2
prerank,transcription coactivator binding (GO:0001223),0.4433732327404163,1.2345208251623,0.195852534562212,0.5385638069659525,1.0,3/20,2.77%,RORA;AR;SMAD3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.3270969834070688,-1.2342547097175103,0.12380952380952381,0.5626297786967968,1.0,19/74,18.84%,NADK2;DGKH;HK1;RFK;FAM20A;PKM;IPMK;HYKK;NMRK1;CHKA;PIK3C2A;SPHK2;PIK3CA;PIK3C2B;TRPT1;DGKZ;POMK;NADK;FAM20B
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5301879485002338,-1.2338645761773968,0.20640569395017794,0.5589306852334249,1.0,5/10,24.24%,ANKRD13A;IDE;USP15;LAPTM5;FAN1
prerank,cAMP response element binding (GO:0035497),0.5259431249639974,1.2336010080385182,0.24175824175824176,0.5359275015067135,1.0,4/10,17.19%,CREB5;CREB3L1;ATF7;ATF2
prerank,copper ion binding (GO:0005507),0.3694693651261149,1.233457203891787,0.18736842105263157,0.5315790287610688,1.0,8/42,11.01%,PAM;HEPH;P2RX4;MOXD1;LOXL2;LOXL3;ANG;SOD3
prerank,ATPase activator activity (GO:0001671),-0.43748227488557834,-1.2307077534014799,0.19429590017825313,0.5619252830578682,1.0,7/20,22.07%,DNAJA2;ATP1B1;DNAJA1;TOR1AIP1;TOR1AIP2;ATP1B2;DNAJB1
prerank,acetylation-dependent protein binding (GO:0140033),-0.43977517563311996,-1.2255863457095373,0.20577617328519857,0.5668870079422464,1.0,7/20,13.98%,MLLT3;BRD3;DPF2;BRD9;BRD4;ZMYND8;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),-0.43977517563311996,-1.2255863457095373,0.20577617328519857,0.5668870079422464,1.0,7/20,13.98%,MLLT3;BRD3;DPF2;BRD9;BRD4;ZMYND8;SMARCA4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4026484947515946,-1.2231415357315816,0.19708029197080293,0.5691890524666764,1.0,8/26,11.02%,ABCG2;SLC6A6;SLC16A6;SLC16A9;SLC5A6;SLC16A13;SLC16A4;SLC16A1
prerank,GDP binding (GO:0019003),-0.33336727220102425,-1.2210414602101314,0.13572854291417166,0.5701671092692465,1.0,17/63,16.47%,RAP1A;RAP1B;RASL12;RAB8B;RAB27A;RALB;MIEF1;RAB18;KRAS;RIT1;RAB8A;RAB11B;RAB7A;RAB4A;HRAS;DYNC1LI1;RRAGD
prerank,metal ion:proton antiporter activity (GO:0051139),-0.49142864116816487,-1.2184878640555963,0.22935779816513763,0.5728878021981011,1.0,2/13,1.78%,SLC9A2;SLC9B2
prerank,Tat protein binding (GO:0030957),-0.5200360427435942,-1.2158212360902023,0.21731123388581952,0.5753502550930212,1.0,6/10,30.94%,ACTB;DNAJA1;SMARCA4;GABARAPL1;NPM1;DLL1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.26553847338255376,-1.2153574205590043,0.053418803418803416,0.5721554205013432,1.0,79/335,16.04%,PRKCH;CDK6;MAP3K5;RPS6KA5;TGFBR2;MAP4K3;PTK2B;BMPR2;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;NEK7;RPS6KA3;CAMK2D;IRAK2;MAP3K1;MAP3K20;MAPKAPK3;FAM20A;TRIO;CSNK1G2;PRKCZ;MINK1;PRKD3;TAOK3;NRBP1;IKBKB;BRD4;PRKDC;BCR;CSNK1G3;SRPK1;MAP3K8;RIPK1;PLK2;DYRK2;AKT1;MAP3K11;CDC42BPB;MAP3K2;VRK3;CSNK2B;STK32B;PIM3;LMTK2;CAMK1;CDK4;TAOK2;ULK3;RPS6KB2;HTATIP2;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;PRKCE;CDK10;CLK1;SYK;FASTK;RPS6KA2;CDKL4;NUAK1;NUAK2;MAST4;EGFR;UHMK1;STK35;LIMK1;NEK3;STK38L;CDK13;CSNK2A1;CSNK2A2
prerank,beta-tubulin binding (GO:0048487),0.3986782845892217,1.2131810922240014,0.20378151260504201,0.572121949380408,1.0,7/31,9.26%,GJB6;EML4;UXT;DLEC1;PACRG;IFT74;CDK5R1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.26976304254008004,-1.2113905027632332,0.07658643326039387,0.5783015287028701,1.0,70/248,22.87%,DNM3;RAP1A;EEF1A1;RHOJ;MYL6;RAP1B;RAB11A;RASL12;KLC1;EEF2;GBP5;RAB8B;GCH1;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;RIT1;GPN3;HBS1L;RAB6B;ATL2;DHX9;RHOT1;CHD1L;RAB8A;RHOB;VCP;ENTPD7;RHOT2;RAB11B;RAB24;RAB7A;KIF26A;RAB4A;GNB1;HRAS;RAB1A;GNG5;EFTUD2;OPA1;ATP2B1;RRAGD;HSP90AA1;HSPA1A;DNM1;AGAP2;ARL2;RAB32;NKIRAS2;ARL8B;PIN1;DNM2;KIF1C;KIF18B;RND2;GNG11;RRAGA;GNA11;RAB23;HSPA1B;RAP1GAP;RRAGC;GNGT2;NRAS
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.44861249291053207,-1.210427800102506,0.20733944954128442,0.5764403458179718,1.0,5/17,16.53%,LBR;DECR1;DHCR24;TM7SF2;MECR
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.49690822186474864,-1.210335949840383,0.22661870503597123,0.5722069067814429,1.0,4/10,24.71%,CDKN1B;CDKN1A;CDKN2C;CDKN2B
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.471414334905381,1.207382075565257,0.23042505592841164,0.580996149366706,1.0,3/14,12.31%,ALDH4A1;ALDH1L1;MTHFD1
prerank,NADP binding (GO:0050661),-0.38343876184732895,-1.2058982541104795,0.2062043795620438,0.5792001367929897,1.0,8/32,16.60%,NOS3;ME1;LBR;DUS2;DECR1;NNT;TM7SF2;SPR
prerank,NF-kappaB binding (GO:0051059),-0.40799436124287514,-1.205219551216847,0.22803738317757008,0.5765989465670711,1.0,12/24,30.06%,NFKBIA;PSMA6;ANXA4;COMMD7;RELA;CDK5RAP3;HIF1AN;BCL10;RNF25;NPM1;COMMD6;HDAC3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.41493392606434515,1.2016567262311786,0.23927765237020315,0.5898549792430952,1.0,8/23,14.55%,PDE1A;PDE7B;PDE1C;PDE3B;PDE11A;PDE4B;PDE3A;PDE4A
prerank,endopeptidase inhibitor activity (GO:0004866),0.3251700148828784,1.200977915654048,0.16432865731462926,0.5865301851767959,1.0,12/82,8.56%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;UBE2O;SERPINE1;COL4A3;TIMP4;PSMF1
prerank,U6 snRNA binding (GO:0017070),-0.469625289153146,-1.2006984636604354,0.24214417744916822,0.5839671046982476,1.0,6/14,21.06%,PRPF8;RBM22;DDX39B;LSM2;LSM7;LSM3
prerank,protein kinase activator activity (GO:0030295),-0.33028807313706227,-1.1996079688245496,0.14343434343434344,0.582657350565933,1.0,15/60,15.87%,AFAP1L2;RPLP1;IQGAP1;WNK1;RICTOR;CALM1;FAM20A;RGCC;WNT11;MTCP1;CALM3;ABI1;CAB39;MADD;CDKN1A
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.35831038863796427,-1.1993226531640957,0.19288389513108614,0.579077334247169,1.0,17/42,19.47%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;SHF;ABL2;SYK;PIK3R3;PTPN6;YES1;BCAR3;PIK3R2;HCK;RASA1;PIN1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.47544176897405876,-1.197938166284827,0.25,0.5783762443051258,1.0,8/14,22.83%,ACO1;ISCA2;ETFDH;RSAD2;CIAO3;NFU1;SDHB;ACO2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4237617311172967,1.1977325583376188,0.22566371681415928,0.5893442183519476,1.0,5/22,16.67%,RBMS3;CPEB3;KHSRP;RBM24;CPEB1
prerank,death receptor activity (GO:0005035),-0.5050798466085542,-1.193538071841998,0.24528301886792453,0.5854650225698462,1.0,5/11,13.25%,TNFRSF1B;TNFRSF11A;FAS;EDA2R;TNFRSF1A
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5075147942081559,-1.1887615222791683,0.26306306306306304,0.5936146444525459,1.0,3/10,8.22%,ANO6;ANO1;CLCN3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4043443938955424,1.1878157257361381,0.25112107623318386,0.6079312351215501,1.0,16/25,28.62%,PARP16;SIRT2;PARP11;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;PARP8;TNKS2;PARP6;SIRT4
prerank,ADP binding (GO:0043531),-0.4010832751009541,-1.185214388421941,0.21507352941176472,0.5986867839123682,1.0,10/25,19.56%,ME1;ATP5F1D;MIEF1;ATP5F1A;ABCG1;PPP5C;PRKAG1;COQ8A;PGK1;GCLC
prerank,death receptor binding (GO:0005123),-0.4632592844188948,-1.1838247833421205,0.24280575539568344,0.59828142951557,1.0,4/15,15.42%,DAB2IP;NGF;RIPK1;MADD
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.49448134737889904,1.1830537673322774,0.28085106382978725,0.6141400522115422,1.0,6/10,26.08%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,metallocarboxypeptidase activity (GO:0004181),0.40612927639244123,1.1827858452533737,0.23903508771929824,0.6098190875295779,1.0,7/26,10.81%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;FOLH1
prerank,frizzled binding (GO:0005109),0.38168423080544234,1.1824974560697459,0.2250996015936255,0.6056882900728522,1.0,6/34,9.20%,WNT4;ZNRF3;SFRP1;RNF43;RYK;DVL3
prerank,ATPase regulator activity (GO:0060590),-0.35726570500837307,-1.1804955340888743,0.22634508348794063,0.6023445855904115,1.0,14/38,23.34%,FNIP2;DNAJA2;ATP1B1;PFN1;DNAJA1;BAG5;TOR1AIP1;KATNB1;ATP5IF1;TOR1AIP2;ATP1B2;DNAJB1;BAG1;BRSK2
prerank,protein kinase C binding (GO:0005080),-0.3450803489219808,-1.179633604518335,0.21839080459770116,0.6003996651874169,1.0,14/43,16.29%,RACK1;CAVIN2;ADCY4;HDAC7;HDAC9;CAVIN3;HSPB1;TIRAP;TRPV4;GRK5;HINT1;TOP2A;YWHAG;DSP
prerank,androgen receptor binding (GO:0050681),-0.39681510275499754,-1.17941407618541,0.26220614828209765,0.5968046221581215,1.0,7/25,17.33%,FOXP1;DDX5;ZBTB7A;KDM3A;TRIM68;SMARCA4;KDM1A
prerank,Hsp90 protein binding (GO:0051879),-0.3750818998992874,-1.178611581959378,0.2413793103448276,0.5948903397238366,1.0,13/33,25.21%,SLC12A2;KDR;RPS3;NR3C1;UNC45B;PPP5C;NOD2;CSNK2A1;PTGES3L;TSC2;STIP1;PPEF2;PPID
prerank,phospholipase C activity (GO:0004629),-0.3860642595425965,-1.1784883118297362,0.23314065510597304,0.5911544762049638,1.0,4/25,3.36%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.3177311602036635,-1.1766868257661485,0.17125984251968504,0.59164223767081,1.0,22/71,23.37%,PTPRB;PTPRG;PTPN14;PTPRJ;CDC14A;PALD1;PTPRM;PTP4A2;DUSP3;CDC14B;PTPN12;PTPN6;DUSP23;UBASH3B;DUSP11;PTPRK;TIMM50;PTPRO;PTPRU;PTPN22;PTPN1;DUSP4
prerank,G protein-coupled receptor binding (GO:0001664),0.2936071688201973,1.1750136132020759,0.17142857142857143,0.6184586244544861,1.0,30/132,18.99%,WNT4;GRK3;GPHB5;GNAI1;ZNRF3;SFRP1;RNF43;PRKN;TAFA5;ADM;PACRG;TULP3;RYK;DVL3;BICD1;CCL25;GNA15;UTS2B;GPRASP2;PNOC;WNT6;GPRC5B;WNT5B;ARHGEF11;INSL3;USP20;AGTR1;CXCL12;HOMER2;PDYN
prerank,omega peptidase activity (GO:0008242),-0.2999345373101158,-1.1730041446977661,0.17034068136272545,0.5970457199228102,1.0,25/89,20.53%,USP53;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;GGT5;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;GGT1;JOSD1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3427336192989304,1.1713753393361601,0.22355289421157684,0.6222605744378359,1.0,7/56,4.01%,PIK3R1;ANGPT2;NRG3;NRG1;CBLB;LRP4;STAP1
prerank,translation initiation factor activity (GO:0003743),-0.3608064827996484,-1.170588035077922,0.2413127413127413,0.5991213042563261,1.0,14/36,24.95%,EIF3F;EIF4G3;EIF5B;EIF3D;EIF3I;COPS5;EIF4A1;EIF3K;EIF2B3;EIF5;EIF1;EIF4G1;EIF4A2;EIF4E
prerank,kinase activator activity (GO:0019209),-0.37075568059659453,-1.1664776606220146,0.2466281310211946,0.6059175457190249,1.0,12/30,25.43%,RPLP1;WNK1;RGCC;WNT11;CAB39;MADD;AGAP2;TPX2;BCL10;RPTOR;TREM2;SPDYA
prerank,kinase activity (GO:0016301),-0.2921369233601223,-1.1662872502631507,0.1801980198019802,0.6023798890886394,1.0,26/109,18.82%,ITPKB;NADK2;DGKH;RFK;TRRAP;PRKD3;IPMK;HYKK;AKT1;SCYL3;CKB;NMRK1;CHKA;PIK3C2A;SPHK2;CERKL;IP6K1;PIK3CA;COQ8A;CSNK2A1;PGK1;PIK3C2B;SEPHS2;DGKZ;POMK;NADK
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4584890224242388,-1.1649695589572777,0.2870201096892139,0.6017669254072477,1.0,7/14,20.16%,NOD1;RACK1;ATP2A3;MAL;RPS27L;BAD;CASP1
prerank,myosin II binding (GO:0045159),-0.506331239698447,-1.1646690253183405,0.2912801484230056,0.5985804306335912,1.0,1/10,0.39%,SHROOM4
prerank,four-way junction DNA binding (GO:0000400),0.4381701437348027,1.1644694194275733,0.2648401826484018,0.634950251346072,1.0,6/17,12.09%,GEN1;MEN1;BLM;RAD51C;RAD51B;FANCM
prerank,tau protein binding (GO:0048156),-0.3515049081784537,-1.1633617486101209,0.22653061224489796,0.5979150404834626,1.0,11/40,20.32%,ACTB;HSP90AB1;S100B;DCTN1;TAOK2;PPP5C;APOE;HSP90AA1;SMAD2;PIN1;MAP1A
prerank,hormone activity (GO:0005179),0.33651245062604296,1.1630973647171514,0.2490272373540856,0.6333664952415416,1.0,2/54,1.28%,IGF1;GPHB5
prerank,anion channel activity (GO:0005253),-0.3129425692706268,-1.1610670586394307,0.21951219512195122,0.5995717561069048,1.0,7/61,2.95%,ANO6;SLC26A7;CLIC4;ANO1;LRRC8C;LRRC8D;CLIC1
prerank,Notch binding (GO:0005112),0.3992336764800494,1.1588262158137816,0.2698412698412698,0.6387478553053095,1.0,4/22,6.22%,SNED1;MEGF10;AAK1;DTX1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.29983070599101797,-1.1566637147950904,0.1926977687626775,0.6067171130374146,1.0,23/83,20.53%,USP53;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;JOSD1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2540335274161612,1.1551769471561986,0.12746858168761221,0.6427134240130074,1.0,59/346,13.67%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;BCOR;PELI2;RNF24;CBLB;TRIM38;RNF145;FBXO24;DTX4;SH3RF1;DDB2;MDM2;ZNRF3;DZIP3;RNF214;TRIP12;RNF43;RNF2;PRKN;TTC3;HECW1;UBE2O;RNF138;RNF149;DTX1;KLHL42;ASB2;SMURF2;FBXO25;UBE2E3;RNF181;TRIM27;CDC23;CUL2;KCMF1;MGRN1;AKTIP;RNF26;TOPORS;UBR3;MIB1;PPIL2;SIAH2;GID4;FBXO7;BTRC;RNF146;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.41539097762533095,-1.153482592475294,0.2806026365348399,0.61074723427687,1.0,10/18,13.28%,TGFBR2;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;SMAD6;TGFB3;ENG;USP15
prerank,MAP kinase phosphatase activity (GO:0033549),-0.4728022797514024,-1.153182056392737,0.3090277777777778,0.6076050208089375,1.0,7/12,38.75%,DUSP3;DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,potassium ion leak channel activity (GO:0022841),0.45144137892807806,1.1511318075122725,0.28820960698689957,0.6477816239386767,1.0,1/15,0.14%,KCNK2
prerank,C-C chemokine receptor activity (GO:0016493),0.4171374019550203,1.1509543758275953,0.2968036529680365,0.6433947821679442,1.0,5/21,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.39676208653212053,-1.1499292116604005,0.2900763358778626,0.6124995218922402,1.0,6/22,17.01%,MINDY2;PRPF8;UIMC1;SPRTN;TNFAIP3;TAB2
prerank,pyridoxal phosphate binding (GO:0030170),0.41891600582103644,1.149012279209831,0.2905982905982906,0.6431025184350277,1.0,5/20,11.57%,ABAT;GLDC;PLPBP;PDXK;PYGM
prerank,small GTPase binding (GO:0031267),-0.26870475641557556,-1.146038633341968,0.15637860082304528,0.6183739154937066,1.0,44/170,20.02%,PLCE1;FGD5;CAV1;EXOC4;EPS8;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;MAPKAP1;RAB8A;TNFAIP1;RTKN;MLPH;CIB1;RCC2;SPHK2;RAB11FIP3;RANBP2;GOLGA5;TNPO3;SIKE1;STRN3;NCKAP1;GCC2;TSC2;EHD1;ARHGEF2;RAB3GAP2;LSM2;RANGAP1;RCC1;FGD2
prerank,adenyl ribonucleotide binding (GO:0032559),-0.24910957030644507,-1.1404984668106504,0.14375,0.6285342117215739,1.0,89/291,23.84%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;ME1;NLK;WNK1;PDE4D;ATP1A1;SMC4;MAP3K20;HSP90AB1;PI4K2A;PDE2A;HSPA8;ATP5F1D;MINK1;MIEF1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;SRPK1;IDE;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;DHX9;CDC42BPB;TRIB1;LMTK2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;STK38;ACVR1;PPP5C;SARS2;PNKP;ABCA2;TARS1;RRM1;HSPA4;TBCK;CAD;CARS2;NUAK2;UHMK1;PRKAG1;COQ8A;STK38L;STK26;PGK1;OAS2;MLKL;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;BMPR1B;GCLC;PYGL;SNRK;RAPGEF2;HSPA1B;BTK;AARS2;EIF4G1;PFKL;MTHFS;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,ferrous iron binding (GO:0008198),-0.3995884121896893,-1.139469140713516,0.2878228782287823,0.6268244510697828,1.0,7/21,12.72%,EGLN3;CDO1;FTL;EGLN2;EGLN1;FTH1;FXN
prerank,intracellular chloride channel activity (GO:0061778),-0.43016555777019116,-1.1382477761681926,0.2895238095238095,0.622254941153894,1.0,4/16,13.46%,ANO6;ANO1;TTYH2;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.43016555777019116,-1.1382477761681926,0.2895238095238095,0.622254941153894,1.0,4/16,13.46%,ANO6;ANO1;TTYH2;ANO2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3642192171901304,-1.1374958811643698,0.26848249027237353,0.6202904147889068,1.0,15/33,25.92%,RNF144B;DCUN1D5;RPS3;RNF125;DCUN1D1;RNF185;TOLLIP;RNF5;UBA2;ZMYM2;FOXL2;RNF19A;TRAF6;DCUN1D3;PARK7
prerank,syntaxin binding (GO:0019905),0.32069633166055217,1.1371275974915644,0.25263157894736843,0.6675639829486825,1.0,21/61,18.35%,ABCA1;UNC13C;STXBP4;SCFD1;DAPK1;SYT1;CPLX2;SNAP25;GOLGA2;TMED10;STX7;BAIAP3;SYP;STXBP3;SNAP47;SCFD2;TMED9;SYT12;VAMP3;SYT6;SYNPR
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.25171861245889904,-1.136759392338349,0.1446280991735537,0.6183436185171385,1.0,58/254,18.22%,MECOM;LEF1;ELK3;ERG;MEF2C;RREB1;ESR1;MEF2A;FOXO1;KLF4;ELF1;FOXO3;ETS1;SOX17;SIX1;KLF7;PRDM16;REL;NR4A2;TFCP2L1;PRDM2;ZBTB16;PRDM4;ATF4;NR3C1;NR2C2;YY1;PLAGL1;NFATC1;HHEX;PRDM15;SOX18;FOXF2;ZIC3;MYBL1;GABPA;FOXC2;E2F3;SOX12;SOX4;SATB2;PLAGL2;GRHL1;FOXD2;ETV5;SRF;SMAD4;ETV4;RFX5;NR1H2;ZNF76;TCF3;KLF6;ZNF319;RELA;SP1;E2F4;SMAD2
prerank,voltage-gated potassium channel activity (GO:0005249),0.3050471470025204,1.1362453128455718,0.23711340206185566,0.6648248438962873,1.0,21/80,18.44%,KCNK2;KCNT2;KCND2;KCNJ16;KCNJ3;KCND1;KCNJ5;KCNJ14;KCNMA1;KCNH7;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNJ9;KCNG4;KCNH5;KCNH1
prerank,C-C chemokine binding (GO:0019957),0.40489861201276633,1.135391235076502,0.3101123595505618,0.6621699239669145,1.0,5/22,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,phospholipase A2 activity (GO:0004623),0.3705837490699561,1.13409900725926,0.2879120879120879,0.6604042925855039,1.0,8/26,25.37%,PLA2G5;PLA2G4A;PLAAT5;PLA2G6;PLA2G12A;PLA2G4C;PNPLA3;PLA2G15
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4412355600200905,1.1320175020946106,0.2972972972972973,0.6609447635307545,1.0,14/14,55.92%,DHRS3;RDH11;AKR1A1;ADH1A;RDH12;SDR16C5;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;DHRS9;RDH10
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.382546376973791,1.128580107871192,0.30376940133037694,0.664465219228772,1.0,10/26,19.38%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;CHSY3;CHSY1;EXTL2;B3GNT6;CHPF2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.23005142545957669,1.126486161948675,0.0944741532976827,0.664591935518791,1.0,102/831,9.61%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;EPAS1;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RBAK;RARB;TRPS1;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;SP7;TFDP1;PHOX2A;AEBP1;HDX;HOXC8;FOSB;ZNF35;CEBPB;HOXB8;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ATF5;BBX;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;CUX1;LHX4;DMTF1;ZNF697;SIX4;NFIX;BCL11A;RFX7;RARG;NFXL1;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3;CREB3L4;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;CUX2;SOX5;HOXC10
prerank,peptide hormone receptor binding (GO:0051428),0.4726500031699155,1.1261660005441638,0.3447488584474886,0.6606837298051752,1.0,1/11,1.28%,GPHB5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4660080654200203,-1.1254800458543812,0.3205828779599271,0.6437831471446749,1.0,6/12,20.16%,NOD1;RACK1;ATP2A3;RPS27L;BAD;CASP1
prerank,glutamate receptor binding (GO:0035254),-0.41400789676236294,-1.1233518081771956,0.31153846153846154,0.6453066652886605,1.0,6/17,19.90%,SHANK3;HIP1;HOMER1;SHISA7;NSF;SHANK1
prerank,antiporter activity (GO:0015297),0.4038250191704906,1.1227521078052571,0.31333333333333335,0.664292959001072,1.0,6/20,15.23%,SLC35D1;SLC35E3;SLC25A10;ATP1A3;SLC35C2;SLC25A30
prerank,water transmembrane transporter activity (GO:0005372),-0.4638754629339024,-1.1211395593448816,0.30783582089552236,0.6473556561258265,1.0,9/11,53.64%,AQP11;AQP4;AQP1;SLC4A11;AQP9;AQP6;PDPN;AQP7;SLC5A1
prerank,potassium channel activity (GO:0005267),0.29565189207825,1.1208335475682965,0.2219959266802444,0.6640839265522628,1.0,23/89,20.15%,KCNK2;KCNT2;CCDC51;GRIK5;GRIK2;KCND2;GRIK1;KCND1;KCNMA1;KCNK10;KCNH7;KCNQ4;KCNS3;KCNS1;KCNG2;KCNC2;KCNN1;KCNG4;KCNH5;KCNH1;KCNK13;KCNS2;KCNH4
prerank,RNA stem-loop binding (GO:0035613),0.45620753641204903,1.1206832498176669,0.3227990970654628,0.6598180383254103,1.0,5/12,13.66%,LARP6;CSDE1;CPEB3;METTL16;MYH10
prerank,hormone receptor binding (GO:0051427),-0.42683675542822147,-1.1202293558368166,0.3284132841328413,0.6457639210629732,1.0,7/14,39.67%,SOCS2;JAK2;ADCYAP1;NCOA6;NPPC;VIP;TYK2
prerank,SH2 domain binding (GO:0042169),-0.3536694912271324,-1.1197957132079313,0.29250457038391225,0.6430220282063559,1.0,17/31,32.96%,AFAP1L2;RACK1;NLK;PTK2;CRK;TRPV4;RUFY1;JAK2;LAT2;CCDC88A;INPPL1;LAX1;SKAP1;LILRB1;SRC;BLNK;ABL1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3465599554886346,1.119304271092506,0.27564102564102566,0.6586811722510414,1.0,4/38,4.01%,PIK3R1;MAGI2;GRIP1;STAP1
prerank,RNA cap binding (GO:0000339),-0.4239103612002262,-1.1190664552030611,0.33579335793357934,0.6412571023022101,1.0,10/16,40.18%,DCPS;EIF3D;EIF4A1;LSM1;NCBP2;EIF4E;CYFIP2;SNUPN;CYFIP1;NCBP1
prerank,ATP binding (GO:0005524),-0.24755946251374822,-1.1190114272224385,0.16204690831556504,0.6376572291590226,1.0,82/266,23.84%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;NLK;WNK1;ATP1A1;SMC4;MAP3K20;HSP90AB1;PI4K2A;HSPA8;ATP5F1D;MINK1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;SRPK1;IDE;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;DHX9;CDC42BPB;TRIB1;LMTK2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;STK38;ACVR1;PPP5C;SARS2;PNKP;ABCA2;TARS1;RRM1;HSPA4;TBCK;CAD;CARS2;NUAK2;UHMK1;PRKAG1;STK38L;STK26;PGK1;OAS2;MLKL;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;BMPR1B;PYGL;SNRK;HSPA1B;BTK;AARS2;EIF4G1;PFKL;MTHFS;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,hexosyltransferase activity (GO:0016758),0.2889158445612561,1.1183746544426705,0.23673469387755103,0.6563729608067218,1.0,27/101,19.56%,TMTC1;B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;ALG5;FUT4;TMTC3;TMTC4;POGLUT2;FUT9;B3GALT2;EXTL1;POMT2;B3GALT5;GBA2;DPY19L1;CHSY3;CHSY1;B4GAT1;B3GNT6;B4GALT7;B4GALT6;CHPF2;DPY19L4;RFNG
prerank,cholesterol binding (GO:0015485),-0.32470800208484607,-1.1146548878404885,0.30632411067193677,0.6455329075233648,1.0,13/47,15.33%,CAV1;PROM1;OSBPL3;CD81;OSBPL1A;STARD3NL;ABCG1;ERLIN2;GRAMD1C;GRAMD1A;STARD5;NPC1;STAR
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4459706494181189,-1.1129929926891569,0.3018181818181818,0.6462987171507085,1.0,6/13,11.60%,PTPRJ;IL1R1;VEGFA;PDGFC;PDGFA;VEGFD
prerank,nuclear export signal receptor activity (GO:0005049),0.4542067980354094,1.1105592750587212,0.3458980044345898,0.6709861512270279,1.0,4/11,12.92%,RANBP17;XPO4;XPO7;XPO5
prerank,ribosome binding (GO:0043022),-0.32562302452857395,-1.1091726240463917,0.2785571142284569,0.6528077638729535,1.0,13/46,23.01%,RACK1;RPSA;EEF2;ERI1;NCLN;FMR1;NOMO1;SEC61B;SRP19;SRP68;SERBP1;YTHDF1;PYM1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.46279076376964123,-1.1028919457938204,0.3671586715867159,0.6651275154277757,1.0,2/11,6.75%,LEF1;GATA2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3518122993855467,1.099825817816065,0.3414141414141414,0.6927905190781793,1.0,11/32,18.05%,BBOX1;KDM7A;JMJD4;PHYH;FTO;KDM2A;PHF8;PHYHD1;ALKBH4;P4HTM;KDM4C
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.4511855398140985,-1.0991771125026573,0.35802469135802467,0.6707138681702668,1.0,3/11,21.23%,RPS3;NEIL1;APEX2
prerank,NADPH binding (GO:0070402),-0.43288431180778864,-1.0990073841853407,0.3655913978494624,0.6673235675197072,1.0,3/13,9.26%,LBR;DUS2;DECR1
prerank,GTPase regulator activity (GO:0030695),-0.24900062000003576,-1.094398740497952,0.2222222222222222,0.6757058306812869,1.0,42/212,11.33%,ARHGAP31;CHN2;RGS3;ARHGAP42;RGS5;RASGRP3;DOCK1;SIPA1L1;OPHN1;SH3BP4;ASAP2;ARAP3;STARD13;SGSM2;RALGAPA2;IQGAP1;STARD8;ARHGAP17;TBC1D8;ARHGAP26;ARHGAP27;GRTP1;SLIT2;ARHGAP1;CHN1;TBC1D1;ARHGAP25;TBC1D12;BCR;TBC1D22A;RALGAPB;RGS6;SIPA1;SIPA1L3;GDI1;ADAP1;WNT11;ARL2BP;PREX1;GMIP;RTKN;NF1
prerank,cysteine-type peptidase activity (GO:0008234),-0.29099555166628543,-1.0942862936844258,0.29045643153526973,0.6722474101190978,1.0,15/73,11.24%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;CTSC;USP7;CASP8;USP8;USP9X;CTSF;UCHL1;USP5;CTSB
prerank,cell adhesion mediator activity (GO:0098631),-0.36863371286995905,-1.0939694624378982,0.33583489681050654,0.6693317701639067,1.0,5/24,5.72%,ESAM;BSG;JAM3;ROBO4;BCAM
prerank,peptidoglycan binding (GO:0042834),-0.4712669092894768,-1.0931344320425,0.3709677419354839,0.6678432669074014,1.0,4/10,15.49%,NOD1;HK1;PGLYRP1;NOD2
prerank,endopeptidase activator activity (GO:0061133),-0.469857478429908,-1.0929938054348702,0.3701067615658363,0.6646325768582094,1.0,4/10,17.36%,PSENEN;PSMD14;APH1A;VSIR
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.333219250276996,-1.089528581458589,0.3364140480591497,0.6701290893346465,1.0,16/37,30.44%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;FARSB;AARS2;IARS1;GARS1;KARS1;NARS1;IARS2
prerank,solute:sodium symporter activity (GO:0015370),0.3614962049532352,1.0875438570907652,0.36225596529284165,0.7194890179626242,1.0,5/27,8.21%,SLC17A1;SLC5A3;SLC28A3;SLC20A2;SLC4A7
prerank,titin binding (GO:0031432),-0.43475970081059295,-1.0874732552820987,0.36185383244206776,0.6718881680410832,1.0,4/13,14.14%,CAMK2D;CALM1;CALM3;MYBPC1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4403437360634679,-1.0870439940834695,0.37383177570093457,0.6693388053511675,1.0,2/12,4.18%,SLC6A6;SLC38A5
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.22454185091254675,1.0870043395852522,0.1824953445065177,0.7162327814531985,1.0,90/731,9.95%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RARB;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;CREB3L1;SP7;HDX;FOSB;CEBPB;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;ZNF697;SIX4;NFIX;BCL11A;RFX7;RARG;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3;CREB3L4;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;SOX5;HOXC10;HOXB9;HOXC6
prerank,filamin binding (GO:0031005),-0.44919888918717943,-1.0861369025632501,0.37894736842105264,0.6680564341209111,1.0,7/11,33.62%,NEBL;TMEM67;MICALL2;RFLNB;FBLIM1;RFLNA;DPYSL4
prerank,acetyltransferase activity (GO:0016407),0.3539441622309641,1.0860731924113802,0.3435448577680525,0.7138770888505354,1.0,6/31,13.45%,NAT8;SAT1;PAFAH2;KAT8;DBT;EP300
prerank,sequence-specific DNA binding (GO:0043565),0.22835300002570474,1.0845472827460931,0.18490566037735848,0.7130921376167353,1.0,80/590,11.53%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;TBX3;EPAS1;HLF;NR2F2;RARB;ZIC1;TEAD1;PPARA;HOXC4;GLI2;TBX18;DLX3;NFAT5;PRDM5;SMAD3;CREB5;TFEC;TBX21;BCL2;KLF15;GLI3;TFCP2;ZEB2;PBX4;CREB3L1;STN1;PHOX2A;HOXC8;FOSB;ZNF35;CEBPB;HOXB8;PKNOX2;HOXC9;LIN28B;ATF5;BBX;PRDM9;FOXA2;ZNF296;DMRTA2;CUX1;LHX4;MBD2;SIX4;CXXC4;KMT2A;NFIX;RFX7;RARG;SOX2;RBPJ;SAFB2;FOXD3;HES5;ZBTB45;CXXC1;CREB3;CREB3L4;GLIS1;GATA3;CTCF;CUX2;HOXC10;HOXB9;FOXR2;ZIC4;SKOR2;HNRNPD;KDM2A;GRHL3;SNAPC1;SLTM;AHR
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.34873965964931913,-1.0845370838882438,0.3603960396039604,0.668933673830466,1.0,7/30,14.06%,SLC39A10;TMEM165;SLC39A8;SLC40A1;SLC39A1;SLC39A11;SLC39A7
prerank,carbohydrate kinase activity (GO:0019200),-0.45700959874229163,-1.0843062730627169,0.37749546279491836,0.6660580904694688,1.0,6/11,39.07%,HK1;POMK;GNE;FGGY;XYLB;HK3
prerank,hyaluronic acid binding (GO:0005540),0.45718720774154037,1.078914090829706,0.3707093821510298,0.7233116277016283,1.0,1/10,0.26%,CEMIP
prerank,cholesterol transfer activity (GO:0120020),-0.4095305503230381,-1.0776240013244165,0.3684210526315789,0.6793969429163352,1.0,5/16,12.23%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,cytokine receptor binding (GO:0005126),0.2857450764326525,1.076928236751368,0.33402489626556015,0.7234973959014303,1.0,17/83,13.70%,TGFBR3;IL34;VEGFB;SMAD3;IL1RAP;IL13RA1;IL4;CD300LF;IL18;IL27;CCL25;CNTF;OSMR;IL6R;PIBF1;PRLR;TSLP
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.22206491918962362,1.0761239853915512,0.2007366482504604,0.7208600634008817,1.0,89/732,9.95%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RARB;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;SP7;HDX;FOSB;CEBPB;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;ZNF697;SIX4;NFIX;BCL11A;RFX7;RARG;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3;CREB3L4;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;SOX5;HOXC10;HOXB9;HOXC6
prerank,phosphatidate phosphatase activity (GO:0008195),0.42885609263759156,1.0745141408694714,0.3680851063829787,0.7204654433134664,1.0,6/13,16.49%,PLPP3;PLPPR1;LPIN3;PLPP4;PLPPR5;LPIN1
prerank,G protein-coupled receptor activity (GO:0004930),0.24559918254685592,1.0729469014473227,0.2896825396825397,0.7198284559846764,1.0,37/239,15.37%,ADGRV1;LGR4;PDGFRL;ADGRB3;LPAR1;GPR88;GPR55;P2RY13;GPR174;GRM1;CCR10;OPRK1;MC5R;GPR171;PDGFRB;HRH1;CALCR;PROKR2;LPAR4;GLP2R;NMBR;ADRA1D;GPR173;C3AR1;ADRA1B;GPR161;CRHR1;GRM4;PAX8;P2RY1;GPR34;CXCR4;DRD2;ADGRL1;HCRTR1;RXFP1;ADRA1A
prerank,cation channel activity (GO:0005261),-0.27205828230501505,-1.0728878984994046,0.32142857142857145,0.687735816292267,1.0,11/94,5.19%,PIEZO2;ANO6;KCNK5;ANO1;TRPC3;TRPM7;ABCC9;TRPM6;PIEZO1;ANXA2;PKD1
prerank,protein kinase inhibitor activity (GO:0004860),-0.3157752762272338,-1.0718350817778568,0.33528265107212474,0.6868875890377799,1.0,18/42,31.80%,RACK1;CDKN1B;TAOK3;DUS2;TRIB1;INKA2;CIB1;CDKN1A;NCK1;CDKN1C;YWHAB;CIT;RPTOR;SPRY4;NPM1;PPP1R1B;SPRED1;SH3BP5
prerank,growth factor receptor binding (GO:0070851),0.278639300845059,1.0696349986934057,0.3182751540041068,0.7234920749390391,1.0,19/95,13.70%,AREG;KL;PDGFRA;TNK2;VEGFB;TGFA;IL1RAP;IL4;GLMN;PDGFRB;PDGFD;CD300LF;ERBB4;CNTF;ESM1;IL6R;PIBF1;BTC;TSLP
prerank,neuropeptide receptor binding (GO:0071855),-0.4247031148318999,-1.0689695104389572,0.3996101364522417,0.6910348888404094,1.0,11/14,54.64%,AGRP;NTS;SHANK1;APLN;NPY;NMU;UCN2;GAL;NPPA;GHRH;QRFP
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2631981747328892,1.0687225476772313,0.3096153846153846,0.7213219975264027,1.0,36/134,15.99%,SLC1A3;SLC13A3;SLC6A9;SLC16A12;GJA1;SLC7A2;SLC6A13;SFXN5;SLC35D1;ABCC2;MFSD12;SLC22A3;SLC26A1;SLC38A1;SLC36A2;SLC7A9;SLC25A13;SLC25A42;SLCO5A1;SLC6A1;SLC1A5;SLC38A3;CTNS;SLC46A1;SLC38A9;SLC25A15;SLC35B1;OCA2;SLC1A2;SLC38A6;SLC7A3;SLC1A7;SLC25A24;SLC3A1;SLC25A18;SLC16A7
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4207889153799279,-1.0677469418861942,0.4,0.6905250004226826,1.0,5/14,21.60%,KCNJ2;KCNQ1;KCNJ8;KCND3;KCNIP2
prerank,retinoic acid receptor binding (GO:0042974),-0.38535580041769,-1.0670623372923287,0.38461538461538464,0.688584439730678,1.0,4/17,6.24%,ACTN4;NR4A2;TACC1;NRIP1
prerank,CCR chemokine receptor binding (GO:0048020),-0.3516058343606475,-1.066146080027663,0.3583180987202925,0.687523898405944,1.0,19/28,49.43%,NES;CCL15;CCL2;NARS1;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL14;MSMP;CX3CL1;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CCR2;CXCL13
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.24291932822246742,-1.0660340540489082,0.2892057026476578,0.6842937413317495,1.0,48/188,18.36%,BNC2;MEF2C;FLI1;JUND;NCOR1;KLF4;FOXO3;ETS1;SOX17;VSX1;SIX1;REST;RBBP5;PRDM16;NFYA;SOX13;FOXK1;SMAD6;GATA6;ATF4;YY1;HDAC4;TAL1;SOX7;DHX9;HHEX;SOX18;GABPA;FOXC2;SOX12;KMT2D;SFPQ;SOX4;GRHL1;MTERF3;NR5A2;ETV5;SMAD4;SOX6;SMARCA2;POU2F2;LIN54;ZBTB48;RELA;SP1;ARID4B;GLI1;ZNF568
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3427963075360993,1.065670972881948,0.36,0.7243329343465742,1.0,14/34,23.43%,METTL21A;PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B;VCPKMT;DOT1L;SETD4;CAMKMT
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.285391592577115,-1.0650385396003326,0.350293542074364,0.6830932495584734,1.0,17/72,10.99%,STXBP6;KCNJ2;PARD3;VILL;ANXA2;KCNQ1;HIP1R;FLII;JPH2;FZD7;PFN1;MAPKAP1;HIP1;RPH3A;TIRAP;FCHO2;EXOC1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3279487681062143,-1.0641978738881754,0.3516068052930057,0.6818241325890442,1.0,14/35,30.32%,FOXP1;NR3C1;H3-3A;POU2F1;SMARCA4;DRAP1;STAT1;RELA;KLF10;PARK7;TAF1B;NPM1;TAF4;MYC
prerank,protease binding (GO:0002020),0.2779266185561887,1.0571970003267839,0.34439834024896265,0.7418555667931671,1.0,12/99,7.28%,CCBE1;COL1A2;TIMP3;SLC2A13;BCL2;CFLAR;PRKN;SUMO1;SERPINE1;TRIP4;ATP9A;TIMP4
prerank,transaminase activity (GO:0008483),0.4416449086877757,1.0529839913999681,0.4108695652173913,0.7478624768360294,1.0,5/11,21.85%,ABAT;BCAT2;GOT1;BCAT1;GOT2
prerank,mannosyltransferase activity (GO:0000030),0.36681308192351214,1.0517508024642124,0.3747276688453159,0.7461399259676245,1.0,9/21,22.69%,TMTC1;TMTC3;TMTC4;POMT2;DPY19L1;DPM1;DPY19L4;PIGB;ALG8
prerank,thioesterase binding (GO:0031996),-0.4424215020357438,-1.0517069132927082,0.4358490566037736,0.7104946815310011,1.0,4/11,24.36%,RAC1;TRAF1;CDC42;TRAF6
prerank,cytokine receptor activity (GO:0004896),0.281699053894794,1.0515134160441388,0.3702928870292887,0.7421914881466836,1.0,15/83,12.64%,IL31RA;CNTFR;LEPR;CCR6;IL1RAP;IL13RA1;ACKR4;ACKR2;GHR;IL1RL2;CCR9;OSMR;IL6R;GFRA2;PRLR
prerank,metalloexopeptidase activity (GO:0008235),0.31412003456201537,1.0514503783929212,0.3412526997840173,0.7378442549515082,1.0,12/51,10.88%,AGBL4;MMP16;CPZ;AEBP1;CPA6;CPQ;PEPD;CPXM1;ANPEP;ENPEP;FOLH1;TRHDE
prerank,pre-mRNA binding (GO:0036002),0.34152651593996747,1.0486674841265033,0.3814229249011858,0.7406468310587511,1.0,5/28,9.28%,CELF2;RBM41;RNPC3;CELF4;SLU7
prerank,Toll-like receptor binding (GO:0035325),-0.4433902164594975,-1.0472327531810945,0.3915343915343915,0.7183488509893006,1.0,7/11,34.24%,DAB2IP;TIRAP;TOLLIP;CD36;TLR6;TLR1;TLR2
prerank,metal ion binding (GO:0046872),0.22463626539414341,1.0470405164625645,0.3018867924528302,0.7404936816169374,1.0,59/477,10.91%,ENPP1;ADGRV1;ADCY2;FBN1;HMGCLL1;CLEC3B;PLSCR2;PAM;FBLN1;SLC8A1;EYA2;KCNIP4;LRP1;NRXN1;CDH8;SCUBE1;ITPR1;PLA2G5;ANXA10;PLA2G4A;CDH18;GNAI1;RAP2A;DCHS1;AMY1A;AMY1B;AMY1C;TNNC1;ATP2A2;MAN1C1;ASTN2;ASPH;CDH11;CDH20;CDH19;CDH7;LOXL2;SYT1;GEN1;SLC25A13;MICU3;OTOF;TRIM27;SCIN;PPA2;S100A7A;PPA1;PDXK;C2CD5;CDK5R1;CDH10;MCTP2;MEX3B;NAALADL1;EML1;SYT13;BRSK1;CDHR3;BAIAP3
prerank,exopeptidase activity (GO:0008238),-0.30142499072876794,-1.0440318199273164,0.3933463796477495,0.7234920816664662,1.0,18/50,22.31%,DPP4;FAP;CTSZ;LTA4H;ERAP1;PRCP;CPE;ACE2;DPEP3;DPP8;LNPEP;ACE;RCE1;CNDP2;METAP1D;BLMH;LAP3;NPEPPS
prerank,protein kinase C activity (GO:0004697),-0.4067285249855177,-1.038814996317199,0.43014705882352944,0.7337212275853334,1.0,3/14,5.46%,PRKCH;PRKCZ;PRKD3
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3205133165608426,-1.0383273364745456,0.39594843462246776,0.7313101654455261,1.0,8/34,16.61%,IQGAP1;RICTOR;CALM1;FAM20A;MTCP1;CALM3;CAB39;CCNK
prerank,nuclear localization sequence binding (GO:0008139),-0.38379913844686664,-1.0341349974185008,0.424812030075188,0.7388654839385228,1.0,8/18,38.23%,NFKBIA;KPNA1;KPNA4;TNPO2;KPNA6;NUP214;IPO5;CABP1
prerank,sterol binding (GO:0032934),0.29401243032053515,1.0303436762565559,0.39634146341463417,0.7803333034351008,1.0,12/56,12.72%,RORA;ABCA1;OSBPL10;OSBPL8;VDAC2;INSIG2;SCAP;GRAMD1B;SYP;OSBP;SIDT1;ERLIN1
prerank,wide pore channel activity (GO:0022829),0.3692613514941418,1.0281735469114697,0.42094017094017094,0.7811728834462514,1.0,2/23,1.53%,GJB6;GJA1
prerank,gap junction channel activity (GO:0005243),0.3750852316253336,1.0279124389958414,0.4227467811158798,0.7772221679444977,1.0,2/22,1.53%,GJB6;GJA1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3959386118543572,1.0232293464841145,0.3955056179775281,0.7849425555110067,1.0,1/15,0.26%,PIK3R1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3161095649307037,1.020722557432604,0.42655935613682094,0.7869334821387791,1.0,4/38,5.80%,SERPINE2;SERPINI2;SERPINF1;SERPINE1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3322176984685727,-1.0201914257508409,0.4218455743879473,0.7724212337610196,1.0,6/28,17.16%,DAB2IP;RIPK1;TRAF1;MADD;STAT1;BABAM2
prerank,I-SMAD binding (GO:0070411),-0.40844795318707344,-1.0196735464439184,0.41968911917098445,0.7700181501852443,1.0,6/13,18.22%,SMAD9;SMAD7;SMAD6;SMURF1;SMAD4;SMAD2
prerank,PDZ domain binding (GO:0030165),0.28216885833593736,1.0156687333123464,0.448692152917505,0.7956483214818159,1.0,8/61,7.72%,TGFBR3;ARHGAP29;GRID2;PLEKHA2;SLC22A4;PRKN;CXXC4;NLGN1
prerank,microtubule binding (GO:0008017),-0.22701003226938518,-1.015500194767816,0.4017094017094017,0.7771336534826491,1.0,69/222,27.14%,MTUS1;DNM3;RAB11A;MID2;RPS3;MAP1LC3B;MAP4;MID1;RP1;CHP1;EZR;CEP57;GAPDH;KIF9;KIF23;KIF1B;CEP290;SPEF1;DCTN1;TRPV4;KIF16B;GAS8;FHDC1;SGIP1;KIF26A;RCC2;KATNB1;FMR1;MAP1LC3A;SNPH;NDE1;NDEL1;GAS2L1;OPA1;MAP1B;REEP4;MAPRE2;DNM1;KIF18A;KRIT1;ARHGEF2;TPX2;KNSTRN;FMN1;MAP1A;DNM2;KIF1C;KIF18B;NEFM;APC2;CAMSAP3;KIF13A;RMDN1;KIF22;CCDC170;CEP44;CLIP1;CLIP2;CCDC88A;KIF17;ARL3;HAUS4;CAPN6;RMDN3;KIFC2;MAP7D3;BIRC5;RACGAP1;EML3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.2932706878824045,1.015014998154535,0.4400871459694989,0.7926725368877887,1.0,8/53,7.62%,MICAL3;KDM1B;PRODH;POR;CYB5R2;KMO;DDO;CRY1
prerank,protein tyrosine kinase binding (GO:1990782),-0.2695824982144202,-1.0145668882256342,0.41509433962264153,0.7760275188619468,1.0,14/71,12.11%,PTPN14;RACK1;BMPR2;GRB14;TJP2;RNF41;NEDD9;DOCK4;CRK;SHC1;PITPNM2;DUSP3;ACVR1;PITPNM3
prerank,sodium channel regulator activity (GO:0017080),0.3239158627529185,1.0140376612028577,0.4344978165938865,0.7906640809850334,1.0,6/37,10.37%,FGF14;SCN3B;GPD1L;FXYD1;FXYD7;FXYD6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.435082697722884,-1.0137403285139335,0.4606164383561644,0.7709929007979576,1.0,6/10,38.75%,DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.435082697722884,-1.0137403285139335,0.4606164383561644,0.7709929007979576,1.0,6/10,38.75%,DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.37355844306555364,-1.0114621161382704,0.45027124773960214,0.773514949099899,1.0,16/18,53.85%,HSD17B10;HSD17B2;HSD11B1;HSD17B1;HSD17B7;SRD5A2;HSD17B8;HSD3B7;HSD3B2;AKR1C1;DHRS9;DHRS11;RDH16;HSD17B6;HSD17B3;RDH5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4274796511402308,-1.010613132583171,0.45878136200716846,0.7720507952564974,1.0,5/10,23.23%,PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2127041735852467,1.0102503683682504,0.4003690036900369,0.7963628800039589,1.0,74/597,10.53%,TCF7L2;TCF4;ARNT2;ZBTB20;MAF;AR;TBX3;HLF;BCOR;TBL1XR1;RARB;MCM3;ZIC1;TEAD1;HOXC4;GLI2;TBX18;DLX3;NFAT5;PRDM5;SMAD3;CREB5;TFEC;ORC4;TBX21;KLF15;GLI3;TFCP2;CREB3L1;PHOX2A;HOXC8;FOSB;CEBPB;HOXB8;PKNOX2;ZNF513;HOXC9;LIN28B;ATF5;BBX;GABPB1;GABPB2;PRDM9;FOXA2;ZNF296;DMRTA2;CUX1;LHX4;MEN1;MBD2;DMTF1;SIX4;NFIX;RFX7;RARG;SOX2;FOXD3;HES5;ZBTB45;CREB3;CREB3L4;GLIS1;GATA3;CTCF;CUX2;SOX5;HOXC10;ERBB4;HOXB9;FOXR2;MCM2;ZIC4;SKOR2;MCM9
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.36978667975519536,1.0095489408730736,0.44150110375275936,0.7938104822155055,1.0,1/18,0.26%,PIK3R1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.31759184891906833,1.0085572478184772,0.4485776805251641,0.7919134096214365,1.0,3/35,2.02%,ENPP1;PLCL1;PLCXD1
prerank,sterol transfer activity (GO:0120015),-0.3784479488389354,-1.0082755069667197,0.4377224199288256,0.7747975712489699,1.0,5/17,12.23%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,platelet-derived growth factor binding (GO:0048407),0.4179357406507871,1.0040806771032857,0.43207126948775054,0.7993847196002233,1.0,3/11,6.77%,COL1A2;PDGFRA;PDGFRB
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36712877820839895,1.0033483669431424,0.44789356984478934,0.7966810212548943,1.0,3/19,8.27%,NRG3;NRG1;ERBB3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.2909980625238036,-1.0022129825536024,0.4641434262948207,0.7877413832503821,1.0,20/49,29.01%,MINDY2;MINDY1;PRPF8;BRCC3;UIMC1;VCP;UBXN1;SPRTN;RAD18;UBL7;TNFAIP3;TAB2;BABAM2;ZFAND2B;RAD23A;EPS15;RAD23B;PARP10;ATRIP;UBQLN2
prerank,chemokine receptor activity (GO:0004950),0.3462589846205634,1.001883261295457,0.44155844155844154,0.7960485598105657,1.0,5/24,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,syntaxin-1 binding (GO:0017075),0.35022615729029977,1.0008532144902085,0.432258064516129,0.794432600144606,1.0,10/22,19.63%,UNC13C;DAPK1;SYT1;CPLX2;SNAP25;SYP;STXBP3;VAMP3;SYNPR;STXBP5
prerank,cation transmembrane transporter activity (GO:0008324),0.29554732176036247,1.0006593145512335,0.42138364779874216,0.7906138884608659,1.0,14/48,14.90%,SLC6A9;SLC7A2;MFSD12;SLC22A3;SLC38A1;SLC36A2;SLC41A1;SLC1A5;SLC38A3;SLC38A9;SLC25A15;OCA2;SLC38A6;SLC7A3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.36182620458745585,-1.0005962906536943,0.4602272727272727,0.7882249377404145,1.0,6/18,29.99%,RPS6KA3;TNFAIP8;SERPINB9;XIAP;BIRC5;RPS6KA1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.40646404206360176,-1.0002682805472827,0.4864376130198915,0.7855036555744068,1.0,5/12,19.33%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,TBP-class protein binding (GO:0017025),-0.352121437976911,-0.9983521694445762,0.45137614678899085,0.7870426620563014,1.0,5/21,16.47%,ESR1;HHEX;PSMC5;DRAP1;PSMC1
prerank,R-SMAD binding (GO:0070412),0.36795744749168563,0.9981201981628448,0.4461883408071749,0.7925578144185773,1.0,4/18,7.29%,LDLRAD4;SMAD3;PMEPA1;MEN1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3253918966994185,0.9972681574687409,0.43254817987152033,0.7904593597336678,1.0,10/32,13.29%,SLC6A9;SLC43A1;MFSD12;SLC38A1;SLC36A2;SLC7A9;SLC1A5;SLC38A3;SLC38A9;SLC38A6
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.3146586730488346,-0.9958894290148267,0.45920303605313095,0.7902035985407689,1.0,5/30,12.06%,RPS6KA3;CAST;TNFAIP8;CST3;SERPINB9
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.4204416280093924,-0.9932673284232104,0.45517241379310347,0.7934680902986309,1.0,4/10,24.24%,ANKRD13A;IDE;LAPTM5;FAN1
prerank,calcium channel regulator activity (GO:0005246),-0.3022085740481154,-0.9928990877674462,0.44886363636363635,0.7908631598207776,1.0,9/37,16.79%,PRKG1;MCUB;CALM1;FKBP1A;REM1;STIM2;CACNB3;SRI;NRXN2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.345097666642956,0.9901204427949618,0.4606986899563319,0.8046662327930932,1.0,5/23,6.46%,SH3PXD2B;WDR45B;SNX14;GBF1;WIPI1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3470367035812996,0.9899974923361677,0.46120689655172414,0.796482072609536,1.0,4/21,10.11%,CDK8;CDK14;CDKL3;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3470367035812996,0.9899974923361677,0.46120689655172414,0.796482072609536,1.0,4/21,10.11%,CDK8;CDK14;CDKL3;CDK20
prerank,calcium channel inhibitor activity (GO:0019855),-0.4107321218545153,-0.9888077056675768,0.49080882352941174,0.797942355583354,1.0,3/11,4.23%,MCUB;CALM1;FKBP1A
prerank,zinc ion binding (GO:0008270),0.22103115341177634,0.9882664108141195,0.48134328358208955,0.7967047336462681,1.0,54/293,13.96%,ENPP1;PAPPA;ADAM33;MYCBP2;PAM;ZEB1;SEC24D;RBAK;CBLB;GLI2;IKZF4;SMAD3;KDM1B;BBOX1;P2RX4;MDM2;MMP16;KDM7A;DUSP12;RNF2;PRKN;MNAT1;HDAC10;BAZ1B;SMPDL3B;SIRT2;ANPEP;CXXC4;KMT2A;ENPEP;NSD1;PDXK;BLM;SLU7;CTCF;CHMP1A;RNF26;SEC24A;NAALADL1;TRHDE;DPP3;KDM2A;ZFYVE1;APIP;SEC23A;PHF8;ZFP37;CXXC5;ZNF205;CDADC1;BIRC2;ARIH2;LITAF;GRIN2A
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4093255893363675,0.9853029929813423,0.47165532879818595,0.8001224796563147,1.0,3/10,8.22%,CACNB4;CACNB2;CACNB1
prerank,ephrin receptor binding (GO:0046875),-0.3441351974074892,-0.9852496405519618,0.48549323017408125,0.8038284624845946,1.0,15/21,37.77%,CHN1;CRK;SHC1;ANKS1A;EFNB3;EFNB1;PTPN1;PIK3CG;EFNA2;EFNA4;SRC;ABL1;CBL;FYN;EFNA1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3273544921671515,0.9839178125236483,0.49209932279909707,0.7993903999209508,1.0,13/29,21.06%,SLC13A3;ABCC2;SLC26A1;SLC25A13;SLC25A10;SLC1A5;SLC46A1;SLC25A30;SLC25A18;SLC26A4;SLC38A7;SLC13A5;SLC19A1
prerank,proton transmembrane transporter activity (GO:0015078),-0.3020211311274082,-0.983027756097103,0.47433264887063653,0.8062569863550197,1.0,22/39,40.20%,COX4I1;COX6B1;CLCN3;NNT;UQCRQ;COX15;NDUFA4;UQCR11;COX10;UQCRH;NDUFA4L2;CLCN5;COX8A;COX4I2;COX7A2L;SLC4A11;COX5B;SLC11A2;UQCRFS1;COX6A1;CLCN4;UQCRC1
prerank,potassium:proton antiporter activity (GO:0015386),-0.4263187398468155,-0.9828917466523218,0.5027223230490018,0.8030527549696612,1.0,1/10,0.51%,SLC9A2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2694433667789552,0.981213986761164,0.4787018255578093,0.8019908678941438,1.0,14/70,17.29%,B3GALT1;B3GALNT1;MGAT4C;GXYLT2;B3GNT7;B3GLCT;POGLUT2;B3GALT2;EXTL1;B3GALT5;CHSY3;CHSY1;B4GAT1;B3GNT6
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.34059766321637963,-0.9810633720219111,0.5126811594202898,0.8043175316001729,1.0,6/22,9.56%,ATP6V0B;ATP2C1;ATP2A3;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,snoRNA binding (GO:0030515),-0.31502782183632183,-0.9809120140487566,0.5018518518518519,0.8012517602436617,1.0,6/30,12.96%,NOP14;PRKDC;NOP56;DHX37;NUDT4;DKC1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.27708785342273473,-0.9807364288067938,0.491588785046729,0.7980808306513985,1.0,13/54,17.19%,ACER2;TGM2;HDAC9;PIGL;HDAC4;ASAH2;GLS;HINT1;MIER2;ACER3;FAAH;MIER1;AMDHD2
prerank,protein heterodimerization activity (GO:0046982),0.23509694325336558,0.9796426933143165,0.5070993914807302,0.8018913994803926,1.0,11/178,3.90%,BMP6;TCF4;ARNT2;ATP1A2;EPAS1;GPHB5;TENM3;ZHX2;DGKD;BCL2;TENM2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.39897835006527965,-0.9777504499363453,0.509469696969697,0.802243184769444,1.0,2/12,5.84%,BACE2;BACE1
prerank,nuclear import signal receptor activity (GO:0061608),-0.374748409693505,-0.9749274558091279,0.499054820415879,0.8056493796666605,1.0,8/15,42.67%,KPNA1;TNPO3;KPNA4;TNPO2;KPNA6;IPO5;KPNA7;IPO9
prerank,fatty acid synthase activity (GO:0004312),-0.41669926976261107,-0.9728385278700837,0.5123339658444023,0.8077053453697882,1.0,3/10,17.96%,ELOVL7;ELOVL5;ELOVL1
prerank,glucuronosyltransferase activity (GO:0015020),-0.351811469874761,-0.972402353536978,0.5127272727272727,0.8054004764624958,1.0,1/19,0.70%,CSGALNACT1
prerank,DNA-binding transcription factor binding (GO:0140297),-0.22392103256723986,-0.971833160591412,0.5131313131313131,0.803300603236807,1.0,50/189,18.45%,MEF2C;LMO2;TLE4;PPARD;NCOR1;MEF2A;KLF4;ZBTB7A;PRDM16;HDAC7;HDAC9;WWP2;CTBP1;BHLHE40;PTMA;USF2;TLE3;ATF4;CHCHD2;HCFC1;HSPB1;CBX5;HDAC4;TAL1;DHX9;TWIST1;ZMYND8;NFATC1;HHEX;RB1;DDRGK1;MTA2;GABPA;MTA1;PSMC5;YWHAZ;MIER2;HES1;SRF;LDB1;ZFPM2;STAT1;TCF3;DDX20;MIER1;RELA;KDM1A;SP1;SMAD2;CHD4
prerank,double-stranded DNA binding (GO:0003690),-0.20010243590181065,-0.9712301998825779,0.5684647302904564,0.8014631412304939,1.0,102/531,18.59%,KLF12;LEF1;FOXP1;ELK3;ERG;MEF2C;TBX15;NR3C2;ESR1;KLF3;FLI1;HMBOX1;JUND;PPARD;KLF2;KLF4;ELF1;TBX1;ZSCAN29;FOXO3;RPS3;ZBTB7A;VSX1;SIX1;LHX6;TBX2;NR4A2;TFCP2L1;BHLHE40;FOXK1;USF2;RARA;PRDM4;GATA6;ATF4;GATA2;PRKDC;SAFB;NR3C1;ZNF276;FOXQ1;HDGF;NR2C2;YY1;ZMYND11;BCL6;SOX7;DHX9;NFATC1;SOX18;ESRRA;JUNB;ZIC3;PRRX2;GABPA;FOXC2;ZBTB18;E2F3;SP3;SOX12;TEAD2;HIVEP1;E2F1;PNKP;SOX4;SPRTN;HES1;GRHL1;AIM2;MLX;RFX2;FOXD2;BCL6B;NR5A2;HEY1;ETV5;EGFR;SRF;IRF9;ETV4;RFX5;POU2F2;STAT1;ZNF76;GMEB2;KLF6;ETS2;ZNF32;ZBTB2;ZBTB48;HOXB4;XBP1;WDR48;FOXL2;NR6A1;SP1;DRGX;GTF2H4;E2F4;SMAD2;IRF8;CGAS
prerank,DNA binding (GO:0003677),0.20167603944166407,0.9697463337031257,0.599290780141844,0.8229793670628124,1.0,105/694,13.64%,TCF7L2;TCF4;RORA;TBX3;EPAS1;HLF;NR2F2;RBMS1;C1D;HIVEP2;DMC1;VDR;RARB;MCM3;TEAD1;PPARA;GLI2;DLX3;PRDM5;SMAD3;TBX21;BCL2;DDB2;TFCP2;ZEB2;PBX4;MPG;SP7;STN1;FOSB;ZNF35;JCHAIN;CAMTA1;CEBPB;ZMYM6;SOX21;ZNF292;ZNF513;TOP1;RNF138;TAF6L;ATF5;PRDM9;FOXA2;TOP3A;SETMAR;KHDRBS1;CUX1;LHX4;MEN1;ATAD5;CRY1;RARG;SOX2;RBPJ;TIGD4;SAFB2;RBM5;SNAPC3;DNMT1;SWSAP1;POLR2G;RADX;BLM;GATA3;FUBP1;RPA2;CTCF;CUX2;TOPORS;MCM2;ZIC4;GTF3C3;MCM9;ANG;NUP35;RAD51C;GRHL3;MCM8;ARID5B;GTF3C2;SNAPC1;SLTM;AHR;RAD51B;POGK;PMS2;GLYR1;ORC1;GTF3C6;SURF6;APLP2;DDX60;CXXC5;NBN;SSBP2;PGR;SATB1;PAX8;PAX3;CENPS;EP300;ATF6;NKX2-1;MYBBP1A
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3413210051419913,-0.9682251161159564,0.4898336414048059,0.805910535190455,1.0,6/20,12.90%,EIF3F;USP7;OTUD5;USP9X;OTUB1;COPS5
prerank,semaphorin receptor binding (GO:0030215),0.3343016706783113,0.9677129301869385,0.4726890756302521,0.8240143555927658,1.0,4/23,4.77%,SEMA5A;SEMA3A;RIT2;SEMA3D
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.2964367021381329,-0.9674868011953114,0.5130597014925373,0.8043412401658604,1.0,13/38,20.98%,PARD3;DAB2IP;DENND1A;ZFYVE26;JPH2;TECPR1;HIP1;KIF16B;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL
prerank,mRNA 3'-UTR binding (GO:0003730),0.25759773390798685,0.9669525015337533,0.4968553459119497,0.8217766354590977,1.0,14/79,15.17%,CELF2;RBMS3;RBMS1;DAZAP1;PABPC1L;CSDC2;IGF2BP2;CPEB3;KHSRP;FXR2;SECISBP2;PARN;RBM24;GEMIN5
prerank,transition metal ion binding (GO:0046914),0.20909641492514658,0.9666747709716438,0.5390070921985816,0.818398883546719,1.0,65/397,13.96%,ENPP1;ADCY2;PAPPA;ADAM33;MYCBP2;PAM;AGMO;ZEB1;HEPH;SEC24D;RBAK;CBLB;GLI2;IKZF4;SMAD3;KDM1B;BBOX1;P2RX4;MDM2;MMP16;KDM7A;DUSP12;MOXD1;RNF2;PRKN;MNAT1;HDAC10;BAZ1B;SMPDL3B;LOXL2;SCD5;SIRT2;ANPEP;CXXC4;KMT2A;LOXL3;ENPEP;NSD1;PDXK;BLM;SLU7;CTCF;CHMP1A;RNF26;SOD2;SEC24A;NAALADL1;ANG;TRHDE;DPP3;KDM2A;SOD3;ZFYVE1;APIP;SEC23A;PHF8;ZFP37;CXXC5;MGAT2;ZNF205;CDADC1;BIRC2;ARIH2;LITAF;GRIN2A
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.32702906918791563,-0.9656789476778986,0.4910394265232975,0.8055545810744928,1.0,8/25,16.50%,ARAP3;HIP1R;AKT1;MAPKAP1;HIP1;KIF16B;GAB2;PHLDA3
prerank,single-stranded DNA helicase activity (GO:0017116),-0.34296953018652904,-0.9631883844851912,0.4857685009487666,0.808309491153491,1.0,11/19,32.39%,DHX9;HELQ;POLQ;RFC3;MCM5;RFC2;DNA2;DSCC1;CHTF18;PIF1;HELB
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3996014960368425,-0.9618828902056373,0.5,0.8081943508448103,1.0,5/11,30.49%,ANAPC11;RBX1;AMFR;UBE4A;PRPF19
prerank,ubiquitin binding (GO:0043130),-0.25313240309096013,-0.9600204671615121,0.53515625,0.8092802932433277,1.0,20/73,17.29%,ASCC2;MVB12B;N4BP1;HSPB1;UBE2L6;PLAA;OTUB1;RNF185;UCHL1;TOLLIP;USP5;UBXN1;SPRTN;FAF2;VPS36;TSG101;TOP2A;TNFAIP3;UCHL3;WDR48
prerank,transcription coregulator binding (GO:0001221),0.28278302003981837,0.9568616951377229,0.5379609544468547,0.8398828426664711,1.0,15/50,18.00%,RORA;AR;SMAD3;CHD6;CTCF;AHR;EHMT2;PER3;PGR;EZH2;THAP7;MTF2;CDK9;USP11;PER1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3558026821467054,-0.9549367147568635,0.5238095238095238,0.8186690923366153,1.0,9/16,33.34%,RPS3;CD38;SMUG1;NEIL1;ADPRH;TDG;BST1;OARD1;NEIL3
prerank,SUMO binding (GO:0032183),-0.3837782819901346,-0.9542453914596795,0.5117117117117117,0.8169408372119912,1.0,6/13,26.43%,HERC2;RNF111;UBA2;USPL1;SERBP1;TDG
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3606161496547704,-0.9539828528561479,0.5278810408921933,0.8141984391260257,1.0,5/15,14.20%,HS3ST3A1;NDST1;NDST3;HS3ST1;HS3ST3B1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.3874489063998212,-0.9537118872103822,0.5148342059336823,0.8115690070968058,1.0,7/12,37.14%,CBR1;NQO1;NQO2;DCXR;DHRS4;NDUFS7;AIFM2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.38215070181972904,0.9527802548900818,0.5142857142857142,0.8457766736310225,1.0,1/12,1.29%,GPR88
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.2220664169385526,-0.9523896415710938,0.5770833333333333,0.8115785594755525,1.0,49/173,23.30%,KLF12;FOXP1;ELK3;DACH1;PPARD;FOXO3;REST;PRDM16;TBX2;PRDM2;BHLHE40;SOX13;FOXK1;HEYL;ZBTB16;LRRFIP1;KLF8;NR3C1;YY1;PLAGL1;BCL6;HHEX;MXD1;FOXP2;SKIL;ZBTB18;HES1;MLX;BCL6B;HEY1;ZFHX3;TCF3;ETS2;ZBTB2;RELA;FOXP4;IRF8;SKI;ZBTB33;NFATC3;ZBTB49;E2F6;THAP11;NR2F1;ETV6;ZBTB34;ATF3;ENO1;GZF1
prerank,transcription cis-regulatory region binding (GO:0000976),0.2084155813286124,0.9511839472763937,0.5962616822429907,0.8455215128093307,1.0,49/406,9.82%,TCF7L2;RORA;ZBTB20;AR;EPAS1;MXI1;BCOR;TBL1XR1;RBAK;TRPS1;TEAD1;TBX18;PRDM5;SMAD3;TBX21;KLF15;GLI3;TFCP2;CREB3L1;TFDP1;PHOX2A;AEBP1;HOXC8;ZNF35;CEBPB;HOXB8;ZNF513;ATF5;BBX;GABPB1;GABPB2;PRDM9;FOXA2;CUX1;LHX4;MEN1;DMTF1;NFXL1;SOX2;SNAPC3;FOXD3;CREB3;GATA3;MLXIP;CTCF;CUX2;SOX5;HOXC10;ERBB4
prerank,chloride channel activity (GO:0005254),0.27418357020393697,0.9511352890145574,0.5347912524850894,0.841443763647993,1.0,17/59,15.96%,ANO7;CLCN2;GABRA2;GABRR3;GLRB;GABRB3;FXYD1;ANO3;GABRR2;GABRA5;CLCN1;CLCN6;GLRA3;ANO5;GABRB1;GABRG1;GABRG3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4071663834963106,-0.9493555049941774,0.5573770491803278,0.8156350205749004,1.0,7/10,41.97%,NCF2;CYBB;NOX1;NCF1;NOX3;NCF4;DUOX1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.32381467473040787,-0.9473907648440417,0.5160075329566854,0.8168997864028125,1.0,9/24,24.38%,KCNJ2;ABCC9;KCNJ10;KCNJ8;KCNJ15;KCNK6;ABCC8;KCNN3;KCNJ13
prerank,leucine zipper domain binding (GO:0043522),0.40572813486660525,0.9466463229278321,0.515695067264574,0.8486573310073345,1.0,5/10,19.24%,PAWR;PMF1;CRX;DDIT3;AATF
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3331786220516946,0.9424914065783732,0.5106382978723404,0.8548039082998097,1.0,4/21,6.15%,PRKACA;AKAP8L;ACBD3;ARFGEF2
prerank,ion gated channel activity (GO:0022839),0.3281922387885807,0.9376078990932883,0.5477707006369427,0.8625598563526377,1.0,4/24,6.42%,KCNT2;ANO7;ANO3;TRPM5
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3312295760912829,-0.9359569944134493,0.5730994152046783,0.8422121218156237,1.0,5/20,14.06%,SLC39A10;SLC39A8;SLC39A1;SLC39A11;SLC39A7
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.2777766005568034,-0.9353654490277666,0.569060773480663,0.8402968353624244,1.0,9/42,19.30%,CCND3;CCNY;CDKN1B;CCNG2;CCNF;CDKN1A;CCNK;CDKN2C;CCND1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.34162850201380923,-0.9349286054392981,0.5602189781021898,0.8379111349240238,1.0,5/17,19.33%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,alkali metal ion binding (GO:0031420),0.37477722731670643,0.9333088499355928,0.5446224256292906,0.8694191095270327,1.0,2/13,8.89%,ATP1A2;PDXK
prerank,MAP kinase kinase activity (GO:0004708),-0.35680728090273794,-0.932119209996308,0.5447897623400365,0.8412580947339691,1.0,2/15,4.10%,MAP2K5;MAPKAPK3
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.25746999686817007,-0.931802199386972,0.5919540229885057,0.8387202493465802,1.0,11/55,11.62%,ITPR2;TRPC3;TRPM7;TMEM165;ATP2C1;ANXA2;PKD1;ATP2A3;ORAI1;TRPV4;ATP2B3
prerank,ATPase binding (GO:0051117),0.25234155220815463,0.9315927519854357,0.5717439293598234,0.8695594062517294,1.0,14/71,14.06%,AR;ATP6V0A4;ABCA1;SLC2A13;ANK2;METTL21A;TMTC4;ANK1;ATXN3;ALDOB;NKD2;USP25;PGR;ATP1B3
prerank,histone methyltransferase activity (GO:0042054),0.2955999987217771,0.930446386793933,0.5576923076923077,0.8681491378827445,1.0,9/32,15.91%,PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B
prerank,protein phosphatase regulator activity (GO:0019888),0.26724627800908907,0.9292096554161713,0.545271629778672,0.8669391648686092,1.0,3/53,2.73%,RCAN2;PTN;DMPK
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.24511637899989588,0.9289481049524898,0.5650406504065041,0.8634201329686529,1.0,12/91,8.16%,SVIL;FRMPD4;SH3PXD2B;WDR45B;SNX14;GBF1;SNAP91;WIPI1;SYTL2;TULP3;GSDMD;SCIN
prerank,thyroid hormone receptor binding (GO:0046966),-0.30191268873417926,-0.9284868291216172,0.5796545105566219,0.8435211168024336,1.0,4/28,7.95%,JMJD1C;NCOR1;TACC1;MED24
prerank,symporter activity (GO:0015293),-0.3998871406142766,-0.9264555710734573,0.5699300699300699,0.8453524427317785,1.0,2/10,6.76%,SLC5A6;MFSD2A
prerank,O-methyltransferase activity (GO:0008171),0.3870550899820493,0.9247268483229664,0.5410628019323671,0.8697183483391533,1.0,3/10,15.81%,HENMT1;COMT;BCDIN3D
prerank,voltage-gated anion channel activity (GO:0008308),-0.3514343361615524,-0.9237705292161033,0.5742049469964664,0.8486334621587736,1.0,6/15,20.98%,ANO6;ANO1;CLCN3;GPR89B;GPR89A;CLCN5
prerank,palmitoyltransferase activity (GO:0016409),-0.301047865142354,-0.9218146386372931,0.581981981981982,0.8500032020793841,1.0,12/28,31.18%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,histone acetyltransferase binding (GO:0035035),0.3242234314911554,0.9196196873255631,0.5490605427974948,0.8780997459275653,1.0,5/21,7.94%,EPAS1;GLI3;TRIP4;SIRT2;CITED2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3970051881501616,-0.9188150056072432,0.574757281553398,0.8539473985956169,1.0,4/10,12.18%,DPP4;FAP;PRCP;DPP8
prerank,cGMP binding (GO:0030553),-0.38162757832143823,-0.917838493300058,0.5622895622895623,0.8529714490246633,1.0,2/11,4.54%,PDE5A;PDE2A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3845156801115914,-0.9152819658930819,0.575139146567718,0.8554671557818306,1.0,2/11,13.67%,PRMT8;PRMT3
prerank,MAP kinase activity (GO:0004707),-0.3517971115576579,-0.9145141858158189,0.5724508050089445,0.8539872146695726,1.0,2/14,2.70%,NLK;MAPK3
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.34681112889137844,-0.9093973928714572,0.5652951699463328,0.8623045520437553,1.0,6/15,23.23%,PI4K2A;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,amyloid-beta binding (GO:0001540),-0.23930399565364735,-0.9091532476103532,0.6506024096385542,0.8594959545395837,1.0,13/79,12.43%,COL25A1;APBB2;ITM2A;FZD6;FZD4;TGFB2;PFDN5;BACE1;INSR;CST3;CD74;APOE;TLR4
prerank,GABA receptor binding (GO:0050811),-0.37669839064868815,-0.9089075730737808,0.5772811918063314,0.8567697699349918,1.0,3/11,7.11%,TRAK1;GABARAP;TRAK2
prerank,chloride channel inhibitor activity (GO:0019869),-0.38576792708999874,-0.9087224283748344,0.5933852140077821,0.8540338265062278,1.0,3/10,17.38%,WNK1;STX1A;VTI1B
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.26902826749876796,0.9078257434101463,0.5690721649484536,0.9030602523694836,1.0,16/44,15.91%,PRDM9;SETMAR;MEN1;KMT2A;KMT5C;NSD1;SMYD1;CXXC1;SETD7;SMYD3;EHMT2;SETD5;NSD3;EZH2;WDR82;KMT5B
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.37546408311840435,-0.9075805461811101,0.5964285714285714,0.8535226367524391,1.0,5/12,16.61%,CDK6;BRD4;CDK4;CDK13;CCNK
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.28345505650021985,-0.9073475116434938,0.5958254269449715,0.8508232444792727,1.0,16/33,38.04%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;EXD2;XRN2;ISG20;DCP2;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,clathrin adaptor activity (GO:0035615),-0.3528727458094767,-0.9057988006622121,0.5927272727272728,0.8511886632064328,1.0,9/15,34.26%,HIP1R;AP2M1;HIP1;AP2A1;AP2A2;AP1G2;AP1G1;AP2B1;STON2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.36725956669755067,-0.9037933482369405,0.611214953271028,0.8524912818854534,1.0,4/12,17.07%,H3-3A;POU2F1;STAT1;RELA
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2590104775997338,-0.9014373375217564,0.6515151515151515,0.8543699525213736,1.0,15/49,25.12%,ESYT2;ANXA1;ANXA2;DYSF;CPNE8;ANXA4;RPH3A;SYT2;ESYT3;CPNE3;SYT15;PLA2G4F;ANXA8;ANXA3;DOC2B
prerank,RNA polymerase II complex binding (GO:0000993),-0.28708110974873213,-0.8994618641974812,0.614100185528757,0.8558890269916948,1.0,14/32,35.80%,RPRD1B;BRD4;ZNF326;DHX9;SMYD2;PCIF1;CCAR2;SCAF1;RPRD1A;RTRAF;ESRRB;PCF11;ELOF1;CDC73
prerank,chemokine binding (GO:0019956),0.2946488791136226,0.8982615212722137,0.5953389830508474,0.922778731573508,1.0,5/30,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.21212903204920433,0.8957142071903682,0.7276264591439688,0.924270012200849,1.0,18/181,9.10%,TCF7L2;ARNT2;LDB2;AR;TBX3;NCOA2;PRRX1;PPARA;TTC8;SMAD3;PTPRT;TRIP4;CRY1;RBPJ;NCOA1;MIER3;ATN1;BRMS1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.38688034777243896,0.8950401191902188,0.5710900473933649,0.9215228649191377,1.0,3/10,7.95%,CFLAR;CASP3;CASP12
prerank,transcription corepressor binding (GO:0001222),0.295197040237519,0.8921893236003823,0.6068376068376068,0.9238038100887175,1.0,8/27,18.00%,RORA;EHMT2;PER3;EZH2;THAP7;MTF2;USP11;PER1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3616379839938884,-0.8920852822698285,0.6068052930056711,0.8692288521281649,1.0,4/12,24.36%,TRAF1;STAT1;BABAM2;TRAF6
prerank,calcium-release channel activity (GO:0015278),-0.32550682436708234,-0.89048209209828,0.6137184115523465,0.869722817189517,1.0,2/17,3.95%,ITPR2;ITPR3
prerank,ribosomal large subunit binding (GO:0043023),-0.37552025025330227,-0.8902281034662496,0.6091549295774648,0.8670700602239082,1.0,5/11,36.48%,NMD3;LTN1;NPM1;RBM3;CPEB2
prerank,telomeric DNA binding (GO:0042162),-0.2807675304613491,-0.8899412354379787,0.6266666666666667,0.8645428855467916,1.0,14/32,33.31%,HMBOX1;HNRNPA2B1;NCL;UPF3A;ZBTB48;KDM1A;SMG7;SMG1;TERF2IP;UPF1;SMG6;PIF1;TERT;RAD50
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.2906169351179632,-0.8887873668291243,0.6366906474820144,0.8638368981412,1.0,13/29,36.25%,PTPRJ;GCH1;MAPKAPK3;NFATC1;ACE;CDK5RAP3;DUSP4;DUSP6;DUSP1;ABL1;DUSP7;MAPK7;DUSP5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.37483604130213977,0.8880329704406187,0.5952380952380952,0.9294186536436749,1.0,3/11,7.95%,CFLAR;CASP3;CASP12
prerank,single-stranded RNA binding (GO:0003727),-0.2591971186611279,-0.8869891307832246,0.646484375,0.8644341450049505,1.0,11/43,20.33%,IFIH1;STRBP;CNBP;SNRPC;DHX9;JMJD6;DHX58;FMR1;HNRNPA1;SRA1;RBM7
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3604905567775418,0.8857979678816638,0.584070796460177,0.9304500900366216,1.0,5/12,14.55%,PDE7B;PDE3B;PDE4B;PDE3A;PDE4A
prerank,phosphoric ester hydrolase activity (GO:0042578),0.25832881053744106,0.8848107242064019,0.6505263157894737,0.9285252738431661,1.0,7/49,10.26%,ATP1A2;PLCXD1;DUSP12;PXYLP1;SMPDL3B;HDHD2;LHPP
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2728490114142057,-0.8824840960283435,0.64030131826742,0.8708348432276343,1.0,14/35,23.72%,QRSL1;DUS2;TRMT9B;GATC;QTRT2;TRDMT1;TRPT1;QTRT1;PTRH2;ELAC1;AARS2;MRPL58;TYW3;GATB
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3061608659173666,-0.8802011211599269,0.6593406593406593,0.8725758794782599,1.0,5/22,15.15%,MESD;AP2M1;DNAJA1;APOE;AP2A1
prerank,mRNA binding (GO:0003729),-0.19672770864331696,-0.8778463104552948,0.8323108384458078,0.8744734982840577,1.0,46/249,14.96%,DDX5;RPS14;RPL41;NOVA2;RPL26;RPS3;HNRNPA2B1;HNRNPLL;RBM20;CNBP;EIF4G3;QKI;RPS5;RPS13;RPL35;SRSF5;PTBP3;RBFOX2;PKM;N4BP1;YBX3;RC3H1;SRSF6;RBM47;NCL;DHX9;PCBP4;ACO1;TDRD7;PPP1R8;RPL13A;LUC7L2;EIF3D;LARP4B;YTHDF2;CIRBP;ZC3H11A;RPS7;RBMS2;RNPS1;FMR1;SRSF4;EIF4A1;RNF20;RBM4B;HNRNPK
prerank,bHLH transcription factor binding (GO:0043425),0.3160143670105816,0.8778349058932647,0.6316964285714286,0.9405834766620864,1.0,2/19,2.77%,FHL2;SMAD3
prerank,phosphatase activator activity (GO:0019211),-0.3369812003355583,-0.877262662894272,0.6326530612244898,0.8726012785928174,1.0,6/14,17.33%,CALM1;PPP2R5A;PHACTR4;CALM3;GTF2F1;PPP2R5E
prerank,ankyrin binding (GO:0030506),-0.31666778044566846,-0.8772616194882734,0.6201117318435754,0.8695030789348275,1.0,2/19,1.41%,CDH1;SPTBN1
prerank,snRNA binding (GO:0017069),-0.2569164209708242,-0.8751454808287978,0.6755218216318786,0.8707294661705767,1.0,14/42,22.84%,PRPF8;SNRPA;SNRPC;RBM22;SNRPD3;LSM11;EFTUD2;DDX39B;LSM2;LSM7;RBM7;MEPCE;NCBP2;LSM10
prerank,alpha-tubulin binding (GO:0043014),0.28812531629537147,0.8745518186175982,0.6505263157894737,0.9436999579264831,1.0,6/31,10.12%,EML4;DLEC1;PACRG;DNAL1;CDK5R1;TBCEL
prerank,carboxypeptidase activity (GO:0004180),0.2820457080600178,0.8738780832290245,0.6371308016877637,0.9410820078426994,1.0,8/35,10.81%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;NAALADL1;FOLH1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.359489438745224,0.8730762954691181,0.6179775280898876,0.9386527795363274,1.0,1/11,3.19%,CNGB3
prerank,endopeptidase activity (GO:0004175),0.19951986131857477,0.8698414547141982,0.8044692737430168,0.9416783424419846,1.0,29/257,12.00%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;PRTN3;ADAMTS5;RHBDL3;CORIN;MMP16;SFRP1;OMA1;USP37;PLG;CASP3;MMP11;PCSK2;PSMA3;SENP1;USP29;PARL;ECE2;EEF1AKMT4-ECE2;USP40;THOP1;USP47;ADAMTS9;USP25;ADAMTSL4
prerank,channel activity (GO:0015267),0.27021183424425593,0.8697720685351934,0.640973630831643,0.9376436000083852,1.0,7/41,13.02%,CHRNA1;STEAP1;BCL2;TRPM5;TRPA1;CHRNA7;CHRNB1
prerank,P-type ion transporter activity (GO:0015662),-0.35665724994455733,-0.86889698439931,0.6370510396975425,0.8808411689411633,1.0,7/12,32.64%,ATP2C1;ATP2A3;ATP2B3;ATP2B1;ATP7B;ATP2C2;ATP2A1
prerank,monocarboxylic acid binding (GO:0033293),0.31605180796918786,0.8675459013597425,0.6023529411764705,0.9384699299825726,1.0,1/18,1.19%,NR2F2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3425494093164967,-0.8674538331224411,0.6126629422718808,0.8807821814002809,1.0,7/13,47.74%,ECH1;ECI1;IDI1;EBP;DCT;HSD3B2;SREBF2
prerank,potassium channel regulator activity (GO:0015459),0.25546171464410244,0.8594369094617067,0.689727463312369,0.9524202124242402,1.0,10/49,15.47%,KCNIP4;DPP10;SLC5A3;SUMO1;KCNIP3;DPP6;AMIGO1;KCNS3;KCNS1;WNK3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2338520527693658,0.8584063353360548,0.7449799196787149,0.9505186963524102,1.0,18/69,18.55%,PLA2G4A;BAAT;KAT8;MOGAT3;DBT;MOGAT2;ZDHHC2;EP300;PLAAT5;MCAT;DGAT2;PORCN;CERS4;ASPG;ZDHHC15;CERS6;GTF2B;ZDHHC6
prerank,endoribonuclease activity (GO:0004521),0.2764720362567492,0.8583301761448136,0.6600877192982456,0.9465245235987209,1.0,10/32,20.54%,NYNRIN;EXOG;RIDA;PIWIL2;ENDOV;RCL1;RNASEL;AGO3;AGO1;AGO2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.26493032947837003,-0.8532014115729727,0.6928982725527831,0.9063626235499623,1.0,15/34,38.04%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;EXD2;XRN2;ISG20;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2860678000611585,-0.8519865360780293,0.687374749498998,0.9056252928128277,1.0,10/26,28.47%,PPP1R1A;PABIR1;PPP1R8;LMTK2;BOD1;MGAT5;ARPP19;PPP1R14B;STYXL1;PPP1R1B
prerank,transferrin receptor binding (GO:1990459),-0.3713868001736814,-0.8516158731016756,0.6501766784452296,0.9032321107543922,1.0,6/10,36.91%,CD81;IKBKB;CHUK;SNX2;IKBKG;SNX1
prerank,voltage-gated ion channel activity (GO:0005244),0.334489085958645,0.8493803460117643,0.6651053864168618,0.9621240941608751,1.0,4/14,10.94%,CACNA1E;VDAC2;KCND2;VDAC3
prerank,methyl-CpG binding (GO:0008327),0.2978550050683337,0.8464099710130487,0.6563876651982379,0.9641846353638732,1.0,5/22,12.76%,LHX4;MBD2;CXXC4;CXXC5;ERH
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.31428053183572674,0.846209969090643,0.6702355460385439,0.9604321865956874,1.0,3/17,12.07%,NME3;CMPK1;NOL9
prerank,3'-5' exonuclease activity (GO:0008408),-0.24709293505561017,-0.8457379158162937,0.733201581027668,0.9115465410233328,1.0,21/45,38.04%,CNOT7;ERI1;RAD1;DIS3L2;REV3L;PAN2;RAD9A;EXD1;DIS3;NOCT;EXOSC9;MRE11;EXD2;XRN2;ISG20;RAD50;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3132024887061,-0.8455773663642461,0.6630434782608695,0.9055576287128208,1.0,4/16,9.56%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3132024887061,-0.8455773663642461,0.6630434782608695,0.9055576287128208,1.0,4/16,9.56%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,tubulin binding (GO:0015631),0.1893112397238995,0.845559528510996,0.9095940959409594,0.9576822221060276,1.0,66/295,18.53%,GJB6;MTUS2;GJA1;IFT81;KIF13B;TTLL11;EML4;AGBL4;UXT;KIF5C;DLEC1;PRKN;TTLL9;MAP9;ATF5;MDM1;SAXO2;GPAA1;PACRG;TUBGCP4;UNC5C;CEP295NL;KIF7;DNAL1;GOLGA2;IFT74;ALMS1;CDK5R1;KIF21A;CAMSAP1;DYNC1I1;TBCEL;KIF3C;EML1;BRSK1;FSD1;MAP10;KIF3A;B9D2;KIF6;KIF1A;VBP1;MACO1;NAV3;MAPT;TUBGCP2;CEP57L1;DLGAP5;SPAST;MAP6;PAK1;CKAP5;CCDC181;ABRAXAS2;DAG1;SVBP;EMD;NUMA1;EFHC1;HAUS6;KIF21B;NDRG1;DRG1;KATNA1;S100A8;S100A9
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.24123652144258367,0.8450931842723863,0.7251082251082251,0.9546578366691011,1.0,7/60,11.74%,PPM1E;LRRK1;ILKAP;PPM1D;PPM1H;PTEN;TAB1
prerank,FMN binding (GO:0010181),-0.3541204633403011,-0.842291356007133,0.6886446886446886,0.9086914399155454,1.0,2/11,7.25%,NOS3;DUS2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2791169426982278,-0.838641402733229,0.7185741088180112,0.9126630224018266,1.0,8/27,18.84%,RNF144B;DCUN1D5;RNF125;DCUN1D1;TOLLIP;ZMYM2;FOXL2;RNF19A
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.33655287341959694,0.8360238828930938,0.647450110864745,0.969649327951125,1.0,6/13,25.20%,FTSJ1;TARBP1;TRMT1L;TRMT5;THUMPD2;THUMPD3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.34614814941123506,-0.8348049772932895,0.6839186691312384,0.9166520228763744,1.0,2/11,12.43%,DCPS;NUDT4
prerank,N-acetyltransferase activity (GO:0008080),0.3112384551292508,0.831834506392397,0.6773455377574371,0.9741410081379983,1.0,3/19,13.45%,NAT8;SAT1;EP300
prerank,endodeoxyribonuclease activity (GO:0004520),-0.297393612197001,-0.830822097722109,0.6976744186046512,0.9205695109819299,1.0,9/20,33.31%,RPS3;ERCC1;DCLRE1C;ERCC4;EXO1;DNA2;MRE11;ENDOG;RAD50
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.33224621630276996,-0.8301288678895502,0.7074074074074074,0.9188913805579163,1.0,3/13,8.26%,SLC7A1;SLC38A5;SLC7A7
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3223105832442041,0.8290526386446859,0.6570796460176991,0.9757120774360832,1.0,2/15,3.83%,PLA2G4A;SH3PXD2B
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.21684880279954638,-0.8280504273912944,0.8088803088803089,0.9194453649120193,1.0,31/85,36.31%,ABHD2;MGLL;NDST3;PNPLA2;PGLS;PLAAT3;PON3;FAAH;LYPLA1;LCAT;DAGLB;GDE1;ABHD8;PTRH2;AARS2;MRPL58;PLA2G4F;ENPP2;BCHE;PLA2G4B;PAFAH1B3;PLA2G7;ESD;ABHD6;AOAH;LIPE;ABHD16A;PLB1;AARS1;LYPLAL1;LYPLA2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2618461726923749,-0.8257738297245425,0.7466666666666667,0.9205092391930982,1.0,7/33,17.25%,RPRD1B;ZNF326;DHX9;MAF1;SMYD2;ERBB2;CCAR2
prerank,galactosyltransferase activity (GO:0008378),-0.3373593275157559,-0.8248757370726206,0.7059859154929577,0.9190098566073536,1.0,3/11,14.83%,A4GALT;B4GALT4;A3GALT2
prerank,nuclease activity (GO:0004518),0.24496232748725927,0.8236009935852172,0.7484787018255578,0.9820821650735397,1.0,8/52,13.44%,ENPP1;SETMAR;EXOG;ANG;RNASE4;REXO5;PARN;ANKLE1
prerank,cyclic nucleotide binding (GO:0030551),0.293178063849038,0.823056972120089,0.7084282460136674,0.9791439704204978,1.0,8/21,21.92%,RAPGEF4;CNGB3;PDE11A;PDE4B;PDE4A;KCNH1;SLC19A1;PDE10A
prerank,histone demethylase activity (GO:0032452),-0.2690725557419053,-0.8195578313659218,0.7254545454545455,0.9254518642236943,1.0,6/27,17.66%,JMJD1C;KDM5C;KDM3A;JMJD6;KDM1A;KDM6A
prerank,aminopeptidase activity (GO:0004177),-0.27258571338130083,-0.8190212530628385,0.7365491651205937,0.9233237779488197,1.0,10/26,22.52%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;METAP1D;BLMH;LAP3;NPEPPS;MMP17
prerank,kinesin binding (GO:0019894),-0.26641852358378226,-0.8176760281278863,0.7449392712550608,0.9226868722987799,1.0,4/27,14.48%,ACTB;PLEKHM2;KIF1B;SPAG9
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2766184994445719,-0.8173030201663611,0.7553956834532374,0.920279629453483,1.0,10/24,31.18%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC17;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,1-phosphatidylinositol binding (GO:0005545),0.32146047067806055,0.8172054036624413,0.6855895196506551,0.9868534120584728,1.0,5/15,16.32%,SNAP91;SCIN;SNX9;ZFYVE1;ZFYVE9
prerank,pyrophosphatase activity (GO:0016462),-0.23566563170674057,-0.8171412605057828,0.7987551867219918,0.9175140008500158,1.0,9/50,12.49%,ENTPD1;PLPP1;DCPS;DHX9;PRUNE1;ENTPD7;PRUNE2;NUDT4;ENTPD6
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3413905113331142,-0.8137575218496049,0.7217235188509874,0.9206098224590853,1.0,3/11,14.95%,KCNQ1;KCNJ8;KCND3
prerank,miRNA binding (GO:0035198),0.2735178143698688,0.8125912798131902,0.7222222222222222,0.9913416831666281,1.0,10/30,22.53%,TUT4;AGO4;SOX2;PNPT1;RBM10;AGO3;AGO1;AGO2;MATR3;ZC3H7B
prerank,retinoid X receptor binding (GO:0046965),0.3457270933706006,0.8120103878084612,0.6853448275862069,0.9883275732160131,1.0,3/11,8.09%,VDR;RARG;NSD1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2737773208328571,-0.8111864309198092,0.7421150278293135,0.9219479858275222,1.0,8/24,25.56%,CERT1;DAB2IP;JPH2;PLEKHF1;SNX3;RUBCNL;GOLPH3;GOLPH3L
prerank,myosin V binding (GO:0031489),-0.3171562720033328,-0.8102540523168055,0.7283236994219653,0.9205027791834258,1.0,4/15,11.50%,RAB11A;RAB6B;RAB8A;RAB11B
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2679381827201797,0.8101061158465434,0.7401247401247402,0.9878178257539404,1.0,7/28,17.50%,TNK2;PRKACA;MAPKAPK5;AURKC;PRKCG;MAP2K4;MAPK10
prerank,glutathione transferase activity (GO:0004364),-0.28357499496368666,-0.8093507860847623,0.7197696737044146,0.9190669875663269,1.0,10/23,29.73%,GSTA4;GSTM2;GSTA3;GSTM1;MGST3;GSTK1;GSTM5;GSTO1;ALOX5AP;MGST2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.2815843559009104,-0.8086612595079684,0.7649186256781193,0.9172104104076385,1.0,11/22,40.16%,PPM1F;DUSP3;DUSP23;DUSP4;MTMR2;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;MTMR3
prerank,RNA polymerase binding (GO:0070063),0.2908798699839039,0.8074337666534405,0.7280701754385965,0.9886306266373782,1.0,8/18,22.96%,PABPN1;YTHDC2;SCAF8;CCNT1;NEDD4;TCERG1L;BIN1;PKN2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.33317069161913676,0.8008960164252993,0.7074235807860262,0.9970952173284854,1.0,1/11,2.70%,SLC5A3
prerank,phospholipase activity (GO:0004620),-0.21361302913110045,-0.800093281237928,0.86,0.9282923148107782,1.0,24/67,36.31%,PLCE1;PLCB3;MGLL;SMPDL3A;PLAAT3;PITPNM3;PLD3;LYPLA1;GDE1;PLA2G4F;NAPEPLD;ENPP2;PLD4;SMPD1;LIPH;PLA2G4B;SMPD2;ABHD6;PLCB2;ABHD16A;PLB1;FAM83B;LYPLAL1;LYPLA2
prerank,chloride channel regulator activity (GO:0017081),-0.3091986033587043,-0.7997002300736223,0.7393822393822393,0.9259032132605132,1.0,2/14,6.19%,WNK1;STX1A
prerank,DNA polymerase binding (GO:0070182),-0.29156849213808844,-0.798516205979261,0.7185741088180112,0.9248815757046351,1.0,7/18,37.70%,HSP90AB1;SMARCA4;HSP90AA1;FANCD2;SMG6;RAD51;LONP1
prerank,CXCR chemokine receptor binding (GO:0045236),0.33341475376639984,0.7947716544166337,0.6905829596412556,1.0,1.0,4/11,21.39%,PPBP;CXCL1;CXCL12;CXCL10
prerank,phosphatase inhibitor activity (GO:0019212),0.28660779107233586,0.7859678551173568,0.7520661157024794,1.0,1.0,1/20,0.72%,PTN
prerank,iron ion binding (GO:0005506),-0.22707186998677042,-0.7854021390724318,0.8404669260700389,0.9424425029388979,1.0,10/48,13.39%,EGLN3;CDO1;KDM3A;FTL;EGLN2;JMJD6;EGLN1;FTH1;FXN;ISCA2
prerank,metalloaminopeptidase activity (GO:0070006),-0.29790174838008115,-0.7848665183431643,0.7518796992481203,0.9402972188534072,1.0,7/16,22.52%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;NPEPPS;MMP17
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3198659146827579,-0.7825929278401594,0.7446428571428572,0.9409142777238169,1.0,6/12,40.18%,DCPS;NCBP2;EIF4E;CYFIP2;CYFIP1;NCBP1
prerank,regulatory RNA binding (GO:0061980),0.24917669481714907,0.7825503929178446,0.7768052516411379,1.0,1.0,12/38,23.08%,TUT4;AGO4;SOX2;PNPT1;PIWIL2;RBM10;AGO3;AGO1;AGO2;MATR3;ZC3H7B;DICER1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2859442833423791,0.7805170170832412,0.7744034707158352,1.0,1.0,9/20,26.11%,MOGAT3;MOGAT2;DGAT2;ABHD5;LCLAT1;PNPLA3;AGPAT4;PLA2G15;LPCAT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.34063355381034344,0.7801756422344189,0.7248908296943232,1.0,1.0,2/10,13.47%,ADARB2;CDADC1
prerank,lipid phosphatase activity (GO:0042577),0.30106467955687394,0.7791565589153119,0.7384615384615385,1.0,1.0,4/14,16.04%,PLPP3;PLPPR1;PLPPR5;PLPP7
prerank,GTPase inhibitor activity (GO:0005095),-0.30909542723126754,-0.7760419418396324,0.7586206896551724,0.9473641553411789,1.0,5/13,19.08%,IQGAP1;SLIT2;RTKN;CDC42SE1;ARL2
prerank,magnesium ion binding (GO:0000287),-0.1861530764798533,-0.7748542316340301,0.9203187250996016,0.9463034722001553,1.0,35/135,26.43%,MAP3K5;NLK;MAP3K20;PI4K2A;PDE2A;PGM1;SRPK1;DYRK2;HACL1;CDC42BPB;DIS3L2;ABL2;STK38;NUAK2;TOP2A;STK38L;STK26;OPA1;XYLT2;UBA2;MAPK12;MAP3K6;IDH3A;GCLC;SNRK;ADPRH;NUDT18;RRAGC;BRSK2;SIK1;NME1;FAN1;SIK3;PDCD6;TDG
prerank,hydro-lyase activity (GO:0016836),-0.23191120274911173,-0.7743788975342035,0.8176795580110497,0.9440875991830012,1.0,13/41,26.94%,CA4;ECHS1;ACO1;UROS;ECI1;HACD4;ACO2;ENO1;ALAD;PARK7;AUH;CDYL;HACD2
prerank,microtubule minus-end binding (GO:0051011),0.3113569533720252,0.7727337244827469,0.734966592427617,1.0,1.0,4/13,17.06%,TUBGCP4;CAMSAP1;TUBGCP2;NUMA1
prerank,fibroblast growth factor binding (GO:0017134),-0.26898831325763795,-0.7717788239251765,0.7904761904761904,0.9450984043643657,1.0,9/21,23.46%,THBS1;RPS19;CEP57;S100A13;FIBP;FGFRL1;ITGB3;API5;FGFR3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2939480054536697,-0.7683922520939667,0.7941176470588235,0.9470278085118403,1.0,4/15,21.70%,AGPAT1;ABHD8;AGPAT5;LPCAT2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.29550096932908176,0.7647491885131265,0.7626050420168067,1.0,1.0,2/14,9.77%,NME3;CMPK1
prerank,exonuclease activity (GO:0004527),-0.2226281195429334,-0.7635705961221172,0.8521400778210116,0.9507139765856815,1.0,19/46,30.72%,CNOT7;ERI1;ISG20L2;RAD1;DCLRE1C;REV3L;AEN;RAD9A;EXOSC8;EXD1;APEX2;ENPP2;FAN1;EXO1;EXOSC9;MRE11;EXD2;XRN2;ISG20
prerank,solute:proton symporter activity (GO:0015295),0.2894243509334471,0.763308713958283,0.7611940298507462,1.0,1.0,4/16,11.47%,SLC2A13;SLC36A2;SLC33A1;CTNS
prerank,Hsp70 protein binding (GO:0030544),-0.24754275884769525,-0.7628762695146302,0.8317399617590823,0.9486964357843007,1.0,12/31,29.90%,RPS3;DNAJC8;DNAJB12;DNAJA1;NOD2;IQCG;DNAJB1;PPEF2;PPID;FICD;ERN1;RNF207
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3285299583011616,0.7610870388597828,0.7288888888888889,1.0,1.0,1/10,3.07%,TATDN1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.24000526316912613,-0.7607677964658125,0.8535645472061657,0.9486643169500107,1.0,14/34,34.73%,UBE2Q2;UBE2L6;UBE2G2;UBE2F;UBE2Q1;UBE2G1;UFC1;UBE2B;UBE2J2;UBE2I;UBE2T;UBE2R2;UBE2QL1;UBE2C
prerank,motor activity (GO:0003774),0.2175468161946799,0.7601448481490166,0.8695652173913043,1.0,1.0,11/60,12.36%,GPR88;KIF13B;KIF5C;DYNC2H1;KIF7;KIF21A;DYNC1I1;KIF3C;KIF3A;KIF6;KIF1A
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.29919870406640214,-0.7595992978793334,0.7922535211267606,0.9473429581402097,1.0,6/13,27.46%,PIP5K1B;PIK3C2A;PIK3CA;PIK3C2B;PIK3CG;PIP5K1A
prerank,kinase inhibitor activity (GO:0019210),-0.23194736616882827,-0.7567517623585069,0.8499025341130604,0.9482165850893091,1.0,18/33,39.66%,CDKN1B;TAOK3;DUS2;WARS1;TRIB1;CDKN1A;NCK1;CDKN1C;YWHAB;SPRY4;NPM1;PPP1R1B;SH3BP5;ITPRIP;LRP6;GSKIP;SOCS3;GMFG
prerank,histone deacetylase activity (GO:0004407),0.2752447811550469,0.756472630415796,0.793859649122807,1.0,1.0,6/19,17.00%,HDAC10;SIRT2;MIER3;HDAC8;SIRT6;HDAC1
prerank,phosphatase activity (GO:0016791),0.2065557708244426,0.7553085155720688,0.9043659043659044,1.0,1.0,27/73,25.01%,ATP1A2;DUSP12;PXYLP1;PLPP3;PLPPR1;HDHD2;LHPP;CILP2;LPIN3;PLPP4;FRA10AC1;PLPPR5;PSPH;LPIN1;OCRL;ARMT1;DUSP28;DUSP26;NT5M;PLPP5;ACP5;DUSP10;PPP1CC;BPNT2;SBF1;PLPPR4;DUSP8
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.24892133986211823,-0.7485922546592069,0.8317399617590823,0.9559308455720291,1.0,3/27,7.32%,SLC9A2;SLC9B2;SLC4A8
prerank,signal sequence binding (GO:0005048),0.23903359097698032,0.7440838104506912,0.8530612244897959,1.0,1.0,7/35,17.63%,CEMIP;KDELR3;TOMM70;TIMM22;PEX5L;IPO4;KDELR2
prerank,tRNA binding (GO:0000049),-0.22366601193439684,-0.7425790096736702,0.864406779661017,0.9607132352976755,1.0,9/43,18.03%,EEF1A1;SARS1;CARS1;TRMT9B;SARS2;TRMT10C;FARS2;RPUSD4;HSD17B10
prerank,chemokine activity (GO:0008009),0.24035858242246083,0.7424688640721983,0.8185840707964602,1.0,1.0,7/31,21.39%,CXCL16;PPBP;CCL25;CXCL1;CKLF;CXCL12;CXCL10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2417214162741919,-0.7380383185042912,0.856858846918489,0.9633180228104093,1.0,10/29,27.64%,ACER2;GANC;IDUA;ACER3;GUSB;NEU3;CTBS;GANAB;NEU1;LCT
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2861298920005452,0.7370181378067244,0.8,1.0,1.0,4/14,17.91%,MTMR7;PTEN;MTMR10;MTMR9
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.20058116147997618,0.735268045603294,0.9173387096774194,1.0,1.0,10/73,15.00%,LGR4;SORCS1;OPRK1;MC5R;CALCR;GLP2R;EDNRB;CRHR1;HCRTR1;RXFP1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.23783857048810264,0.7328594380274098,0.8662551440329218,1.0,1.0,14/33,24.69%,AR;SCAF8;NCOA3;LLPH;GTF2B;RPRD2;WAC;AGO1;PAF1;AGO2;UVSSA;URI1;CTR9;SUPT4H1
prerank,gamma-tubulin binding (GO:0043015),0.25577286706099883,0.7321752893164443,0.843010752688172,1.0,1.0,11/21,28.67%,TUBGCP4;BRSK1;B9D2;TUBGCP2;PAK1;NDRG1;ARHGEF7;OFD1;DDX3X;GIT1;TUBGCP5
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.2290077308534659,-0.7256799888814307,0.8702702702702703,0.9749177955891112,1.0,6/32,21.37%,KCNB1;KCNQ1;KCNC3;KCNA4;KCNA2;KCNB2
prerank,cAMP binding (GO:0030552),-0.3028223074915059,-0.7215375842841583,0.8375,0.9766857171162372,1.0,2/11,4.54%,PDE4D;PDE2A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.2917135694164653,-0.7215234267458089,0.817531305903399,0.973735186949359,1.0,2/12,6.71%,JMJD1C;KDM3A
prerank,amino acid binding (GO:0016597),0.23461246314653686,0.7204870045397452,0.8498942917547568,1.0,1.0,8/31,17.48%,GRIN3A;GLDC;GLRB;GLRA3;ASS1;DDAH2;CASR;GRIN2B
prerank,microtubule plus-end binding (GO:0051010),-0.2510968419771131,-0.7202067637233709,0.8679245283018868,0.9723882134101681,1.0,7/20,28.74%,DCTN1;MAPRE2;KIF18A;KNSTRN;CLIP1;CLIP2;DST
prerank,DNA secondary structure binding (GO:0000217),0.23214733514472985,0.7193628512750814,0.8713968957871396,1.0,1.0,8/31,13.81%,GEN1;MEN1;KMT2A;BLM;RAD51C;RAD51B;FANCM;MAPT
prerank,N-acyltransferase activity (GO:0016410),0.23261530088392143,0.7189748235438443,0.8803418803418803,1.0,1.0,7/32,17.53%,NAT8;SAT1;BAAT;EP300;PLAAT5;CERS4;CERS6
prerank,exoribonuclease activity (GO:0004532),-0.29224356926719475,-0.7165077901015383,0.8252788104089219,0.9736338938779533,1.0,3/12,28.29%,CNOT7;EXOSC8;EXOSC9
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.2917892698106857,-0.7152200313690453,0.8180147058823529,0.9721838047479023,1.0,2/12,14.94%,CNOT7;PAN2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.26778170789774813,0.711965790458692,0.8230088495575221,1.0,1.0,2/16,7.03%,ALOX12;TDO2
prerank,WW domain binding (GO:0050699),0.2427444487064205,0.7109557790929039,0.8537117903930131,1.0,1.0,4/26,13.94%,TNK2;PMEPA1;TCEAL1;LITAF
prerank,methylated histone binding (GO:0035064),-0.19766753472826593,-0.7103651768579992,0.9196078431372549,0.9746545865951523,1.0,8/62,9.11%,RBBP5;ING5;DPF2;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.30173675552026,0.708093671399688,0.8043956043956044,1.0,1.0,1/10,2.08%,PRKAG2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.27572040367585204,0.7048685255945629,0.8367816091954023,1.0,1.0,4/15,8.68%,PRDM9;SETMAR;KMT2A;CXXC1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2900430200700391,0.7036782405781118,0.8266666666666667,1.0,1.0,3/11,14.57%,STN1;RPA2;RPA1
prerank,ATP hydrolysis activity (GO:0140603),0.21923141526794485,0.6994973510431555,0.8924050632911392,1.0,1.0,9/41,15.04%,ABCA4;ABCD2;CLPX;SWSAP1;RHOBTB3;SMCHD1;ABCG4;MYO18A;MYO1E
prerank,damaged DNA binding (GO:0003684),-0.20586907647518507,-0.699198199851583,0.9146341463414634,0.9832160235265588,1.0,10/44,19.11%,RPS3;ERCC1;RAD1;PNKP;DCLRE1C;RAD18;XRCC1;RPA3;POLQ;ERCC4
prerank,manganese ion binding (GO:0030145),0.20598464231259858,0.6989632540681522,0.9261477045908184,1.0,1.0,1/48,0.23%,ADCY2
prerank,histone acetyltransferase activity (GO:0004402),-0.22549160674630356,-0.6955540683155471,0.9235181644359465,0.9838501309559102,1.0,13/30,32.61%,BAZ1A;EPC1;NAA60;USP22;BRCA2;TADA3;CLOCK;TAF9;KAT6B;TAF10;NAA50;KAT2A;CREBBP
prerank,AMP binding (GO:0016208),0.27416413214921875,0.6922409099731175,0.8358862144420132,1.0,1.0,4/11,20.95%,PRKAG2;ACSS2;APRT;MPPED2
prerank,actinin binding (GO:0042805),-0.23894918895910228,-0.6921145392341664,0.8766114180478821,0.9840605765720812,1.0,6/21,21.50%,PROM1;RARA;CACNA1D;RELA;CACNA1C;PKD2
prerank,carboxylic acid binding (GO:0031406),-0.21163144279247478,-0.6909166938607401,0.9176245210727969,0.9822566638636087,1.0,19/38,35.45%,NOS3;PSAP;CAD;GCLC;SESN2;CASTOR2;HIF1AN;RTN4R;THNSL2;GRIN1;SESN1;GNMT;NOS2;EPDR1;SRR;NOS1;SHMT2;GLRA1;MAG
prerank,5'-3' exonuclease activity (GO:0008409),-0.262742140059149,-0.6901362117670009,0.8766114180478821,0.9801140624184301,1.0,6/14,33.10%,DCLRE1C;FAN1;EXO1;MRE11;XRN2;DCP2
prerank,triglyceride lipase activity (GO:0004806),-0.24317887986139392,-0.6894933950134787,0.883495145631068,0.9778423815913314,1.0,5/20,33.37%,PNPLA2;LCAT;DAGLB;LIPH;LIPE
prerank,sequence-specific mRNA binding (GO:1990825),0.2915139632287986,0.6884229699133485,0.8293216630196937,1.0,1.0,4/10,22.72%,LARP6;RBM24;SHFL;SSB
prerank,microtubule motor activity (GO:0003777),0.2045784954257381,0.6869909389163205,0.9453441295546559,1.0,1.0,9/51,12.36%,KIF13B;KIF5C;KIF7;KIF21A;DYNC1I1;KIF3C;KIF3A;KIF6;KIF1A
prerank,chemoattractant activity (GO:0042056),0.23520231202048658,0.6836242328041386,0.8662280701754386,1.0,1.0,3/26,7.30%,GDNF;VEGFB;SCG2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2723752094783251,0.6830814830102351,0.8438914027149321,1.0,1.0,3/13,15.07%,ZGRF1;GEN1;ENDOV
prerank,carboxy-lyase activity (GO:0016831),-0.22821007569356924,-0.6828826412907754,0.8931451612903226,0.9810993402168291,1.0,9/23,46.28%,AMD1;DDC;FAHD1;UMPS;UXS1;PCK2;ODC1;GAD1;AZIN1
prerank,methyltransferase activity (GO:0008168),0.20412184380688347,0.6816352042695543,0.9219088937093276,1.0,1.0,12/46,21.58%,FTSJ1;HENMT1;COQ5;DNMT1;COMT;NDUFAF7;METTL3;BCDIN3D;ARMT1;METTL27;GCSH;DNMT3B
prerank,adrenergic receptor binding (GO:0031690),0.26647819514556287,0.6813397618419387,0.8738095238095238,1.0,1.0,4/16,16.08%,MAGI2;APLP1;DLG4;NEDD4
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2538948812342221,0.6769658772082919,0.8669438669438669,1.0,1.0,3/16,13.04%,MTMR7;PTEN;MTMR10
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2373580899856395,-0.6759905857819452,0.888030888030888,0.9843665969599791,1.0,2/20,5.05%,TJP2;MAGI3
prerank,methylation-dependent protein binding (GO:0140034),-0.1881569955558565,-0.671171694716404,0.972972972972973,0.9855461838223737,1.0,7/57,9.11%,RBBP5;ING5;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.25933239796905744,0.6699973624496598,0.8788546255506607,1.0,1.0,5/14,19.74%,KMO;MICAL1;CYB5R4;AIFM1;NOX4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21942610923085268,0.6666704077181078,0.9066937119675457,1.0,1.0,14/28,29.33%,POP4;ENDOV;DROSHA;RNASEH1;AGO3;AGO2;PRORP;MRPL44;DICER1;EDC3;DBR1;RPP14;FEN1;POP1
prerank,pentosyltransferase activity (GO:0016763),0.21090092184149334,0.6642797792150403,0.9358407079646017,1.0,1.0,14/36,24.81%,PARP16;SIRT2;PARP11;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;LACC1;PARP8
prerank,dynactin binding (GO:0034452),0.2664607169405894,0.6625152866994237,0.8512035010940919,1.0,1.0,7/12,27.91%,BICD1;MAPT;SNX6;BBS4;BICDL1;SNX5;PAFAH1B1
prerank,SUMO transferase activity (GO:0019789),0.2540980974271094,0.6591645639473003,0.8793103448275862,1.0,1.0,5/16,18.37%,MDM2;TOPORS;PIAS1;PIAS2;NSMCE2
prerank,CoA hydrolase activity (GO:0016289),-0.24921796378091043,-0.6563438777341346,0.9042145593869731,0.9944062750173416,1.0,10/16,41.34%,ACAA2;ACOT8;HIBCH;ACOT2;ACOT13;ACOT1;ACOT6;ACOT12;ACOT7;ABCD1
prerank,general transcription initiation factor binding (GO:0140296),-0.22450205132355028,-0.6547688270722436,0.9416195856873822,0.992649701188282,1.0,6/25,17.07%,ESR1;HHEX;PSMC5;DRAP1;PSMC1;RELA
prerank,pseudouridine synthase activity (GO:0009982),0.251340040242123,0.6534517571012038,0.8956521739130435,1.0,1.0,5/13,22.80%,RPUSD2;RPUSD3;PUS7;PUS1;PUS10
prerank,serine-type peptidase activity (GO:0008236),-0.1648999667691936,-0.6523575655301995,0.9920948616600791,0.9915733060448715,1.0,6/96,5.95%,DPP4;F3;FAP;TPP1;RHBDD1;PIK3IP1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22869443692754166,0.6480122203274056,0.8995726495726496,1.0,1.0,2/21,6.24%,KL;NPTN
prerank,adenyl nucleotide binding (GO:0030554),0.26882781932126204,0.6476749506656554,0.8896103896103896,1.0,1.0,6/11,24.55%,HSPBP1;HSPH1;BAG3;GRPEL2;BAG4;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.26882781932126204,0.6476749506656554,0.8896103896103896,1.0,1.0,6/11,24.55%,HSPBP1;HSPH1;BAG3;GRPEL2;BAG4;SIL1
prerank,lipoprotein particle receptor binding (GO:0070325),0.21366272756292493,0.6466284002703282,0.941834451901566,1.0,1.0,10/27,25.27%,LRP1;SYT1;HSP90B1;HSPG2;LDLRAP1;CRP;APBB3;LANCL1;RELN;CLTC
prerank,ubiquitin-specific protease binding (GO:1990381),0.23775666096104528,0.6463954912410744,0.9105145413870246,1.0,1.0,5/19,16.84%,PRKN;SUMO1;PTEN;SART3;SPATA2
prerank,RNA methyltransferase activity (GO:0008173),0.23561755984624336,0.6396198808640473,0.8973214285714286,1.0,1.0,5/19,16.82%,FTSJ1;HENMT1;METTL3;BCDIN3D;METTL8
prerank,vitamin D receptor binding (GO:0042809),-0.24820869645776417,-0.6364701085054484,0.9083969465648855,0.9996105977939921,1.0,3/14,22.43%,MED24;MED14;MED13
prerank,diacylglycerol kinase activity (GO:0004143),-0.26984348692395443,-0.6349218447905808,0.9182156133828996,0.9977013666925855,1.0,1/11,1.69%,DGKH
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.27012817283035756,0.6312224253462804,0.8952772073921971,1.0,1.0,3/11,19.35%,DDAH2;PADI1;PADI2
prerank,lysophospholipase activity (GO:0004622),-0.2275900706595833,-0.6307100591254918,0.9380692167577414,0.9974536759935377,1.0,9/20,36.31%,MGLL;LYPLA1;GDE1;ENPP2;PLA2G4B;ABHD16A;PLB1;LYPLAL1;LYPLA2
prerank,neuropeptide hormone activity (GO:0005184),-0.21843225137162284,-0.6260161315978733,0.9368836291913215,0.99754288558366,1.0,15/22,54.64%,AGRP;SPX;NPFF;ADCYAP1;NPY;VIP;GAL;CALCB;PENK;UCN;NMB;GRP;NPPA;GHRH;QRFP
prerank,endonuclease activity (GO:0004519),0.18349285725364034,0.6257991453061259,0.9836734693877551,1.0,1.0,14/49,23.08%,SETMAR;NYNRIN;EXOG;ANG;PIWIL2;ANKLE1;RCL1;RNASEL;AGO3;AGO1;AGO2;ZRANB3;APLF;DICER1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2694227616734455,0.6232059701075052,0.9070796460176991,1.0,1.0,5/10,22.86%,KAT8;EP300;ATF2;MSL3;NAA40
prerank,tau-protein kinase activity (GO:0050321),0.221433626859307,0.6218944036518983,0.9202453987730062,1.0,1.0,2/20,10.85%,ROCK2;BRSK1
prerank,cardiolipin binding (GO:1901612),0.2709170473480921,0.6148556518496695,0.9146608315098468,1.0,1.0,2/10,13.50%,GSDMD;GSDME
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.20588447650368408,0.6135028025968308,0.948936170212766,1.0,1.0,11/27,26.20%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;PRIM1;POLR2B;CRCP;POLR3K;MED21;POLR3F
prerank,serine-type endopeptidase activity (GO:0004252),0.16587976148161276,0.6131650811807291,0.9938524590163934,1.0,1.0,6/80,9.82%,PRTN3;RHBDL3;CORIN;PLG;PCSK2;PARL
prerank,endopeptidase regulator activity (GO:0061135),0.1852325750738205,0.6041604899799412,0.9747899159663865,1.0,1.0,5/40,12.14%,AHSG;RECK;PSMF1;PSME3;SPINK1
prerank,heme binding (GO:0020037),0.1676621206446123,0.6006706699173844,0.9933035714285714,1.0,1.0,15/65,19.74%,CYP27A1;PTGIS;CYP2A6;PTGES2;TDO2;CYP46A1;CYB5R4;HCCS;BACH1;CYP26B1;CYP51A1;HEBP1;EIF2AK1;PTGS2;NOX4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.18950218180800527,-0.5995732490643675,0.9704251386321626,1.0,1.0,5/31,14.47%,UBE2Q2;UBE2L6;UBE2G2;UBE2Q1;UBE2G1
prerank,calcium-activated potassium channel activity (GO:0015269),0.2431736865231311,0.5968950558874778,0.9520697167755992,1.0,1.0,11/11,75.70%,KCNMA1;KCNN1;KCNU1;KCNN2;KCNMB3;KCNMB2;PKD2L1;KCNN4;KCNMB1;KCNMB4;KCNN3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.1782516084935164,-0.5966636765038185,0.9830508474576272,1.0,1.0,14/40,32.70%,PRMT8;CARNMT1;ICMT;LCMT1;MEPCE;NNMT;PEMT;METTL2B;METTL2A;METTL18;GNMT;PCMTD2;COMTD1;DPH5
prerank,peptidase inhibitor activity (GO:0030414),0.19332970914702674,0.5946909311220926,0.9630434782608696,1.0,1.0,2/33,2.53%,AHSG;RECK
prerank,mRNA methyltransferase activity (GO:0008174),-0.24379660828168626,-0.5944784865974291,0.9467889908256881,1.0,1.0,3/12,18.60%,TRMT10C;PCIF1;TRMT61B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.19812917168892824,-0.5882002327178768,0.9638783269961977,1.0,1.0,1/24,0.61%,ITPKB
prerank,mannose binding (GO:0005537),0.24648373616129832,0.5869620329012732,0.9301801801801802,1.0,1.0,1/12,4.55%,LMAN1L
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.256598910958461,-0.5829341992978745,0.9511278195488722,1.0,1.0,4/10,30.78%,GALM;RENBP;GALE;GNE
prerank,telomerase RNA binding (GO:0070034),-0.2013881829509071,-0.5768587358182172,0.9655172413793104,1.0,1.0,10/22,35.68%,SNRPD3;DKC1;SMG7;SNRPB;SMG6;TERT;HNRNPC;DCP2;WRAP53;NOP10
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.22792630106061318,-0.571557262457494,0.9588014981273408,1.0,1.0,3/13,21.70%,AGPAT1;AGPAT5;LPCAT2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.19047577212853165,0.5651002810109134,0.9764957264957265,1.0,1.0,11/27,26.20%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;TENT2;POLR2B;CRCP;POLR3K;MED21;POLR3F
prerank,3'-5' DNA helicase activity (GO:0043138),0.21451854467684986,0.5621222990545227,0.9568034557235421,1.0,1.0,6/16,23.13%,BLM;MCM2;FANCM;NAV2;FBH1;MCM7
prerank,muscle alpha-actinin binding (GO:0051371),0.2182151353540437,0.5568590591161998,0.9506172839506173,1.0,1.0,7/15,26.24%,PDLIM2;PDLIM5;LDB3;PRICKLE4;PALLD;PDLIM7;SYNPO2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.1458917534202033,-0.5534111005427961,1.0,1.0,1.0,9/75,18.03%,ABCC4;ME1;KDSR;IMPDH1;LDHA;ME2;SPR;CBR1;HSD17B10
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.23595050951335717,-0.5495832028746503,0.9708029197080292,1.0,1.0,2/10,15.59%,OTUD5;TNFAIP3
prerank,alpha-actinin binding (GO:0051393),0.19164270070190004,0.548539120611583,0.9674620390455532,1.0,1.0,6/24,18.81%,PDLIM2;MAGI1;PDLIM5;DAG1;LDB3;PPARG
prerank,receptor antagonist activity (GO:0048019),0.20453226633799104,0.5483125089824021,0.9502369668246445,1.0,1.0,1/17,3.34%,DKK3
prerank,chemokine receptor binding (GO:0042379),0.17341990719321787,0.5478997118082161,0.9801324503311258,1.0,1.0,6/35,18.41%,CXCL16;PPBP;CCL25;CXCL1;CKLF;CXCL12
prerank,ribonuclease activity (GO:0004540),-0.15273454040630788,-0.5472936752300925,0.9960629921259843,1.0,1.0,20/56,35.81%,CNOT7;N4BP1;PPP1R8;NOB1;DIS3L2;SAMHD1;RNASE12;EXOSC8;RNASEK;TSNAX;EXOSC9;ERN1;SMG6;ENDOG;RNASE7;RPP40;ZC3H12D;PIWIL4;RNASEH2A;ENDOU
prerank,DNA polymerase activity (GO:0034061),-0.1919776069818402,-0.5434863731892144,0.9801801801801802,1.0,1.0,10/22,34.22%,REV3L;POLQ;POLK;POLE3;POLL;CHRAC1;POLB;TERT;POLE;POLA1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.22994080862160823,0.5392839879641232,0.9445676274944568,1.0,1.0,1/10,4.94%,ECHDC2
prerank,lysine N-methyltransferase activity (GO:0016278),0.19456386355873595,0.5392125118890815,0.9786324786324786,1.0,1.0,3/20,11.56%,METTL21A;SETD7;EHMT2
prerank,adenylyltransferase activity (GO:0070566),-0.18662393276302153,-0.5338126558361682,0.984070796460177,1.0,1.0,8/21,32.96%,OAS2;PAPOLG;NMNAT3;SELENOO;FICD;NMNAT2;KARS1;ABL1
prerank,N-methyltransferase activity (GO:0008170),0.18787255223876945,0.5293431970100252,0.982532751091703,1.0,1.0,6/20,23.77%,HNMT;DIMT1;TFB1M;TRMT1L;METTL15;RNMT
prerank,neuropeptide receptor activity (GO:0008188),0.17319173003204907,0.5219750561061778,0.9939516129032258,1.0,1.0,29/29,82.71%,SORCS1;NPY5R;GRPR;GALR1;OPRM1;TACR3;SORCS3;TACR1;HCRTR2;GPR37;SSTR5;GALR3;GALR2;NPSR1;SSTR4;MCHR1;TACR2;GAL;NPFFR1;NTSR1;NMUR1;SSTR1;NPY2R;GPR143;SORCS2;SSTR2;KISS1R;NMUR2;NPY1R
prerank,tRNA methyltransferase activity (GO:0008175),-0.19119233554382553,-0.5134295779930521,0.9847619047619047,1.0,1.0,7/16,32.81%,TRMT9B;TRDMT1;TRMT44;TYW3;METTL2B;METTL2A;TRMT13
prerank,acyl-CoA hydrolase activity (GO:0047617),0.19115262951875162,0.5088267453758837,0.9804772234273319,1.0,1.0,2/17,7.30%,BAAT;ACOT11
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.2074205362572608,0.5067082916392509,0.9719222462203023,0.9985856210198465,1.0,3/11,21.06%,SLC25A42;SLC25A24;SLC19A1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.17894061636990177,0.5007558663457433,0.9842696629213483,0.996785233826883,1.0,7/21,21.10%,POLN;POLE4;POLI;POLD4;POLD1;POLD3;POLM
prerank,O-acyltransferase activity (GO:0008374),-0.15732648627731444,-0.4998293905097816,0.9980237154150198,1.0,1.0,6/30,21.70%,LPCAT3;MBOAT7;MBOAT1;PIGW;LCAT;LPCAT2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.2013238867561181,0.49901704153998794,0.9716157205240175,0.9939877296106941,1.0,3/12,21.06%,SLC25A42;SLC25A24;SLC19A1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.21550030990596733,-0.49299868606101627,0.9775086505190311,1.0,1.0,6/10,50.20%,NAA60;NAA50;NAA80;NAA11;NAA25;NAA10
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.20556842280088142,0.48060740647813843,0.9863013698630136,0.9942419549786574,1.0,2/10,17.91%,DPYSL3;DPYSL2
prerank,neuropeptide binding (GO:0042923),0.1724190740559702,0.4582442560434469,0.9936440677966102,0.99436469864128,1.0,1/18,5.02%,OPRK1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.18025293295395878,-0.45637881891764565,0.9870609981515711,1.0,1.0,9/14,51.03%,RPP38;RPP21;TSEN2;RPP40;RPP30;RPP25;ELAC2;TSEN34;POP5
prerank,ribonuclease P RNA binding (GO:0033204),-0.19128259389138952,-0.44854816190298935,0.9924812030075187,1.0,1.0,5/10,43.92%,RPP38;RPP21;RPP40;RPP30;RPP25
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.17469085430920844,-0.41158211384505616,0.9982456140350877,1.0,1.0,11/11,82.55%,NAA60;NAA50;NAA80;NAA11;NAA25;NAA10;NAA30;NAA16;NAA15;NAA40;NAA20
prerank,ribonuclease P activity (GO:0004526),-0.1424508718788262,-0.3432431193752317,0.99812382739212,0.9999048087880527,1.0,2/11,19.88%,RPP38;RPP21
